0001144204-12-002550.txt : 20120117 0001144204-12-002550.hdr.sgml : 20120116 20120117135300 ACCESSION NUMBER: 0001144204-12-002550 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20111130 FILED AS OF DATE: 20120117 DATE AS OF CHANGE: 20120117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEW ENERGY TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001071840 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 593509694 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-127953 FILM NUMBER: 12529170 BUSINESS ADDRESS: STREET 1: 9192 RED BRANCH RD STREET 2: SUITE 110 CITY: COLUMBIA STATE: MD ZIP: 21045 BUSINESS PHONE: 800-213-0689 MAIL ADDRESS: STREET 1: 9192 RED BRANCH RD STREET 2: SUITE 110 CITY: COLUMBIA STATE: MD ZIP: 21045 FORMER COMPANY: FORMER CONFORMED NAME: OCTILLION CORP DATE OF NAME CHANGE: 19981008 10-Q 1 v245254_10q.htm FORM 10-Q Unassociated Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

x
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For quarterly period ended November 30, 2011

¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission file number 333-127953

NEW ENERGY TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

Nevada
59-3509694
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)
   
9192 Red Branch Road, Suite 110
 
Columbia, Maryland
21045
(Address of principal executive offices)
(Zip Code)

(800) 213-0689
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes T   No ¨
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨   No ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
o  
Accelerated filer
¨
         
Non-accelerated filer (Do not check if a smaller reporting company)
o  
Smaller reporting company
x
 
Indicate by check mark whether the registrant is a shell company (as defined in 12b-2 of the Exchange Act.)  Yes ¨ No x
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 20,638,360 shares of common stock, par value $0.001, were outstanding on January 11, 2012.
 
 
 

 
 
NEW ENERGY TECHNOLOGIES, INC.
FORM 10-Q

For the Quarterly Period November 30, 2011

Table of Contents

PART I  FINANCIAL INFORMATION
 
   
Item 1.  Consolidated Financial Statements (Unaudited)
 
   
Consolidated Balance Sheets
1
   
Consolidated Statements of Operations
2
   
Consolidated Statements of Stockholders’ Equity (Deficit)
3
   
Consolidated Statements of Cash Flows
4
   
Notes to Consolidated Financial Statements
5
   
Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations
18
   
Item 4.  Controls and Procedures
23
   
PART II   OTHER INFORMATION
 
   
Item 1.  Legal Proceedings
24
   
Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds
24
   
Item 3.  Defaults Upon Senior Securities
24
   
Item 5.  Other Information
24
   
Item 6.  Exhibits
24
   
Signatures
27
   
Certifications
 
 
 
 

 

PART I — FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements (Unaudited)
 
NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED BALANCE SHEETS
NOVEMBER 30, 2011 AND AUGUST 31, 2011

   
November 30,
   
August 31,
 
   
2011
   
2011
 
             
ASSETS
           
             
Current assets
           
Cash and cash equivalents
  $ 1,700,110     $ 2,320,185  
Deferred research and development costs
    132,426       156,279  
Deferred offering costs
    20,000       20,000  
Prepaid expenses and other current assets
    19,252       49,382  
Total current assets
    1,871,788       2,545,846  
                 
Equipment, net of accumulated depreciation of $1,341 and $463 at November 30, 2011 and August 31, 2011
    20,348       927  
                 
Total assets
  $ 1,892,136     $ 2,546,773  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
                 
Current liabilities
               
Accounts payable
  $ 172,290     $ 119,868  
Accrued liabilities
    4,369       161,009  
Total current liabilities
    176,659       280,877  
                 
Total liabilities
    176,659       280,877  
                 
Commitments and contingencies
               
                 
Stockholders' equity
               
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding at November 30, 2011 or August 31, 2011
    -       -  
Common stock: $0.001 par value; 300,000,000 shares authorized, 20,638,360 shares issued and outstanding at November 30, 2011 and August 31, 2011
    20,638       20,638  
Additional paid-in capital
    12,667,616       12,593,184  
Deficit accumulated during the development stage
    (10,972,777 )     (10,347,926 )
Total stockholders' equity
    1,715,477       2,265,896  
                 
Total liabilities and stockholders' equity
  $ 1,892,136     $ 2,546,773  

(The accompanying notes are an integral part of these consolidated financial statements)

 
1

 
 
NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011 AND 2010 AND FOR THE
PERIOD FROM INCEPTION (MAY 5, 1998) TO NOVEMBER 30, 2011

               
Cumulative
 
   
Three Months Ended
   
May 5, 1998
 
   
November 30,
   
(Inception) to
 
   
2011
   
2010
   
November 30, 2011
 
                   
Revenue
  $ -     $ -     $ -  
                         
Operating expense
                       
Selling, general and administrative
    650,736       449,740       10,388,642  
Research and development
    130,192       57,122       2,047,888  
Total operating expense
    780,928       506,862       12,436,530  
                         
Loss from operations
    (780,928 )     (506,862 )     (12,436,530 )
                         
Other income (expense)
                       
Interest income
    -       -       98,582  
Interest expense
    -       (251 )     (12,393 )
Loss on disposal of fixed assets
    -       -       (5,307 )
Gain on dissolution of foreign subsidiary
    -       -       59,704  
Foreign exchange loss
    (32 )     (497 )     (86,405 )
Change in fair value of warrant liability
    -       (689,346 )     2,128,331  
Change in contingent liability
    156,109       -       186,109  
Total other income (expense)
    156,077       (690,094 )     2,368,621  
                         
Loss from continuing operations
    (624,851 )     (1,196,956 )     (10,067,909 )
                         
Loss from discontinued operations
    -       -       (162,097 )
                         
Net loss
  $ (624,851 )   $ (1,196,956 )   $ (10,230,006 )
                         
Net loss per common share - basic and diluted
  $ (0.03 )   $ (0.06 )        
                         
Weighted average number of common shares outstanding - basic and diluted
    20,638,360       19,692,018          

(The accompanying notes are an integral part of these consolidated financial statements)

 
2

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)
FROM MAY 5, 1998 (INCEPTION) TO NOVEMBER 30, 2011

                            
Deficit
             
                     
Accumulated
   
Accumulated
             
                     
Other
   
During the
             
   
Common Stock
   
Additional
   
Comprehensive
   
Development
   
Comprehensive
   
Total Stockholders'
 
   
Shares
   
Amount
   
Paid-in Capital
   
Income (Loss)
   
Stage
   
Income (Loss)
   
Equity (Deficit)
 
Restricted common stock issued to related parties for management services at $0.001 per share
    3,000,000     $ 3,000     $ -     $ -     $ -     $ -     $ 3,000  
Unrestricted common stock sales to third parties at $0.40 per share
    375,000       375       149,625       -       -       -       150,000  
Net loss for the year ended August 31, 1998
                                    (12,326 )     (12,326 )     (12,326 )
Balance, August 31, 1998
    3,375,000       3,375       149,625       -       (12,326 )     (12,326 )     140,674  
                                                         
Net loss for the year ended August 31, 1999
                                    (77,946 )     (77,946 )     (77,946 )
Balance, August 31, 1999
    3,375,000       3,375       149,625       -       (90,272 )     (77,946 )     62,728  
                                                         
Net loss for the year ended August 31, 2000
                                    (12,446 )     (12,446 )     (12,446 )
Balance, August 31, 2000
    3,375,000       3,375       149,625       -       (102,718 )     (12,446 )     50,282  
                                                         
Net loss for year ended August 31, 2001
                                    (12,904 )     (12,904 )     (12,904 )
Balance, August 31, 2001
    3,375,000       3,375       149,625       -       (115,622 )     (12,904 )     37,378  
                                                         
Net loss for the year ended August 31, 2002
                                    (54,935 )     (54,935 )     (54,935 )
Balance, August 31, 2002
    3,375,000       3,375       149,625       -       (170,557 )     (54,935 )     (17,557 )
                                                         
Restricted common stock issued at $.001 per share to two related parties to satisfy outstanding management fees.
    10,333,200       10,333       92,999       -       -       -       103,332  
Net loss for the year ended August 31, 2003
                                    (97,662 )     (97,662 )     (97,662 )
Balance, August 31, 2003
    13,708,200       13,708       242,624       -       (268,219 )     (97,662 )     (11,887 )
                                                         
Net loss for the year ended August 31, 2004
                                    (19,787 )     (19,787 )     (19,787 )
Balance, August 31, 2004
    13,708,200       13,708       242,624       -       (288,006 )     (19,787 )     (31,674 )
                                                         
Net loss for the year ended August 31, 2005
                                    (103,142 )     (103,142 )     (103,142 )
Balance, August 31, 2005
    13,708,200       13,708       242,624       -       (391,148 )     (103,142 )     (134,816 )
                                                         
Issuance of common stock and warrants at $0.50 per share
    1,000,000       1,000       499,000       -       -       -       500,000  
Net loss for the year ended August 31, 2006
                                    (157,982 )     (157,982 )     (157,982 )
Balance, August 31, 2006
    14,708,200       14,708       741,624       -       (549,130 )     (157,982 )     207,202  
                                                         
Exercise of Class A Warrants  at $0.50 per share
    1,000,000       1,000       499,000       -       -       -       500,000  
Exercise of Class B Warrants  at $0.55 per share
    1,000,000       1,000       549,000       -       -       -       550,000  
Exercise of Class C Warrants  at $1.50 per share
    326,667       327       489,673       -       -       -       490,000  
Exercise of Class D Warrants  at $1.65 per share
    293,333       293       483,707       -       -       -       484,000  
Exercise of Class E Warrants  at $1.80 per share
    293,333       293       527,707       -       -       -       528,000  
Issuance of common stock and warrants at $1.50 per share
    333,333       333       499,667       -       -       -       500,000  
Dividend paid - spin off of MircoChannel Technologies Corporation
    -       -       -       -       (400,000 )     -       (400,000 )
Comprehensive income (loss)
                                                       
Foreign currency translation adjustments
                            (1,811 )     -       (1,811 )     (1,811 )
Net loss for the year ended August 31, 2007
                                    (1,442,769 )     (1,442,769 )     (1,442,769 )
Balance, August 31, 2007
    17,954,866       17,955       3,790,377       (1,811 )     (2,391,899 )     (1,444,580 )     1,414,622  
                                                         
Common stock and warrants issued for cash and services at $3.00 per Unit
    1,225,000       1,225       3,394,730       -       -       -       3,395,955  
Exercise of Class C Warrants  at $1.50 per share
    6,667       7       9,993       -       -       -       10,000  
Exercise of Class D Warrants  at $1.65 per share
    6,667       7       10,993       -       -       -       11,000  
Exercise of Class F Warrants  at $3.75 per share
    58,333       58       218,692       -       -       -       218,750  
Stock based compensation
    -       -       3,600,303       -       -       -       3,600,303  
Comprehensive income (loss)
                                                       
Foreign currency translation adjustments
                            12,504       -       12,504       12,504  
Net loss for the year ended August 31, 2008
                                    (5,721,545 )     (5,721,545 )     (5,721,545 )
Balance, August 31, 2008
    19,251,533       19,251       11,025,089       10,693       (8,113,444 )     (5,709,041 )     2,941,589  
                                                         
Exercise of Class E Warrants  at $1.80 per share
    6,667       7       11,993       -       -       -       12,000  
Exercise of Class F Warrants  at $3.75 per share
    275,333       275       1,032,225       -       -       -       1,032,500  
Stock based compensation
    -       -       183,312       -       -       -       183,312  
Reversal of stock based compensation due to forfeiture of stock options
    -       -       (3,591,093 )     -       -       -       (3,591,093 )
Comprehensive income
                                                       
Foreign currency translation adjustments
                            (10,693 )     -       (10,693 )     (10,693 )
Net loss for the year ended August 31, 2009
                                    1,961,175       1,961,175       1,961,175  
Balance, August 31, 2009
    19,533,533       19,533       8,661,526       -       (6,152,269 )     1,950,482       2,528,790  
                                                         
Stock based compensation
    -       -       661,040       -       -       -       661,040  
Reversal of stock based compensation due to forfeiture of stock options
    -       -       (478,971 )     -       -       -       (478,971 )
Cumulative adjustment upon adoption of ASC 815-40
    -       -       (1,785,560 )     -       (342,771 )     -       (2,128,331 )
Net loss for the year ended August 31, 2010
                                    (233,136 )     (233,136 )     (233,136 )
Balance, August 31, 2010
    19,533,533       19,533       7,058,035       -       (6,728,176 )     (233,136 )     349,392  
                                                         
Rounding due to reverse one for three stock split effective March 16, 2011
    (3 )     -       -       -       -       -       -  
Exercise of Class F Warrants at $3.75 per share
    1,054,512       1,055       3,953,320       -       -       -       3,954,375  
Exercise of stock options
    50,318       50       30,750       -       -       -       30,800  
Stock based compensation
    -       -       2,855,630       -       -       -       2,855,630  
Reversal of stock based compensation due to forfeiture of stock options
    -       -       (1,304,551 )     -       -       -       (1,304,551 )
Net loss for the year ended August 31, 2011
                                    (3,619,750 )     (3,619,750 )     (3,619,750 )
Balance, August 31, 2011
    20,638,360     $ 20,638     $ 12,593,184     $ -     $ (10,347,926 )     (3,619,750 )   $ 2,265,896  
                                                         
Stock based compensation
    -       -       82,675       -       -       -       82,675  
Reversal of stock based compensation due to forfeiture of stock options
    -       -       (8,243 )     -       -       -       (8,243 )
Net loss for the three months ended November 30, 2011
                                    (624,851 )     (624,851 )     (624,851 )
Balance, November 30, 2011
    20,638,360     $ 20,638     $ 12,667,616     $ -     $ (10,972,777 )   $ (624,851 )   $ 1,715,477  

(The accompanying notes are an integral part of these consolidated financial statements)

 
3

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011 AND 2010 AND FOR THE
PERIOD FROM INCEPTION (MAY 5, 1998) TO NOVEMBER 30, 2011

               
Cumulative
 
   
Three Months Ended
   
May 5, 1998
 
   
November 30,
   
(Inception) to
 
   
2011
   
2010
   
November 30, 2011
 
Cash flows from operating activities
                 
Loss from continuing operations
    (624,851 )   $ (1,196,956 )   $ (10,067,909 )
Add: loss from discontinued operations
    -       -       (162,097 )
Adjustments to reconcile net loss to net cash used in operating activities
                       
Depreciation
    878       116       5,823  
Stock based compensation expense
    82,675       247,153       7,382,960  
Reversal of stock based compensation expense due to forfeiture of stock options
    (8,243 )     -       (5,382,858 )
Change in fair value of warrant liability
    -       689,346       (2,128,331 )
Loss on disposal of fixed assets
    -       -       5,307  
Payable written off
    -       -       (30,000 )
Common stock issued for services
    -       -       3,000  
Common stock issued for debt settlement
    -       -       103,332  
Changes in operating assets and liabilities:
                       
Decrease (increase) in deferred research and development costs
    23,853       (42,074 )     (132,426 )
Decrease (increase) in prepaid expenses and other current assets
    30,130       1,262       (39,252 )
Increase (decrease) in accounts payable
    52,422       (27,911 )     202,290  
Increase (decrease) in accrued liabilities
    (156,640 )     23,201       4,369  
                         
Net cash used in operating activities
    (599,776 )     (305,863 )     (10,235,792 )
                         
Cash flows from investing activity
                       
Purchase of fixed assets
    (20,299 )     (1,390 )     (31,478 )
Net cash used in investing activity
    (20,299 )     (1,390 )     (31,478 )
                         
Cash flows from financing activities
                       
Proceeds from the issuance of common stock, exercise of warrants and stock options, net
    -       2,474,730       12,367,380  
Repayment of promissory note
    -       -       (155,000 )
Proceeds from promissory notes
    -       -       155,000  
Dividend paid
    -       -       (400,000 )
Net cash provided by financing activities
    -       2,474,730       11,967,380  
                         
Increase (decrease) in cash and cash equivalents
    (620,075 )     2,167,477       1,700,110  
                         
Cash and cash equivalents at beginning of period
    2,320,185       502,528       -  
                         
Cash and cash equivalents at end of period
  $ 1,700,110     $ 2,670,005     $ 1,700,110  
                         
Supplemental disclosure of cash flow information:
                       
Interest paid in cash
  $ -     $ 251     $ 12,393  
Income taxes paid in cash
  $ -     $ -     $ -  
                         
Supplemental disclosure of non-cash transactions:
                       
Accrued management fees converted to equity
  $ -     $ -     $ 103,332  
Warrants issued for broker commissions
  $ -     $ -     $ 642,980  

(The accompanying notes are an integral part of these consolidated financial statements)

 
4

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011

NOTE 1 - Organization and Summary of Significant Accounting Policies

Basis of Presentation

The unaudited financial statements of New Energy Technologies, Inc. as of November 30, 2011, and for the three months ended November 30, 2011 and 2010, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial reporting. Accordingly, they do not include all of the disclosures required by accounting principles generally accepted in the United States for complete financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended August 31, 2011, as filed with the Securities and Exchange Commission as part of the Company's Form 10-K. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the interim financial information have been included. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year.

Organization

New Energy Technologies, Inc. (the “Company”) was incorporated in the State of Nevada on May 5, 1998, under the name “Octillion Corp.” On December 2, 2008, the Company amended its Articles of Incorporation to effect a change of name to New Energy Technologies, Inc. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Sungen Energy, Inc. (“Sungen”), Kinetic Energy Corporation (“KEC”), New Energy Solar Corporation (“New Energy Solar”) and Nakoda Energy, Inc. (“Nakoda”).

Sungen was incorporated on July 11, 2006, in the State of Nevada and is currently inactive.

KEC was incorporated on June 19, 2008, in the State of Nevada and holds the patents related to the Company’s MotionPower™ technology. The Company’s business activities related to the MotionPower™ technology are conducted through KEC.

New Energy Solar was incorporated on February 9, 2009, in the State of Florida and has entered into a License Agreement, an Addendum to the License Agreement, an Option Agreement and a Sponsored Research Agreement with the University of South Florida Research Foundation, Inc.

On March 16, 2011, pursuant to a February 7, 2011, written consent signed by the shareholders owning a majority of the Company’s issued and outstanding shares and a February 24, 2011, unanimous written consent of the Company’s Board of Directors (the “Board”) (collectively the “Consents”), the Company underwent a one-for-three reverse stock split whereby holders of three shares of the Company’s common stock as of March 15, 2011, received one share of its common stock after the reverse stock split, with all fractional shares being rounded up to the nearest whole share.

All share and per share amounts have been retrospectively restated to reflect the one-for-three reverse stock split effected March 16, 2011 and declared effective by the Financial Industry Regulatory Authority (“FINRA”) as of March 21, 2011.

On March 16, 2011, pursuant to the Consents, the Company filed a Certificate of Amendment to its Certificate of Incorporation increasing its authorized shares of common stock, $0.001 par value, from 100,000,000 to 300,000,000.

On August 19, 2011, the Company established Nakoda, a California corporation and wholly-owned subsidiary of the Company, which began operations in September 2011. Nakoda is an energy savings and management corporation that provides a broad range of energy solutions and savings projects with the goal of implementing energy conservation, load management, and reducing building energy consumption in target markets. During December 2011, management initiated a review of the costs associated with start-up operations, financing, and allocation of resources, and suspended all operations associated with Nakoda pending further review.

The Company is a renewable and alternative energy company, actively developing two novel technologies for generating sustainable electricity, one of which harvests solar energy of the sun and artificial light, and the other harvests the available kinetic energy present in moving vehicles. The Company’s proprietary, patent-pending technologies and products, which are the subjects of 43 patent-filings, have been invented, designed, engineered, and prototyped in preparation for further field testing, product development, and commercial deployment.

 
5

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011

NOTE 1 - Organization and Summary of Significant Accounting Policies (Continued)

Organization (Continued)

The Company’s SolarWindow™ technology generates electricity when glass surfaces are sprayed with electricity-generating coatings, creating, semi-transparent, see-through solar cells. If successfully developed, SolarWindow™ could potentially be used on any of the more than 85 million commercial and residential buildings in the United States alone (U.S. Census Bureau, 2007 American Housing Survey & U.S. Energy Information Administration, 2003 Commercial Buildings Energy Consumption Survey).

The Company’s MotionPower™ technology harvests the available kinetic or motion energy of cars, trucks, buses, and heavy commercial vehicles when they slow down before coming to a stop. MotionPower™ converts this captured energy into electricity. If successfully developed, MotionPower™ could potentially be used to harvest kinetic energy generated by any of the estimated 250 million vehicles registered in America (U.S. Department of Transportation Federal Highway Administration, 2008 Highway Statistics), which drive approximately six billion miles on our nation’s roadways every day (U.S. Environmental Protection Agency).

The Company’s product development programs involve ongoing research and development efforts, and the commitment of significant resources to support the extensive invention, design, engineering, testing, prototyping, and intellectual property initiatives carried-out by its contract engineers, scientists, and consultants.

Going Concern

The Company is a development stage company, does not have any commercialized products and has not generated any revenue since inception. The Company has an accumulated deficit of $10,972,777 as of November 30, 2011, and does not have positive cash flows from operating activities. The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates continuation of the Company as a going concern, which is dependent upon the Company’s ability to establish itself as a profitable business.

In its report with respect to the Company’s financial statements for the year ended August 31, 2011, the Company’s independent auditors expressed substantial doubt about the Company’s ability to continue as a going concern. Because the Company has not yet generated revenues from its operations and does not expect to do so in the near future, its ability to continue as a going concern is wholly dependent upon its ability to obtain additional financing. Currently, the Company is seeking additional financing but has no commitments to obtain any such financing, and there can be no assurance that financing will be available in amounts or on terms acceptable to the Company, if at all.

As of November 30, 2011, the Company had cash and cash equivalents of $1,700,110. The Company will remain engaged in research and product development activities at least through November 30, 2012. Based upon its current and near term anticipated level of operations and expenditures, the Company believes that, absent any modification or expansion of its existing research, development and testing activities, cash on hand should be sufficient to enable it to continue operations through August 31, 2012. However, any significant expansion in scope or acceleration in timing of the Company’s current research and development activities, or commencement of any marketing and sales activities, will require additional funds.

If adequate funds are not available on reasonable terms or at all, it would result in a material adverse effect on the Company’s business, operating results, financial condition and prospects. In particular, the Company may be required to delay, reduce the scope of or terminate one or more of its research programs, sell rights to its SolarWindow™ technology and/or MotionPowerTM technology or other technologies or products based upon such technologies, or license the rights to such technologies or products on terms that are less favorable to the Company than might otherwise be available.

In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon achieving a profitable level of operations and on the ability of the Company to obtain necessary financing to fund ongoing operations. These consolidated financial statements do not give effect to any adjustments which will be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying consolidated financial statements.

 
6

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011

NOTE 1 - Organization and Summary of Significant Accounting Policies (Continued)

Summary of Significant Accounting Policies

Principles of Consolidation
 
These consolidated financial statements presented are those of the Company and its wholly-owned subsidiaries, Sungen, KEC, New Energy Solar and Nakoda. All significant intercompany balances and transactions have been eliminated.

Estimates
 
The preparation of the Company’s consolidated financial statements requires management to make estimates and use assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. On an on-going basis, the Company evaluates its estimates. Actual results and outcomes may differ materially from these estimates and assumptions.

Cash and Cash Equivalents
 
Cash and cash equivalents includes highly liquid investments with original maturities of three months or less. On occasion, the Company has amounts deposited with financial institutions in excess of federally insured limits.

Reclassifications
 
Certain reclassifications have been made to prior fiscal year amounts or balances to conform to the presentation adopted in the current fiscal year.

Fair Value Measurement
 
The Company measures fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The Company utilizes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

Level 1. Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. The Company has no assets or liabilities valued with Level 1 inputs.

Level 2. Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. The Company has no assets or liabilities valued with Level 2 inputs.

Level 3. Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company has no assets or liabilities valued with Level 3 inputs.

Fair Value of Financial Instruments
 
The carrying value of cash and cash equivalents, accounts payable, and accrued liabilities approximate their fair value because of the short-term nature of these instruments and their liquidity. Management is of the opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments.

Research and Development
 
Research and development costs represent costs incurred to develop the Company’s technology, including salaries and benefits for research and development personnel, allocated overhead and facility occupancy costs, supplies, equipment purchase and repair and other costs. Research and development costs are expensed when incurred, except for nonrefundable advance payments for future research and development activities which are capitalized and recognized as expense as the related services are performed.

During the three months ended November 30, 2011 and 2010, the Company incurred $130,192 and $57,122 on research and development activities. From inception (May 5, 1998) to November 30, 2011, the Company incurred $2,047,888 on research and development activities.

 
7

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011
 
NOTE 1 - Organization and Summary of Significant Accounting Policies (Continued)

Summary of Significant Accounting Policies (Continued)

Stock-Based Compensation
 
The Company measures all employee stock-based compensation awards using a fair value method on the date of grant and recognizes such expense in its consolidated financial statements over the requisite service period. The Company uses the Black-Scholes pricing model to determine the fair value of stock-based compensation awards on the date of grant. The Black-Scholes pricing model requires management to make assumptions regarding the warrant and option lives, expected volatility, and risk free interest rates. See “Note 5 - Capital Stock” and “Note 6 - Stock Options” for additional information on the Company’s stock-based compensation plans.

Income Taxes
 
The Company accounts for income taxes using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credits and loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carry-forwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized. The Company reports a liability for unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return. Estimated interest and penalties are recorded as a component of interest expense or other expense, respectively.

Segment Reporting
 
The Company’s business is considered as operating in one segment based upon the Company’s organizational structure, the way in which the operations are managed and evaluated, the availability of separate financial results and materiality considerations.

Net Income (Loss) Per Share
 
Pursuant to ASC 260-10-45-10, the computation of basic earnings per share (“EPS”) is based on the weighted average number of shares that were outstanding during the period, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted EPS is based on the number of basic weighted-average shares outstanding plus the number of common shares that would be issued assuming the exercise of all potentially dilutive common shares outstanding using the treasury stock method. However, pursuant to ASC 260-10-45-17, the computation of diluted net income per share shall not assume conversion, exercise or contingent issuance of securities that would have an antidilutive effect on earnings per share. Therefore, when calculating EPS if the Company experienced a loss, there is no inclusion of dilutive securities as their inclusion in the EPS calculation is antidilutive. Furthermore, pursuant to ASC 260-10-45-25, options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants (they are in the money). See “Note 2 - Net Loss Per Share” for further discussion.

All share and per share amounts reflect the 1-for-3 reverse stock split declared effective on March 21, 2011 by FINRA.

Recently Adopted Accounting Pronouncements

The Company reviews new accounting standards as issued. Although some of these accounting standards issued or effective after the end of the Company’s previous fiscal year may be applicable to the Company, it has not identified any standards that it believes merit further discussion. The Company believes that none of the new standards will have a significant impact on its consolidated financial statements.

 
8

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011

NOTE 2 - Net Loss Per Share

Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. The Company has not included the effects of stock options on net loss per share for the past two fiscal years because to do so would be antidilutive. The Company has excluded from the computation of diluted net loss per share stock options to acquire 950,005 and 766,667 shares of common stock as of November 30, 2011 and 2010, respectively.

Following is the computation of basic and diluted net loss per share for the three months ended November 30, 2011 and 2010:

   
Three Months Ended
 
   
November 30,
 
   
2011
   
2010
 
Basic and Diluted EPS Computation
           
Numerator:
           
Loss available to common stockholders'
  $ (624,851 )   $ (1,196,956 )
                 
Denominator:
               
Weighted average number of common shares outstanding
    20,638,360       19,692,018  
                 
Basic and diluted EPS
  $ (0.03 )   $ (0.06 )
 
NOTE 3 - SolarWindow™ Technology

Stevenson-Wydler Cooperative Research and Development Agreement with the Alliance for Sustainable Energy

On March 18, 2011, in the Company’s efforts to advance the commercial development of its SolarWindow™ technology, it entered into a Stevenson-Wydler Cooperative Research and Development Agreement (the “CRADA”) with the Alliance for Sustainable Energy, LLC, which is the operator of The National Renewable Energy Laboratory (“NREL”) under its U.S. Department of Energy contract. Under terms of the CRADA, NREL researchers will make use of the Company’s exclusive intellectual property and NREL’s background intellectual property in order to work towards specific product development goals.

Pursuant to SEC Rule 24b-2, the Company submitted a request to the SEC for confidential treatment of certain portions of the CRADA, which has been granted. Accordingly, certain terms of the CRADA have not been disclosed. The disclosure of such confidential information may potentially harm the Company’s competitive position and jeopardize its ability to effectively negotiate future development and sublicensing agreements on preferential terms; and, ongoing relationship with NREL and its ability to negotiate favorable terms with NREL in regards to the ongoing development of the Company’s technologies.

Pursuant to the CRADA, during the three months ended November 30, 2011 and 2010, the Company recorded $33,668 and $0, respectively, as research and development expense. From inception (May 5, 1998) to November 30, 2011, the Company recorded $159,576 as research and development expense.

 
9

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011

NOTE 3 - SolarWindow™ Technology (Continued)

University of South Florida Research Foundation, Inc. License Agreement, Option Agreement and Sponsored Research Agreement

Through New Energy Solar the Company is a party to a License Agreement, an Addendum to the License Agreement, an Option Agreement and a Sponsored Research Agreement with the University of South Florida Research Foundation, Inc. These agreements provide for the Company’s support of a project relating to the development of the SolarWindow™ technology and grant it an exclusive worldwide commercial license under certain patents relating to the SolarWindow™ technology. Pursuant to SEC Rule 24b-2, the Company has submitted requests to the SEC for confidential treatment of certain portions of these agreements, which have been granted. Accordingly, certain terms of these agreements have not been disclosed.

On July 5, 2011, the Company entered into a letter agreement pursuant to which the Company agreed to reimburse the University of South Florida (“USF”) for filing fees associated with USF’s Provisional Patent and future PCT Applications (the “Applications”) for certain identified technologies (the “Letter Agreement”). Pursuant to the terms of the Letter Agreement, the Company committed to reimburse USF for all documented, out-of-pocket costs directly related to the filing and maintenance of the Applications. In return, USF granted the Company the exclusive right to negotiate a definitive option or license agreement with USF for the technologies underlying the Applications for a period of time after USF files a Provisional Patent for an identified technology (the “Negotiation Period”). Should the Negotiation Period expire without the Company and USF entering into an agreement, the Company could extend the Negotiation Period for an additional period of time by paying USF a one-time payment of a specified sum. If after this additional time the Company and USF fail to enter into an agreement, USF is free to enter into negotiations and license the underlying technologies to a third-party.

During the three months ended November 30, 2011 and 2010, the Company recorded $17,853 and $20,167, respectively, as research and development expense pursuant to these agreements. From inception (May 5, 1998) to November 30, 2011, the Company recorded $308,723 as research and development expense pursuant to these agreements.

University of Illinois at Urbana-Champaign Sponsored Research Agreement

Through Sungen the Company was a party to a Sponsored Research Agreement with the University of Illinois at Urbana-Champaign (“UIUC”) that provided for the Company’s support of the development of a new technology to integrate films of silicon nanoparticle material on glass substrates. This agreement expired on August 22, 2008. As of such date, the Company had advanced a total of $266,709 to UIUC pursuant to the terms of the agreement. Pursuant to the terms of the agreement, the Company was to advance an additional $156,109 to UIUC, which is included in other accrued liabilities at August 31, 2011. The Company had not made the advance as the advance was contingent on the determination as to whether funds previously paid to UIUC under the terms of the agreement had been fully expended. The Company was of the opinion that to the extent these funds were not expended, they are refundable to the Company.

During the three months ended November 30, 2011, The Company evaluated the status of the aforementioned agreement and related contingent liability to UIUC. The Company determined that the $156,109 liability is no longer valid and has been eliminated to other income.

The Company has not recorded any research and development expense pursuant to this agreement since its fiscal year ending August 31, 2008. During the period from inception (May 5, 1998) to August 31, 2011, the Company recorded $422,818 as research and development expense pursuant to this agreement and a $156,109 credit to other income during the three months ended November 30, 2011.

NOTE 4 - MotionPower™ Technology

Veryst Agreement
 
Through KEC the Company is a party to certain agreements with Veryst Engineering LLC, a Boston area engineering and consulting firm with experience in product development and energy harvesting; one dated November 4, 2008, two dated September 9, 2009 and one dated July 6, 2010 (collectively, the “Veryst Agreements”), all relating to the development of the Company’s MotionPowerTM technologies. Pursuant to SEC Rule 24b-2, the Company submitted a request to the SEC for confidential treatment of certain portions of the November 4, 2008 agreement, relating to the payment terms, scope of work and the milestone terms of the agreement, which has been granted. Accordingly, certain terms and provisions of the November 4, 2008, agreement have not been disclosed.

 
10

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011

NOTE 4 - MotionPower™ Technology (Continued)

Veryst Agreement (Continued)
 
During the three months ended November 30, 2011 and 2010, the Company recorded $2,564 and $10,533, respectively, as research and development expense pursuant to these agreements. From inception (May 5, 1998) to November 30, 2011, the Company recorded $560,880 as research and development expense pursuant to these agreements.

Veryst Engineering LLC has successfully completed its contracted services associated with the Veryst Agreements.

Sigma Design Agreement
 
Through KEC the Company continues to be a party to certain consulting agreements with Sigma Design Company, a Middlesex, New Jersey based engineering and design firm, pursuant to which Sigma Design provides ongoing engineering, product development and testing services primarily relating to the development of the Company’s MotionPower™ technology.

During the three months ended November 30, 2011 and 2010, the Company recorded $74,137 and $26,422, respectively, as research and development expense pursuant to these agreements. From inception (May 5, 1998) to November 30, 2011, the Company recorded $487,831, respectively, as research and development expense pursuant to these agreements. The Company continues to utilize Sigma Design Company on a consulting basis to further test, calibrate, and develop the Company’s MotionPower™ technology.

NOTE 5 - Capital Stock

Preferred Stock
 
At November 30, 2011, there were 1,000,000 shares of preferred stock (par value $0.10 per share) authorized, of which no shares were issued and outstanding. The Board has the authority to issue such stock in one or more series, to fix the number of shares and to fix and determine the relative rights and preferences of the shares of any such series so established to the full extent permitted by the laws of the State of Nevada and the Articles of Incorporation.

Reverse Stock Split
 
On March 16, 2011, pursuant to a February 7, 2011, written consent signed by the shareholders owning a majority of the Company’s issued and outstanding shares and a February 24, 2011, unanimous written consent of the Company’s Board, the Company underwent a one-for-three reverse stock split whereby holders of three shares of the Company’s common stock as of March 15, 2011, received one share of its common stock after the reverse stock split, with all fractional shares being rounded up to the nearest whole share.

All share and per share amounts have been retrospectively restated to reflect the one-for-three reverse stock split effected March 16, 2011. FINRA declared the reverse stock split effective as of March 21, 2011.

Common Stock
 
On February 12, 2008, the Company consummated the sale of an aggregate of 1,225,000 shares of its common stock and Class F Callable Warrants to purchase up to an additional 1,225,000 shares of the Company’s common stock for aggregate gross proceeds of $3,675,000 pursuant to the terms of a Securities Purchase Agreement dated February 8, 2008 with certain institutional and other accredited investors. The Class F Callable Warrants were exercisable for a period of three years from the date of issuance at an initial exercise price of $3.75 per share.

On September 1, 2009, the Company adopted guidance which is now part of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 815-40, Contracts in Entity’s Own Equity. The Company determined that its Class F Callable Warrants contained a dilutive issuance provision. As a result, the Company reclassified 1,062,833 of its Class F Callable Warrants to long-term warrant liability. The Company’s Class F Callable Warrants were considered derivative financial liabilities and were therefore required to be adjusted to fair value each quarter. During the three months ended November 30, 2010, the warrants were adjusted to their fair value resulting in a $689,346 loss recorded as Other Expense. During the year ended August 31, 2011, investors exercised 1,054,512 Class F Callable Warrants for aggregate gross proceeds of $3,954,375. On February 12, 2011, all unexercised Class F Callable Warrants expired resulting in the adjustment to their fair value to $0.

 
11

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011

NOTE 6 - Stock Options

On October 10, 2006, the Board adopted and approved the 2006 Incentive Stock Option Plan (the “2006 Stock Plan”) that provides for the grant of stock options to employees, directors, officers and consultants. The 2006 Stock Plan provides for the granting of stock options to purchase a maximum of 5,000,000 shares of the Company’s common stock. Stock options granted to employees under the Company’s 2006 Stock Plan generally vest over two to five years or as otherwise determined by the plan administrator. Stock options to purchase shares of the Company’s common stock expire no later than ten years after the date of grant.

The per share exercise price for each stock option is determined by the Board and may not be below the underlying stock price on the date of grant as listed on the OTC Markets Group, Inc. QB tier (the “OTCQB”), or, if the Company’s common stock is not traded on the date of grant, the first day of active trading following the date of grant.

The Company measures all stock-based compensation awards using a fair value method on the date of grant and recognizes such expense in its consolidated financial statements over the requisite service period. The grant date fair value of stock options is calculated using the Black-Scholes option pricing model which requires management to make assumptions regarding option time to expiration, expected volatility, and risk-free interest rates, all of which impact the fair value of the option and, ultimately, the expense that will be recognized over the life of the option.

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for a bond with a similar term. The Company does not anticipate declaring dividends in the foreseeable future. Volatility is calculated based on the historical weekly closing stock prices for the same period as the expected life of the option. The Company uses the “simplified” method for determining the expected term of its “plain vanilla” stock options. The Company recognizes compensation expense for only the portion of stock options that are expected to vest. Therefore, the Company applies an estimated forfeiture rate that is derived from historical employee termination data and adjusted for expected future employee turnover rates. If the actual number of forfeitures differs from those estimated by the Company, additional adjustments to compensation expense may be required in future periods.

A summary of the Company’s stock option activity for the three months ended November 30, 2011 and the year ended August 31, 2011, and related information follows:

   
Number of
Options
   
Weighted
Average
Exercise
Price ($)
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value ($)
 
                     
Outstanding at August 31, 2010
    900,003       1.71          
Grants
    610,002       5.97          
Exercises
    (73,334 )     1.61          
Forfeitures
    (476,666 )     5.59          
Outstanding at August 31, 2011
    960,005       2.49          
Forfeitures
    (10,000 )     3.27          
Outstanding at November 30, 2011
    950,005       2.48  
8.38 years
    7,000  
                           
Exercisable at November 30, 2011
    223,668       4.16  
7.76 years
    4,900  
                           
Available for grant at November 30, 2011
    3,976,661                    

The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of its first quarter of fiscal 2012 and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all option holders exercised their options on November 30, 2011. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock.

 
12

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011
 
NOTE 6 - Stock Options (Continued)

The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Statements of Operations for the three months ended November 30, 2011 and 2010, and from May 5, 1998 (inception) to November 30, 2011:

               
Cumulative
 
   
Three Months Ended
   
May 5, 1998
 
   
November 30,
   
(Inception) to
 
      2,011       2,010    
November 30, 2011
 
Stock Compensation Expense:
                     
Selling general and administrative expense
  $ 74,432     $ 247,153     $ 2,000,102  

As of November 30, 2011, the Company had $291,188 of total unrecognized compensation cost related to unvested stock options which is expected to be recognized over a period of 3.75 years.

Stock Option Activity During the Three Months Ended November 30, 2011
 
On December 8, 2011, Mr. Pitcher resigned from the Board. Mr. Pitcher had vested 6,667 stock options and forfeited 10,000 unvested stock options. During the year ended August 31, 2011, the Company recorded stock compensation of $27,784 for the amortization of the fair value of his stock option. Since the stock option was forfeited prior to 10,000 options vesting, $8,243 previously recognized for stock compensation was reversed on November 30, 2011, resulting in total stock compensation expense related to Mr. Pitcher’s stock option grant of $19,541. Mr. Pitcher has until December 8, 2013, to exercise his 6,667 vested stock options.

Stock Option Activity During the Year Ended August 31, 2011
 
On April 5, 2011, the Company granted a stock option to purchase up to 10,000 shares of the Company’s common stock at an exercise price of $2.50 per share, the fair market value of the Company’s common stock on the date of grant, to an employee as partial compensation for services. The stock options expire ten years from the date of grant, on April 5, 2021 and vests as follows: (a) 2,000 shares on December 1, 2011, and (b) 2,000 shares on each of April 1 of 2012, 2013, 2014, and 2015. The stock option is further subject to the terms and conditions of a stock option agreement between the Company and the employee. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that employee ceases to be one of the Company’s employee. Upon termination of such service, the employee will have a specified period of time to exercise vested stock options, if any. The grant date fair value of the stock option granted was $23,536, estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 133.0%, risk-free rate of 2.9%, and a term of 7.67 years. During the three months ended November 30, 2011, the Company recognized $4,217 of expense related to this issuance.

On March 21, 2011, the Board appointed Mr. Todd Pitcher and Mr. Peter Fusaro as directors and granted them each a stock option to purchase 16,667 shares of the Company’s common stock at an exercise price of $3.27 per share, the fair market value of the Company’s common stock on the date of grant. The stock options expire ten years from the date of grant, on March 21, 2021 and vests as follows: (a) 6,667 shares on March 21, 2011; (b) 5,000 shares on March 21, 2012; and (c) 5,000 shares on March 21, 2013. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and each of Mr. Pitcher and Mr. Fusaro. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that either Mr. Pitcher or Mr. Fusaro ceases to be one of the Company’s directors. Upon termination of such service, Mr. Pitcher or Mr. Fusaro will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each of the stock options granted to Mr. Pitcher and Mr. Fusaro was $48,850, estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 133.3%, risk-free rate of 2.0%, and a term of 5.75 years. On December 8, 2011, Mr. Pitcher resigned from the Board. Mr. Pitcher had vested 6,667 stock options and forfeited 10,000 unvested stock options. During the year ended August 31, 2011, the Company recorded stock compensation of $27,784 for the amortization of the fair value of his stock option. Since the stock option was forfeited prior to 10,000 options vesting, $8,243 previously recognized for stock compensation was reversed on November 30, 2011 resulting in total stock compensation expense related to Mr. Pitcher’s stock option grant of $19,541. During the three months ended November 30, 2011, the Company recognized $5,496 of expense related to Mr. Fusaro's option grant and $8,243 of other income related to Mr. Pitchers unvested options described above.
 
 
13

 
 
NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011
 
NOTE 6 - Stock Options (Continued)

On January 17, 2011, the Board appointed Mr. Javier Jimenez as a director and granted him a stock option to purchase 16,667 shares of the Company’s common stock at an exercise price of $6.51 per share, the fair market value of the Company’s common stock on the date the stock option agreement was executed by Mr. Jimenez, January 19, 2011. The stock option expires ten years from the date of grant, on January 19, 2021 and vests as follows: (a) 6,667 shares on January 19, 2011; (b) 5,000 shares on January 19, 2012; and (c) 5,000 shares on January 19, 2013. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and Mr. Jimenez. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that Mr. Jimenez ceases to be one of the Company’s directors. Upon termination of such service, Mr. Jimenez will have a specified period of time to exercise vested stock options, if any. The grant date fair value of the stock option granted to Mr. Jimenez was $97,250 estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 133.4%, risk-free rate of 2.0%, and a term of 5.75 years. During the three months ended November 30, 2011, the Company recognized $10,941 of expense related to this issuance.

On December 23, 2010, the Board approved, and the Company granted, a stock option to each of the Company’s three non-employee directors to purchase 16,667 shares of its common stock at an exercise price of $5.94 per share, the fair market value of the Company’s common stock on the date of grant. Each stock option expires ten years from the date the applicable stock option agreement was executed, on January 17, 2021, and vests as follows: (a) 6,667 shares on January 17, 2011; (b) 5,000 shares on January 17, 2012; and (c) 5,000 shares on January 17, 2013. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and each director. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that the director ceases to be one of the Company’s directors. Upon termination of such service, the director will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each of the stock options granted to each of the Company’s three non-employee directors was $89,228 ($267,683 total) estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 134.4%, risk-free rate of 2.8%, and a term of 5.75 years. During the three months ended November 30, 2011, the Company recognized $30,114 of expense related to these issuances.

On December 17, 2010, the Board approved, and the Company granted, Mr. Andrew Farago, the Company's former Chief Operating Officer, a stock option to purchase 500,000 shares of the Company’s common stock at an exercise price of $6.21 per share, the fair market value of the Company’s common stock on the date of grant. The grant date fair value of the stock option granted to Mr. Farago was $2,878,274 estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 134.4%, risk-free rate of 2.7%, and a term of 6.8 years. The stock option expired ten years from the date of grant and vested in certain blocks based on Mr. Farago achieving certain milestones. Effective as of August 12, 2011, Mr. Andrew Farago resigned as the Chief Operating Officer. On the date of his resignation Mr. Fargo had vested 83,334 as a result of the Company appointing two new directors to its Board, who were recommended by Mr. Farago. During the year ended August 31, 2011, the Company recognized $479,712 as stock based compensation expense related to Mr. Farago’s 83,334 vested options which Mr. Farago has until August 12, 2012, to exercise.

Stock Option Grants During the Year Ended August 31, 2010

On December 15, 2009, the Board approved, and the Company granted, a stock option to each of three of its non-employee directors permitting each to purchase, subject to applicable vesting provisions, 16,667 shares of the Company’s common stock at an exercise price of $1.32 per share, the fair market value of the Company’s common stock on the date of grant. Each stock option expires five years from the date of grant, on December 15, 2014 and vests as follows: (a) as to 6,667 shares on December 16, 2009; (b) as to 5,000 shares on December 16, 2010; and (c) as to 5,000 shares on December 16, 2011. The stock options are further subject to the terms and conditions of a stock option agreement between each director and the Company. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that the director ceases to be a director of the Company. Upon termination of such service, the director will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each 16,667 stock option was estimated at $1.05 each, for a total of $17,500, using the Black-Scholes option pricing model with the following weighted average assumptions: 0% dividend yield, expected volatility of 140.41%, risk-free interest rate of 1.38%, and expected life of 3.25 years. During the three months ended November 30, 2011 and 2010, the Company recorded stock compensation of $1,969 and $5,906, respectively for the amortization of the fair value of these stock options.
 
 
14

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011
 
NOTE 6 - Stock Options (Continued)
 
Stock Options Granted to and Forfeited by John A. Conklin
 
On April 1, 2010, the Company entered into a consulting agreement with Mr. John A. Conklin whereby Mr. Conklin provided technical advice, guidance, and management oversight to help advance the commercial development of the Company’s technologies, including but not necessarily limited to its SolarWindow™ and MotionPower™ technologies. In consideration of Mr. Conklin’s services, the Company paid Mr. Conklin $11,000 per calendar month for the first three calendar months of the consulting agreement and $12,444 for each calendar month of service thereafter. In additional consideration of Mr. Conklin’s services, the Company granted Mr. Conklin a stock option to purchase up to 83,334 shares of the Company’s common stock at an exercise price of $1.62 per share, the fair market value of the Company’s common stock on the date of grant. The stock option granted Mr. Conklin vests upon the achievement of specific technical, product development, and/or business milestones. The grant date fair value of the 83,334 stock options was estimated at $1.44 each for a total of $119,975, using the Black-Scholes option pricing model with the following weighted average assumptions: 0% dividend yield, expected volatility of 139.53%, risk-free interest rate of 2.59%, and expected life of five years. Under the terms of the stock option agreement, the stock option agreement terminates and there will be no further vesting of stock options effective as of the date that Mr. Conklin ceases to provide consulting services to the Company. Upon termination of such service, Mr. Conklin will have a specified period of time to exercise vested stock options, if any.

Upon Mr. Patel’s resignation, the Company appointed Mr. Conklin to serve as the Company’s President, CEO, and CFO, effective August 9, 2010. Pursuant to Mr. Conklin’s Employment Agreement dated August 9, 2010, the 83,334 stock options previously granted to him on April 1, 2010, were forfeited. During the year ended August 31, 2010, the Company recorded stock compensation of $13,131 for the amortization of the fair value of the 83,334 stock options. Since the stock option was forfeited prior to any of it vesting, the $13,131 previously recognized for stock compensation was reversed on August 9, 2010, the date of forfeiture, resulting in a net $0 impact to the consolidated financial statements.

Pursuant to Mr. Conklin’s Employment Agreement dated August 9, 2010, the Board granted a stock option to purchase up to 666,666 shares of the Company’s common stock, subject to certain vesting requirements, at an exercise price of $1.65 per share. The stock option expires ten years from the date of grant, on August 9, 2020. Subject to the restrictions and earlier termination provisions set forth in the stock option agreement, the option vests as follows:

1. as to 166,667 shares or such portion thereof as may be determined by the Board at its sole discretion, when one or more of the following items related to the development, production, manufacturing, and sale of any commercially viable product have been successfully executed: (a) completion of final design and/or engineering; (b) the establishment of manufacturing facilities, whether in-house or outsourced; and (c) the initial filing of any product safety approval applications, if required, in order to allow for the commercial sale of products by the Company;

2. as to 166,667 shares upon commencing commercial sales of any of the Company’s products, as reported in the Company's financial statements, whether to retail customers or wholesale customers;

3. 33,333 shares for each calendar year of service in an Executive Position for the next five years (166,667 shares in the aggregate), which shall become exercisable as to 33,333 shares on August 9, 2011 and 33,333 shares on each anniversary thereof through August 9, 2015.

4. as to 166,667 shares when, to the Board’s satisfaction, the Company enters into a favorable business partnership with a third-party commercial organization in the industry segment related to the Company’s product development and sales efforts, under any of the following conditions:

(a) a product development relationship whereby the third-party partner makes a significant financial investment, as determined at the Board’s discretion, directed towards the development of the Company’s products; or
(b) a product development relationship whereby the third-party partner invests significant research and development resources, as determined at the Board’s discretion, directed towards the development of the Company’s products; or
(c) a strategic partnership with the third-party partner where, as determined at the Board’s discretion, such a partnership provides significant business advantages to the Company which it would otherwise not have, whether related to product development, commercial sales, industry position, or business reputation.
 
 
15

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011
 
NOTE 6 - Stock Options (Continued)

Stock Options Granted to and Forfeited by John A. Conklin (Continued)
 
The fair market value of the Company’s common stock on the date of grant was $1.62 per share. The grant date fair value of the 666,666 stock options was estimated at $1.50 each, for a total of $1,008,814, using the Black-Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, expected volatility of 134.81%, risk-free interest rate of 2.21%, and expected life of 7.2 years. During the three months ended November 30, 2011 and 2010, the Company recorded stock compensation of $26,823 and $235,822, respectively for the amortization of the fair value of this stock option.

The following table summarizes information about stock options outstanding and exercisable at November 30, 2011:
 
     
Stock Options Outstanding
   
Stock Options Exercisable
 
           
Weighted
   
Weighted
         
Weighted Average
   
Weighted
 
Range of
   
Number of
   
Average
   
Average
   
Number
   
Remaining
   
Average
 
Exercise
   
Options
   
Contractural
   
Exercise
   
of Options
   
Contractual
   
Exercise
 
Prices
   
Outstanding
   
Life (years)
   
Price
   
Exercisable
   
Live (Years)
   
Price
 
                                       
$ 1.32       50,001       3.04     $ 1.32       35,001       3.04     $ 1.32  
$ 1.65       666,667       8.70     $ 1.65       33,334       8.70     $ 1.65  
$ 2.50       10,000       9.35     $ 2.50       2,000       9.35     $ 2.50  
$ 2.55       33,334       6.78     $ 2.55       19,998       6.78     $ 2.55  
$ 3.27       23,334       9.31     $ 3.27       13,334       9.31     $ 3.27  
$ 4.98       16,667       6.28     $ 4.98       9,999       6.28     $ 4.98  
$ 5.94       50,001       9.14     $ 5.94       20,001       9.14     $ 5.94  
$ 6.21       83,334       9.05     $ 6.21       83,334       9.05     $ 6.21  
$ 6.51       16,667       9.15     $ 6.51       6,667       9.15     $ 6.51  
                                                     
Total
      950,005       8.38     $ 2.48       223,668       7.76     $ 4.16  

In addition to stock compensation recorded for the stock option grants and forfeitures discussed above, the Company recorded stock compensation of $3,115 and $5,425 during the three months ended November 30, 2011 and 2010, respectively for stock options previously granted and vesting over time.

The Company does not repurchase shares to fulfill the requirements of options that are exercised. Further, the Company issues new shares when options are exercised.

NOTE 7 - Related Party Transactions

A related party is generally defined as (i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

For services rendered in the capacity of a Board member, non-employee Board members received $2,500 during our quarter ended November 30, 2010, and $3,750 per quarter starting in our second quarter ending February 28, 2011. New Board member compensation is pro rated in their first quarter. During the three months ended November 30, 2011 and 2010, the Company incurred $29,100 and $7,500, respectively in cash based Board compensation. Additionally, during the three months ended November 30, 2011 and 2010, the Company incurred $43,392 and $11,331, respectively in stock based compensation related to stock options granted (See “Note 6 - Stock Options” above) for services rendered by non-employee directors of the Company, which is included in professional fees.

March 21, 2011, Todd Pitcher was elected to the Board and received $3,750 per quarter for his Board related services. On May 19, 2011, the Company entered into an Advisory Engagement Agreement (the “Agreement”) with Aspire Clean Tech Communications, Inc., a private corporation wholly owned by Todd Pitcher, Director. Pursuant to the Agreement Mr. Pitcher will provide ongoing corporate advisory and support services - until the parties agree otherwise in writing - in exchange for compensation of $3,500 per month plus reimbursement of business related, out-of-pocket expenses. On July 1, 2011, the Agreement was amended to increase the monthly compensation from $3,500 to $10,000 due to the increased level of time required for Mr. Pitcher to execute his duties. On September 30, 2011 the Agreement was further amended to include the addition of a $1,000 per month health insurance reimbursement retroactively applied to include the month of July 2011.

 
16

 

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2011


NOTE 7 - Related Party Transactions (Continued)

On December 8, 2011, Mr. Pitcher resigned from the Board and ceased performing services for the Company. The Company paid Mr. Pitcher $30,000 upon receipt of an executed Mutual Termination and Release.

On February 2, 2011, the Company entered into an employment agreement with Mr. Scott Taper pursuant to which Mr. Taper was appointed the Company’s Vice President of Business Development. Pursuant to the terms of the employment agreement, Mr. Taper was entitled to an annual salary of $90,000, which would increase to $100,800 if certain milestone were met, and a stipend of $1,000 per month to cover medical insurance premiums until such time as the Company could provide an alternative medical insurance plan. The employment agreement provides that Mr. Taper’s employment by the Company was “at-will employment” and may be terminated by Mr. Taper or the Company at any time, with or without cause, and for any reason whatsoever, upon written notice to the other. On February 28, 2011, Mr. Taper, resigned as the Company’s Vice President of Business Development.

On February 1, 2011, the Company entered into a consultancy agreement with Mr. Elliot Maza pursuant to which Mr. Maza was appointed the Company’s Chief Financial Officer. Pursuant to the terms of the consultancy agreement, Mr. Maza is entitled to a monthly fee of $7,500. The consultancy agreement provides that Mr. Maza’s engagement is on a part-time basis and is “at-will” and may be terminated by Mr. Maza or the Company at any time, with or without cause, and for any reason whatsoever, upon written notice to the other. On August 31, 2011, Mr. Maza, resigned as the Company’s CFO.

On December 17, 2010, the Company entered into an employment agreement with Mr. Farago pursuant to which Mr. Farago was appointed the Company’s Chief Operating Officer. Pursuant to the employment agreement, Mr. Farago was entitled to an annual salary of $150,000, to increase to $250,000 if the Company consummates either an equity or debt financing or series of financings with net proceeds of at least $7,000,000 and a stipend of $1,000 per month to cover medical insurance premiums until such time as the Company could provide an alternative medical insurance plan. The employment agreement provides that Mr. Farago’s employment by the Company was “at-will employment” and may be terminated by Mr. Farago or the Company at any time, with or without cause, and for any reason whatsoever, upon written notice to the other. Also on December 17, 2010, the Board approved, and the Company granted, Mr. Farago a stock option to purchase 500,000 shares of the Company’s common stock at an exercise price of $6.21 per share, the fair market value of the Company’s common stock on the date of grant. The stock option expires ten years from the date of grant and is subject to various vesting terms. Effective as of August 12, 2011, Mr. Andrew Farago resigned as the Chief Operating Officer. On the date of his resignation Mr. Fargo had vested 83,334 options which Mr. Farago has until August 12, 2012 to exercise.

The law firm of Sierchio & Company, LLP, of which Joseph Sierchio, one of our directors, is a principal, has provided counsel to us since the Company's inception. In July 2008, the Company asked Mr. Sierchio to join the Company's Board. During the three months ended November 30, 2011 and 2010, the law firm of Sierchio & Company, LLP provided $62,175 and $21,638, respectively, of legal services. At November 30, 2011, the Company owed S&C LLP $40,800 which is included in accounts payable.

The Company’s corporate office is located at 9192 Red Branch Road, Suite 110, Columbia, Maryland 21045. On December 1, 2009, the Company entered into a one year sublease agreement with MVP Law Group, P.A., of which the Company's former Chief Executive Officer and President is a founder. Mr. Patel sold this practice and has an “Of Counsel” relationship with MVP Law Group. Rent for this office space is $1,100 per month through November 30, 2011. The Company’s sublease with MVP Law Group, P.A., renewed effective December 1, 2011, for an additional twelve months at $1,100 per month.

All related party transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.

NOTE 8 - Subsequent Events

During December 2011, management initiated a review of the costs associated with start-up operations, financing, and allocation of resources, and suspended all operations associated with Nakoda pending further review.
 
 
17

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Report on Form 10-Q contains forward-looking statements which involve assumptions and describe our future plans, strategies, and expectations, and are generally identifiable by use of words such as “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project,” or the negative of these words or other variations on these words or comparable terminology. These statements are expressed in good faith and based upon a reasonable basis when made, but there can be no assurance that these expectations will be achieved or accomplished.

Such forward-looking statements include statements regarding, among other things, (a) the potential markets for our technologies, our potential profitability, and cash flows, (b) our growth strategies, (c) expectations from our ongoing research and development activities, (d) anticipated trends in the technology industry, (e) our future financing plans, and (f) our anticipated needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in this Form 10-Q generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the matters described in this Form 10-Q generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. In addition to the information expressly required to be included in this filing, we will provide such further material information, if any, as may be necessary to make the required statements, in light of the circumstances under which they are made, not misleading.

Although forward-looking statements in this report reflect the good faith judgment of our management, forward-looking statements are inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect our actual results may vary materially from those expected or projected.

Except where the context otherwise requires and for purposes of this Form 10-Q only, “we,” “us,” “our,” “Company,” “our Company,” and “New Energy” refer to New Energy Technologies, Inc., a Nevada corporation, and its consolidated subsidiaries.

Overview

We are a development stage renewable and alternative energy company, actively developing two novel technologies for generating sustainable electricity, one of which collects energy from the sun and artificial light, and the other harvests the available kinetic energy present in moving vehicles. Our proprietary, patent-pending technologies and products, which are the subjects of 43 US and international patent-filings, have been invented, designed, engineered, and prototyped in preparation for advanced field testing, product development, and commercial deployment.

We are currently focusing our development efforts on two technologies, SolarWindow™ technology, which enables see-through glass windows to generate electricity by applying electricity-generating coatings to their glass surfaces, and MotionPower™ technology for capturing the kinetic energy of moving vehicles and using it to generate electricity.

 
18

 

We do not currently have any commercial products and there is no assurance that we will successfully be able to design, develop, manufacture, or sell any commercial products in the future. Our product development programs involve ongoing research and development efforts, and the commitment of significant resources to support the extensive invention, design, engineering, testing, prototyping, and intellectual property initiatives carried-out by our contract engineers, scientists, and consultants.

Ultimately, we plan to market any SolarWindow™ technology and/or MotionPower™ technology products through co-marketing, co-promotion, licensing and distribution arrangements with third party collaborators. We believe that this approach could provide immediate access to pre-existing distribution channels, therefore potentially increasing market penetration and commercial acceptance of our products and enabling us to avoid expending significant funds for development of a large sales and marketing organization.

We cannot accurately predict the amount of funding or the time required to successfully commercialize either the SolarWindow™ technology, or the MotionPower™ technology. The actual cost and time required to commercialize these technologies and business may vary significantly depending on, among other things, the results of our research and development efforts, the cost of developing, acquiring, or licensing various enabling technologies, changes in the focus and direction of our research and development programs, competitive and technological advances, the cost of filing, prosecuting, defending and enforcing claims with respect to patents, the regulatory approval process and manufacturing, marketing and other costs associated with commercialization of these technologies. Because of this uncertainty, even if financing is available to us, we may not secure sufficient funding to effectuate our business plan or secure such funding on terms and conditions which may be commercially onerous. If adequate funds are not available on reasonable terms or at all, it would result in a material adverse effect on our business, operating results, financial condition and prospects.

As of November 30, 2011, we had working capital of $1,695,129. Based upon our current level of operations and expenditures, we believe that, absent any modification or expansion of our existing research, development and testing, cash on hand should be sufficient to enable us to continue operations through at least August 31, 2012. However, any significant expansion in scope or acceleration in time of our current research and development activities, or commencement of any marketing activities, will require additional funds.

Research and Related Agreements

We are a party to certain agreements related to the development of our SolarWindow™ technology and our MotionPower™ technology. These agreements, and certain effects of these agreements on our financial statements for the periods presented in this prospectus, are summarized below.

SolarWindow™ Technology

Stevenson-Wydler Cooperative Research and Development Agreement with the Alliance for Sustainable Energy

We are a party to a cooperative research and development agreement (“CRADA”) with the U.S. Department of Energy’s National Renewable Energy Laboratory (“NREL”) in Golden, Colorado. Under the terms of the CRADA, NREL researchers will make use of our exclusive intellectual property and NREL’s background intellectual property in order to work towards specific development goals. Pursuant to SEC Rule 24b-2, we have submitted requests to the SEC for confidential treatment of certain portions of these agreements, which have been granted. Accordingly, certain terms of these agreements have not been disclosed.

University of South Florida Research Foundation, Inc. License Agreement, Option Agreement and Sponsored Research Agreement

Through our wholly-owned subsidiary, New Energy Solar Corporation, we are a party to a License Agreement, an Addendum to the License Agreement, an Option Agreement, and a Sponsored Research Agreement with the University of South Florida Research Foundation, Inc. These agreements provide our support of the development of the SolarWindow™ technology and grant us an exclusive worldwide commercial license under certain patents relating to the SolarWindow™ technology. Pursuant to SEC Rule 24b-2, we have submitted requests to the SEC for confidential treatment of certain portions of these agreements, which have been granted. Accordingly, certain terms of these agreements have not been disclosed.

 
19

 
 
MotionPower™ Technology

Veryst Agreement

Through KEC, our wholly-owned subsidiary, we are a party to certain agreements with Veryst Engineering LLC (“Veryst”), a Boston area engineering and consulting firm with experience in product development and energy harvesting; one dated November 4, 2008, two dated September 9, 2009 and one dated July 6, 2010 (collectively, the “Veryst Agreements”), all relating to the development of a car and truck energy harvester. Pursuant to Rule 24b-2 we submitted a request for confidential treatment of certain portions of the November 4, 2008, agreement, relating to the payment terms, scope of work and the milestone terms of the agreement, which has been granted. Accordingly, certain terms and provisions of the November 4, 2008 agreement have not been disclosed.

Veryst has successfully completed its contracted services associated with the Veryst Agreements.

Sigma Design Agreement

Through KEC, we also have been and continue to be a party to certain consulting agreements with Sigma Design Company (“Sigma Design”), a New Jersey based engineering and design firm, pursuant to which Sigma Design provides ongoing engineering, product development and testing services relating to the development of our MotionPower™ technology.

We continue to utilize Sigma Design Company on a consulting basis to further test, calibrate, and develop our MotionPower™ technology.

Results of Operations

Three Months Ended November 30, 2011 Compared with the Three Months Ended November 30, 2010

Operating Expenses

A summary of our operating expense for the three months ended November 30, 2011 and 2010 follows:
 
   
Three Months Ended
             
   
November 30,
   
Increase /
   
Percentage
 
   
2011
   
2010
   
(Decrease)
   
Change
 
                         
Operating expense
                       
Selling, general and administrative
  $ 650,736     $ 449,740     $ 200,996       45 %
Research and development
    130,192       57,122       73,070       128 %
Total operating expense
  $ 780,928     $ 506,862     $ 274,066       54 %

Selling, General and Administrative

Selling, general and administrative (“SG&A”) costs include all expenditures incurred other than research and development related costs, including costs related to personnel, professional fees, travel and entertainment, public company costs, insurance and other office related costs. The $200,996 year-over-year increase is primarily due to 1) a $85,142 increase in personnel costs primarily related to Nakoda Energy, Inc.; 2) $39,852 increase in travel related costs primarily related to Nakoda Energy, Inc.; 3) $229,915 increase in professional fees primarily related to patent to legal and patent filing fees; and 4) $29,817 increase in general and administrative costs offset by reduction of $172,721 in stock compensation expense and $11,009 in public company related costs primarily related to fees paid to publicize our SolarWindow™ and MotionPower™ technologies within the industry and investor community.

 
20

 

Research and Development

Research and development (“R&D”) costs represent costs incurred to develop our SolarWindow™ and MotionPower™ technologies and are incurred pursuant to our research agreements and agreements with other third party providers. Payments under these agreements include salaries and benefits for R&D personnel, allocated overhead and facility occupancy costs, contract services and other costs. R&D costs are expensed when incurred, except for nonrefundable advance payments for future research and development activities which are capitalized and recognized as expense as the related services are performed. See “Research and Related Agreements,” above for disclosure regarding the terms and amounts incurred under our research agreements.

The amount of R&D expense incurred for our various research related agreements follows:

     
Three Months Ended
   
May 5, 1998
 
 
Development
 
November 30,
   
(Inception) to
 
 
Activity
 
2011
   
2010
   
November 30, 2011
 
University of Illinois
Solar WindowTM
  $ -     $ -     $ 422,818  
Alliance for Sustainable Energy, LLC
Solar WindowTM
    33,668       -       159,576  
University of South Florida
Solar WindowTM
    17,853       20,167       308,723  
Sigma Design Company, LLC
Motion PowerTM
    74,137       26,422       487,831  
Veryst Engineering LLC
Motion PowerTM
    2,564       10,533       560,880  
Other
      1,970       -       108,060  
      $ 130,192     $ 57,122     $ 2,047,888  
 
R&D costs increased $73,070 due to the inclusion of the Stevenson-Wydler Cooperative Research and Development Agreement with the Alliance for Sustainable Energy, LLC, which is the operator of The National Renewable Energy Laboratory under its U.S. Department of Energy contract which accounted for $33,668 of the increase, $47,715 increase in expenses to Sigma Design Company, LLC offset by $8,313 reductions primarily related to the completion of the Veryst Engineering LLC contract in fiscal year 2011.

Other Income (Expense)

A summary of our other income (expense) for the three months ended November 30, 2011 and 2010 follows:

   
Three Months Ended
       
   
November, 30,
       
   
2011
   
2010
   
Change
 
                   
Other income (expense)
                 
Interest expense
  $ -     $ (251 )   $ 251  
Foreign exchange loss
    (32 )     (497 )     465  
Change in fair value of warrant liability
    -       (689,346 )     689,346  
Change in contingent liability
    156,109       -       156,109  
Total other income (expense)
  $ 156,077     $ (690,094 )   $ 846,171  

Change in Fair Value of Warrant Liability
 
On September 1, 2009, the Company adopted guidance which is now part of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 815-40, Contracts in Entity’s Own Equity. The Company determined that its Class F Callable Warrants contained a dilutive issuance provision. As a result, the Company reclassified 1,062,833 of its Class F Callable Warrants to long-term warrant liability. The Company’s Class F Callable Warrants were considered derivative financial liabilities and were therefore required to be adjusted to fair value each quarter. During the three months ended November 30, 2010, the warrants were adjusted to their fair value resulting in a $689,346 loss recorded as Other Expense. During the year ended August 31, 2011, investors exercised 1,054,512 Class F Callable Warrants for aggregate gross proceeds of $3,954,375. On February 12, 2011, all unexercised Class F Callable Warrants expired resulting in the adjustment to their fair value to $0.

 
21

 

Change in Contingent Liability

Through the Company’s wholly-owned subsidiary, Sungen Energy, Inc., it was a party to a Sponsored Research Agreement with the University of Illinois at Urbana-Champaign (“UIUC”) that provided for the Company’s support of the development of a new technology to integrate films of silicon nanoparticle material on glass substrates. This agreement expired on August 22, 2008. As of such date, the Company had advanced a total of $266,709 to UIUC pursuant to the terms of the agreement. Pursuant to the terms of the agreement, the Company was to advance an additional $156,109 UIUC, which is included in other accrued liabilities at August 31, 2011. The Company had not made the advance pending determination as to whether funds previously paid to UIUC under the terms of the agreement had been fully expended. The Company was of the opinion that to the extent these funds were not expended, they are refundable to the Company.

During the three months ended November 30, 2011, The Company evaulated the status of the aforementioned agreement and related contingent liability to UIUC. The Company determined that the $156,109 liability is no longer valid and has been eliminated to other income.

Liquidity and Capital Resources

The accompanying financial statements have been prepared assuming we will continue as a going concern. We have an accumulated deficit of $10,972,777 through November 30, 2011. Due to the “start up” nature of our business, we expect to incur losses as we continue development of our photovoltaic and energy harvesting technologies and expand. These conditions raise substantial doubt about our ability to continue as a going concern. Management recognizes that in order for us to meet our capital requirements, and continue to operate, additional financing will be necessary. We expect to raise additional funds through private or public equity investment in order to expand the range and scope of its business operations. We will seek access to private or public equity but there is no assurance that such additional funds will be available for us to finance our operations on acceptable terms, if at all. If we are unable to raise additional capital or generate positive cash flow, it is unlikely that we will be able to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Our principal source of liquidity is cash in the bank. At November 30, 2011, we had a cash and cash equivalent balance of $1,700,110. We have financed our operations primarily pursuant to a securities purchase agreement in which we received net proceeds of $3,395,955 in February 2008 and from the exercise of warrants and stock options.

Net cash used in operating activities was $599,776 for the three months ended November 30, 2011, compared to net cash used in operating activities of $305,863 for the three months ended November 30, 2010. The increase in cash used in operating activities of $293,913 substantially reflects increases in amounts paid for professional fees, personnel, travel, research and development and general office expenses.

Net cash used by investing activities was $20,299 and $1,390 for the three months ended November 30, 2011 and 2010, respectively, primarily related to MotionPower demonstration equipment and computer hardware.

Net cash provided by financing activities was $0 and $2,474,730 for the three months ended November 30, 2011 and 2010, respectively. During the year ended August 31, 2011, we received $3,954,375 from the exercise of Class F Callable Warrants and $30,800 from the exercise of stock options.

 
22

 

Other Contractual Obligations

In addition to our contractual obligations under the research agreements, as of November 30, 2011, we have future minimum lease payments of $13,763 under our corporate and other office operating leases. In addition, we have future minimum payments totaling $52,000 pursuant to agreements with third party providers that we utilize for investor and public relations and marketing and business development.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Recently Issued Accounting Pronouncements

We review new accounting standards as issued. Although some of these accounting standards issued or effective after the end of our previous fiscal year may be applicable to us, we have not identified any standards that we believe merit further discussion. We believe that none of the new standards will have a significant impact on our consolidated financial statements.

Item 4.  Controls and Procedures

Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this quarterly report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of November 30, 2011 that our disclosure controls and procedures were effective such that the information required to be disclosed in our United States Securities and Exchange Commission (the “SEC”) reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 
23

 

PART II – OTHER INFORMATION

Item 1.  Legal Proceedings
 
None.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds
 
None.

Item 3.  Defaults Upon Senior Securities
 
None.

Item 5.  Other Information
 
None.

Item 6.  Exhibits

Exhibit No.
 
Description of Exhibit
     
3.1
 
Articles of Incorporation, as amended (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
3.2
 
Certificate of Amendment to the Articles of Incorporation changing name to New Energy Technologies, Inc. (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
3.3
 
Certificate of Amendment to the Articles of Incorporation increasing the authorized shares from 100,000,000 to 300,000,000 (Incorporated by reference to the Form 8-K filed by New Energy Technologies, Inc. on March 21, 2011)
     
3.4
 
Certificate of Change to the Articles of Incorporation relating to the one-for-three reverse stock split (Incorporated by reference to the Form 8-K filed by New Energy Technologies, Inc. on March 21, 2011)
     
3.5
 
By Laws. (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
4.1
 
Securities Purchase Agreement dated February 8, 2008 (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
10.1
 
Employment Termination Agreement with Mr. Cucinelli (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
10.2
 
Employment Agreement dated June 24, 2009, between New Energy Technologies, Inc. and Mr. Meetesh Patel (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
10.3
 
Amendment to the Employment Agreement dated April 6, 2010, between New Energy Technologies, Inc. and Meetesh Patel (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
10.4
 
Stock Option Agreement Dated April 6, 2010, between New Energy Technologies, Inc. and Meetesh Patel (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)

 
24

 
 
10.5
 
Employment Agreement dated February 1, 2010, between New Energy Technologies, Inc. and James B. Wilkinson (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
10.6
 
Resignation and Mutual Determination to terminate employment between New Energy Technologies, Inc. and James B. Wilkinson, dated February 15, 2010 (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
10.7
 
Amended Form of Stock Option Agreement dated as of December 15, 2009, between Meetesh Patel and New Energy Technologies, Inc., correcting the grant date (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
10.8
 
Amended Form of Stock Option Agreement dated as of December 15, 2009, between New Energy Technologies, Inc. and its non-employee directors, correcting the grant date (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010)
     
10.9
 
Employment Agreement dated August 9, 2010, between New Energy Technologies, Inc. and John A. Conklin (Incorporated by reference to the exhibits filed as part of the report on Form 10-K filed by New Energy Technologies, Inc. on December 13, 2010)
     
10.10
 
Stock Option Agreement Dated August 9, 2010, between New Energy Technologies, Inc. and John A. Conklin (Incorporated by reference to the exhibits filed as part of the report on Form 10-K filed by New Energy Technologies, Inc. on December 13, 2010)
     
10.11
 
Employment Agreement dated December 17, 2010, between New Energy Technologies, Inc. and Andrew Farago (Incorporated by reference to the Form 8-K filed by New Energy Technologies, Inc. on December 23, 2010)
     
10.12
 
Stock Option Agreement dated December 17, 2010, between New Energy Technologies, Inc. and Andrew Farago (Incorporated by reference to the Form 8-K filed by New Energy Technologies, Inc. on December 23, 2010)
     
10.13
 
Stock Option Agreement dated January 17, 2011, between New Energy Technologies, Inc. and Jatinder Bhogal (Incorporated by reference to the Form 8-K/A filed by New Energy Technologies, Inc. on January 21, 2011)
     
10.14
 
Stock Option Agreement dated January 17, 2011, between New Energy Technologies, Inc. and Alistair Livesey (Incorporated by reference to the Form 8-K/A filed by New Energy Technologies, Inc. on January 21, 2011)
     
10.15
 
Stock Option Agreement dated January 17, 2011, between New Energy Technologies, Inc. and Joseph Sierchio (Incorporated by reference to the Form 8-K/A filed by New Energy Technologies, Inc. on January 21, 2011)
     
10.16
 
Stock Option Agreement dated January 19, 2011, between New Energy Technologies, Inc. and Javier Jimenez (Incorporated by reference to the Form 8-K/A filed by New Energy Technologies, Inc. on January 21, 2011)
     
10.17
 
Consultancy Agreement dated February 1, 2011, between New Energy Technologies, Inc. and Elliot Maza (Incorporated by reference to the Form 8-K dated February 1, 2011, filed by New Energy Technologies, Inc. on February 4, 2011)

 
25

 
 
10.18
 
Employment Agreement dated February 2, 2011, between New Energy Technologies, Inc. and Scott Taper (Incorporated by reference to the Form 8-K filed by New Energy Technologies, Inc. on February 8, 2011)
     
10.19
 
Redacted USF Sponsored Research Agreement (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010. Confidential treatment has been granted with respect to certain portions of this exhibit)
     
10.20
 
Redacted USF Option Agreement (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010. Confidential treatment has been granted with respect to certain portions of this exhibit)
     
10.21
 
Redacted Veryst Agreement (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010, and Form 8-K filed on February 8, 2011)
     
10.22
 
Redacted Sigma Design Agreement (Incorporated by reference to the exhibits filed as part of the report on Form 10-Q filed by New Energy Technologies, Inc. on April 16, 2010, and Form 8-K filed on February 8, 2011)
     
10.23
 
Redacted Standard Exclusive License Agreement with Sublicensing Terms entered into on June 21, 2010, by and between the University of South Florida Research Foundation and New Energy Solar Corporation (the “License Agreement”) (Incorporated by reference to the Form 8-K filed by New Energy Technologies, Inc. on June 28, 2010. Confidential treatment has been granted with respect to certain portions of this exhibit)
     
10.24
 
Redacted Addendum 1 dated November 30, 2010, to the License Agreement by and between the University of South Florida Research Foundation and New Energy Solar Corporation (Incorporated by reference to the exhibits filed as part of the report on Form 10-K filed by New Energy Technologies, Inc. on December 13, 2010. Confidential treatment has been granted with respect to certain portions of this exhibit)
     
10.25
 
Redacted Stevenson-Wydler Cooperative Research and Development Agreement dated March 18, 2011, by and between New Energy Technologies, Inc. and the Alliance for Sustainable Energy, LLC, operator of The National Renewable Energy Laboratory under its U.S. Department of Energy Contract No. DE-AC36-08GO28308 (Incorporated by reference to the Form 8-K/A filed by New Energy Technologies, Inc. filed on April 7, 2011. Confidential treatment has been granted with respect to certain portions of this exhibit)
     
10.26
 
Redacted letter agreement dated June 16, 2011 by and between the University of South Florida and New Energy Technologies, Inc. (Incorporated by reference to the Form 8-K/A filed by New Energy Technologies, Inc. filed on July 20, 2011. Confidential treatment has been granted with respect to certain portions of this exhibit)
     
10.27
 
2006 Incentive Stock Option Plan (Incorporated by reference to the Form S-8 filed by New Energy Technologies, Inc. on March 15, 2011)
     
31.1*
 
Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1*
 
Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 

 
*Filed herewith

 
26

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

New Energy Technologies, Inc.
(Registrant)
 
January 17, 2012
By
 /s/ John A. Conklin
   
John A. Conklin
   
Chief Executive Officer, Chief Financial Officer and Director
   
(Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer)
 
 
27

 
EX-31.1 2 v245254_ex31-1.htm CONSENT Unassociated Document
Exhibit 31.1

CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, John A. Conklin, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of New Energy Technologies, Inc. (the “Registrant”);

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
As the registrant’s certifying officer I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
As the registrant's certifying officer I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:
January 17, 2012
/s/ John A. Conklin
   
John A. Conklin
   
President, Chief Executive Officer,
   
Chief Financial Officer and Director

 
 

 
EX-32.1 3 v245254_ex32-1.htm CONSENT Unassociated Document
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the accompanying Quarterly Report on Form 10-Q of New Energy Technologies, Inc. for the fiscal quarter ending November 30, 2011, I, John Conklin, Chief Executive Officer and Chief Financial Officer of New Energy Technologies, Inc., hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
 
1.       Such Quarterly Report on Form 10-Q for the fiscal quarter ending November 30, 2011, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.       The information contained in such Quarterly Report on Form 10-Q for the fiscal quarter ending November 30, 2011, fairly presents, in all material respects, the financial condition and results of operations of New Energy Technologies, Inc.
 
Date:
January 17, 2012
/s/ John A. Conklin
   
John A. Conklin
   
President, Chief Executive Officer,
   
Chief Financial Officer and Director
 
 
 

 
EX-101.INS 4 nene-20111130.xml XBRL INSTANCE DOCUMENT 20638360 2670005 176659 4369 19252 1892136 20638 20000 20638360 1000000 1871788 10972777 1700110 0.001 12667616 132426 1341 1892136 1715477 20638360 0.10 20348 300000000 176659 172290 20638360 20638 -624851 12667616 -10972777 140674 0.001 3375000 3375 -12326 149625 -12326 62728 3375000 3375 -77946 149625 -90272 50282 3375000 3375 -12446 149625 -102718 37378 3375000 3375 -12904 149625 -115622 -17557 3375000 3375 -54935 149625 -170557 -11887 0.001 13708200 13708 -97662 242624 -268219 -31674 13708200 13708 -19787 242624 -288006 -134816 13708200 13708 -103142 242624 -391148 207202 14708200 14708 -157982 741624 -549130 1414622 -1811 17954866 17955 -1444580 3790377 -2391899 0.50 0.55 1.50 1.65 1.80 2941589 10693 19251533 19251 -5709041 11025089 -8113444 1.50 1.65 3.75 2528790 19533533 19533 1950482 8661526 -6152269 1.80 3.75 502528 349392 19533533 19533 -233136 7058035 -6728176 280877 161009 49382 2546773 20638 20000 20638360 1000000 2545846 10347926 2320185 0.001 12593184 156279 463 2546773 2265896 20638360 0.10 927 300000000 280877 119868 20638360 20638 -3619750 12593184 -10347926 3.75 -12326 375 375000 149625 150000 0.40 3000 3000000 3000 -12326 -12326 -77946 -77946 -77946 -12904 -12904 -12904 -54935 -54935 -54935 -97662 10333 10333200 92999 103332 -97662 -97662 -103142 -103142 -103142 -157982 500000 0.50 1000 1000000 -157982 499000 -157982 -400000 -1811 -1442769 500000 1.50 -1811 333 333333 1000 1000000 1000 1000000 327 326667 293 293333 293 293333 -1811 -1442769 499667 499000 549000 489673 483707 527707 -400000 -1442769 500000 550000 490000 484000 528000 -10693 1961175 -10693 7 6667 275 275333 -10693 1961175 11993 1032225 183312 -3591093 1961175 12000 1032500 183312 -3591093 -233136 -2128331 -1785560 -342771 -233136 661040 -478971 -233136 661040 -478971 30800 -3619750 3 50318 50 1055 1054512 -3619750 30750 3953320 2855630 -1304551 -3619750 3954375 2855630 -1304551 -12446 -12446 -12446 -19787 -19787 -19787 12504 -5721545 3395955 3.00 12504 1225 1225000 7 6667 7 6667 58 58333 12504 -5721545 3394730 9993 10993 218692 3600303 -5721545 10000 11000 218750 3600303 -31478 98582 -10067909 12436530 -10235792 12367380 3000 7382960 5823 -5307 4369 12393 -10230006 155000 2368621 2047888 2128331 59704 31478 30000 -12436530 -86405 202290 186109 10388642 1700110 39252 12393 400000 11967380 -162097 155000 132426 103332 -103332 642980 5382858 -1390 -1196956 506862 -305863 2474730 247153 116 23201 251 -1196956 -690094 57122 -689346 1390 -506862 -497 -27911 449740 2167477 -1262 251 2474730 -0.06 42074 19692018 Q1 NENE NEW ENERGY TECHNOLOGIES, INC. false Smaller Reporting Company 2012 10-Q 2011-11-30 0001071840 --08-31 <div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">NOTE 5 - Capital Stock</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Preferred Stock</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At November 30, 2011, there were 1,000,000 shares of preferred stock (par value $0.10 per share) authorized, of which no shares were issued and outstanding. The Board has the authority to issue such stock in one or more series, to fix the number of shares and to fix and determine the relative rights and preferences of the shares of any such series so established to the full extent permitted by the laws of the State of Nevada and the Articles of Incorporation.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Reverse Stock Split</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 16, 2011, pursuant to a February 7, 2011, written consent signed by the shareholders owning a majority of the Company&#x2019;s issued and outstanding shares and a February 24, 2011, unanimous written consent of the Company&#x2019;s Board, the Company underwent a one-for-three reverse stock split whereby holders of three shares of the Company&#x2019;s common stock as of March 15, 2011, received one share of its common stock after the reverse stock split, with all fractional shares being rounded up to the nearest whole share.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All share and per share amounts have been retrospectively restated to reflect the one-for-three reverse stock split effected March 16, 2011. FINRA declared the reverse stock split effective as of March 21, 2011.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Common Stock</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 12, 2008, the Company consummated the sale of an aggregate of 1,225,000 shares of its common stock and Class F Callable Warrants to purchase up to an additional 1,225,000 shares of the Company&#x2019;s common stock for aggregate gross proceeds of $3,675,000 pursuant to the terms of a Securities Purchase Agreement dated February 8, 2008 with certain institutional and other accredited investors. The Class F Callable Warrants were exercisable for a period of three years from the date of issuance at an initial exercise price of $3.75 per share.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On September 1, 2009, the Company adopted guidance which is now part of Financial Accounting Standards Board (&#x201C;FASB&#x201D;) Accounting Standards Codification (&#x201C;ASC&#x201D;) 815-40, <font style="FONT-STYLE: italic; DISPLAY: inline">Contracts in Entity&#x2019;s Own Equity.</font> The Company determined that its Class F Callable Warrants contained a dilutive issuance provision. As a result, the Company reclassified 1,062,833 of its Class F Callable Warrants to long-term warrant liability. The Company&#x2019;s Class F Callable Warrants were considered derivative financial liabilities and were therefore required to be adjusted to fair value each quarter. During the three months ended November 30, 2010, the warrants were adjusted to their fair value resulting in a $689,346 loss recorded as Other Expense. During the year ended August 31, 2011, investors exercised 1,054,512 Class F Callable Warrants for aggregate gross proceeds of $3,954,375. On February 12, 2011, all unexercised Class F Callable Warrants expired resulting in the adjustment to their fair value to $0.</font></div> </div> -20299 <div> <div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">NOTE 6 - Stock Options</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On October 10, 2006, the Board adopted and approved the 2006 Incentive Stock Option Plan (the &#x201C;2006 Stock Plan&#x201D;) that provides for the grant of stock options to employees, directors, officers and consultants. The 2006 Stock Plan provides for the granting of stock options to purchase a maximum of 5,000,000 shares of the Company&#x2019;s common stock. Stock options granted to employees under the Company&#x2019;s 2006 Stock Plan generally vest over two to five years or as otherwise determined by the plan administrator. Stock options to purchase shares of the Company&#x2019;s common stock expire no later than ten years after the date of grant.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The per share exercise price for each stock option is determined by the Board and may not be below the underlying stock price on the date of grant as listed on the OTC Markets Group, Inc. QB tier (the &#x201C;OTCQB&#x201D;), or, if the Company&#x2019;s common stock is not traded on the date of grant, the first day of active trading following the date of grant.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company measures all stock-based compensation awards using a fair value method on the date of grant and recognizes such expense in its consolidated financial statements over the requisite service period. The grant date fair value of stock options is calculated using the Black-Scholes option pricing model which requires management to make assumptions regarding option time to expiration, expected volatility, and risk-free interest rates, all of which impact the fair value of the option and, ultimately, the expense that will be recognized over the life of the option.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for a bond with a similar term. The Company does not anticipate declaring dividends in the foreseeable future. Volatility is calculated based on the historical weekly closing stock prices for the same period as the expected life of the option. The Company uses the &#x201C;simplified&#x201D; method for determining the expected term of its &#x201C;plain vanilla&#x201D; stock options. The Company recognizes compensation expense for only the portion of stock options that are expected to vest. Therefore, the Company applies an estimated forfeiture rate that is derived from historical employee termination data and adjusted for expected future employee turnover rates. If the actual number of forfeitures differs from those estimated by the Company, additional adjustments to compensation expense may be required in future periods.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A summary of the Company&#x2019;s stock option activity for the three months ended November 30, 2011 and the year ended August 31, 2011, and related information follows:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div align="left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number&#xA0;of</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price&#xA0;($)</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="23%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value&#xA0;($)</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td valign="bottom" width="41%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at August 31, 2010</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">900,003</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.71</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="41%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grants</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">610,002</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.97</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td valign="bottom" width="41%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercises</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(73,334</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.61</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="41%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeitures</font></div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> (476,666</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.59</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="23%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td valign="bottom" width="41%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at August 31, 2011</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">960,005</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.49</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="41%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeitures</font></div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> (10,000</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.27</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="23%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="41%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at November 30, 2011</font></div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 950,005</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.48</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="23%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.38 years</font></div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,000</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="41%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable at November 30, 2011</font></div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 223,668</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.16</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="23%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.76 years</font></div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,900</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="41%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Available for grant at November 30, 2011</font></div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 3,976,661</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="23%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all &#x201C;in-the-money&#x201D; options (i.e. the difference between the Company&#x2019;s closing stock price on the last trading day of its first quarter of fiscal 2012 and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all option holders exercised their options on November 30, 2011. The intrinsic value of the option changes based upon the fair market value of the Company&#x2019;s common stock.</font><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><br /> &#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company&#x2019;s Statements of Operations for the three months ended November 30, 2011 and 2010, and from May 5, 1998 (inception) to November 30, 2011:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div align="left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cumulative</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three Months Ended</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">May 5, 1998</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> November 30,</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Inception) to</font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 2,011</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 2,010</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> November 30, 2011</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td valign="bottom" width="64%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock Compensation Expense:</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt" valign="bottom" width="64%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Selling general and administrative expense</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">74,432</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">247,153</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,000,102</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of November 30, 2011, the Company had $291,188 of total unrecognized compensation cost related to unvested stock options which is expected to be recognized over a period of 3.75 years.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Option Activity During the Three Months Ended November 30, 2011</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 8, 2011, Mr. Pitcher resigned from the Board. Mr. Pitcher had vested 6,667 stock options and forfeited 10,000 unvested stock options. During the year ended August 31, 2011, the Company recorded stock compensation of $27,784 for the amortization of the fair value of his stock option. Since the stock option was forfeited prior to 10,000 options vesting, $8,243 previously recognized for stock compensation was reversed on November 30, 2011, resulting in total stock compensation expense related to Mr. Pitcher&#x2019;s stock option grant of $19,541. Mr. Pitcher has until December 8, 2013, to exercise his 6,667 vested stock options.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Option Activity During the Year Ended August 31, 2011</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 5, 2011, the Company granted a stock option to purchase up to 10,000 shares of the Company&#x2019;s common stock at an exercise price of $2.50 per share, the fair market value of the Company&#x2019;s common stock on the date of grant, to an employee as partial compensation for services. The stock options expire ten years from the date of grant, on April 5, 2021 and vests as follows: (a) 2,000 shares on December 1, 2011, and (b) 2,000 shares on each of April 1 of 2012, 2013, 2014, and 2015. The stock option is further subject to the terms and conditions of a stock option agreement between the Company and the employee. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that employee ceases to be one of the Company&#x2019;s employee. Upon termination of such service, the employee will have a specified period of time to exercise vested stock options, if any. The grant date fair value of the stock option granted was $23,536, estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 133.0%, risk-free rate of 2.9%, and a term of 7.67 years. During the three months ended November 30, 2011, the Company recognized $4,217 of expense related to this issuance.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 21, 2011, the Board appointed Mr. Todd Pitcher and Mr. Peter Fusaro as directors and granted them each a stock option to purchase 16,667 shares of the Company&#x2019;s common stock at an exercise price of $3.27 per share, the fair market value of the Company&#x2019;s common stock on the date of grant. The stock options expire ten years from the date of grant, on March 21, 2021 and vests as follows: (a) 6,667 shares on March 21, 2011; (b) 5,000 shares on March 21, 2012; and (c) 5,000 shares on March 21, 2013. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and each of Mr. Pitcher and Mr. Fusaro. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that either Mr. Pitcher or Mr. Fusaro ceases to be one of the Company&#x2019;s directors. Upon termination of such service, Mr. Pitcher or Mr. Fusaro will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each of the stock options granted to Mr. Pitcher and Mr. Fusaro was $48,850, estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 133.3%, risk-free rate of 2.0%, and a term of 5.75 years. On December 8, 2011, Mr. Pitcher resigned from the Board. Mr. Pitcher had vested 6,667 stock options and forfeited 10,000 unvested stock options. During the year ended August 31, 2011, the Company recorded stock compensation of $27,784 for the amortization of the fair value of his stock option. Since the stock option was forfeited prior to 10,000 options vesting, $8,243 previously recognized for stock compensation was reversed on November 30, 2011 resulting in total stock compensation expense related to Mr. Pitcher&#x2019;s stock option grant of $19,541. During the three months ended November 30, 2011, the Company recognized $5,496 of expense related to Mr. Fusaro's option grant and $8,243 of other income related to Mr. Pitchers unvested options described above.</font></div> </div> <div>&#xA0;</div> <div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 17, 2011, the Board appointed Mr. Javier Jimenez as a director and granted him a stock option to purchase 16,667 shares of the Company&#x2019;s common stock at an exercise price of $6.51 per share, the fair market value of the Company&#x2019;s common stock on the date the stock option agreement was executed by Mr. Jimenez, January 19, 2011. The stock option expires ten years from the date of grant, on January 19, 2021 and vests as follows: (a) 6,667 shares on January 19, 2011; (b) 5,000 shares on January 19, 2012; and (c) 5,000 shares on January 19, 2013. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and Mr. Jimenez. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that Mr. Jimenez ceases to be one of the Company&#x2019;s directors. Upon termination of such service, Mr. Jimenez will have a specified period of time to exercise vested stock options, if any. The grant date fair value of the stock option granted to Mr. Jimenez was $97,250 estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 133.4%, risk-free rate of 2.0%, and a term of 5.75 years. During the three months ended November 30, 2011, the Company recognized $10,941 of expense related to this issuance.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 23, 2010, the Board approved, and the Company granted, a stock option to each of the Company&#x2019;s three non-employee directors to purchase 16,667 shares of its common stock at an exercise price of $5.94 per share, the fair market value of the Company&#x2019;s common stock on the date of grant. Each stock option expires ten years from the date the applicable stock option agreement was executed, on January 17, 2021, and vests as follows: (a) 6,667 shares on January 17, 2011; (b) 5,000 shares on January 17, 2012; and (c) 5,000 shares on January 17, 2013.&#xA0;The stock options are further subject to the terms and conditions of a stock option agreement between the Company and each director. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that the director ceases to be one of the Company&#x2019;s directors. Upon termination of such service, the director will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each of the stock options granted to each of the Company&#x2019;s three non-employee directors was $89,228 ($267,683 total) estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 134.4%, risk-free rate of 2.8%, and a term of 5.75 years. During the three months ended November 30, 2011, the Company recognized $30,114 of expense related to these issuances.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 17, 2010, the Board approved, and the Company granted, Mr. Andrew Farago, the Company's former Chief Operating Officer, a stock option to purchase 500,000 shares of the Company&#x2019;s common stock at an exercise price of $6.21 per share, the fair market value of the Company&#x2019;s common stock on the date of grant. The grant date fair value of the stock option granted to Mr. Farago was $2,878,274 estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 134.4%, risk-free rate of 2.7%, and a term of 6.8 years. The stock option expired ten years from the date of grant and vested in certain blocks based on Mr. Farago achieving certain milestones. Effective as of August 12, 2011, Mr. Andrew Farago resigned as the Chief Operating Officer. On the date of his resignation Mr. Fargo had vested 83,334 as a result of the Company appointing two new directors to its Board, who were recommended by Mr. Farago. During the year ended August 31, 2011, the Company recognized $479,712 as stock based compensation expense related to Mr. Farago&#x2019;s 83,334 vested options which Mr. Farago has until August 12, 2012, to exercise.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Option Grants During the Year Ended August 31, 2010</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 15, 2009, the Board approved, and the Company granted, a stock option to each of three of its non-employee directors permitting each to purchase, subject to applicable vesting provisions, 16,667 shares of the Company&#x2019;s common stock at an exercise price of $1.32 per share, the fair market value of the Company&#x2019;s common stock on the date of grant. Each stock option expires five years from the date of grant, on December 15, 2014 and vests as follows: (a) as to 6,667 shares on December 16, 2009; (b) as to 5,000 shares on December 16, 2010; and (c) as to 5,000 shares on December 16, 2011. The stock options are further subject to the terms and conditions of a stock option agreement between each director and the Company. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that the director ceases to be a director of the Company. Upon termination of such service, the director will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each 16,667 stock option was estimated at $1.05 each, for a total of $17,500, using the Black-Scholes option pricing model with the following weighted average assumptions: 0% dividend yield, expected volatility of 140.41%, risk-free interest rate of 1.38%, and expected life of 3.25 years. During the three months ended November 30, 2011 and 2010, the Company recorded stock compensation of $1,969 and $5,906, respectively for the amortization of the fair value of these stock options.</font></div> <div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&#xA0;</div> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Stock Options Granted to and Forfeited by John A. Conklin</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 1, 2010, the Company entered into a consulting agreement with Mr. John A. Conklin whereby Mr. Conklin provided technical advice, guidance, and management oversight to help advance the commercial development of the Company&#x2019;s technologies, including but not necessarily limited to its SolarWindow&#x2122; and MotionPower&#x2122; technologies. In consideration of Mr. Conklin&#x2019;s services, the Company paid Mr. Conklin $11,000 per calendar month for the first three calendar months of the consulting agreement and $12,444 for each calendar month of service thereafter. In additional consideration of Mr. Conklin&#x2019;s services, the Company granted Mr. Conklin a stock option to purchase up to 83,334 shares of the Company&#x2019;s common stock at an exercise price of $1.62 per share, the fair market value of the Company&#x2019;s common stock on the date of grant. The stock option granted Mr. Conklin vests upon the achievement of specific technical, product development, and/or business milestones. The grant date fair value of the 83,334 stock options was estimated at $1.44 each for a total of $119,975, using the Black-Scholes option pricing model with the following weighted average assumptions: 0% dividend yield, expected volatility of 139.53%, risk-free interest rate of 2.59%, and expected life of five years. Under the terms of the stock option agreement, the stock option agreement terminates and there will be no further vesting of stock options effective as of the date that Mr. Conklin ceases to provide consulting services to the Company. Upon termination of such service, Mr. Conklin will have a specified period of time to exercise vested stock options, if any.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Upon Mr. Patel&#x2019;s resignation, the Company appointed Mr. Conklin to serve as the Company&#x2019;s President, CEO, and CFO, effective August 9, 2010. Pursuant to Mr. Conklin&#x2019;s Employment Agreement dated August 9, 2010, the 83,334 stock options previously granted to him on April 1, 2010, were forfeited. During the year ended August 31, 2010, the Company recorded stock compensation of $13,131 for the amortization of the fair value of the 83,334 stock options. Since the stock option was forfeited prior to any of it vesting, the $13,131 previously recognized for stock compensation was reversed on August 9, 2010, the date of forfeiture, resulting in a net $0 impact to the consolidated financial statements.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Mr. Conklin&#x2019;s Employment Agreement dated August 9, 2010, the Board granted a stock option to purchase up to 666,666 shares of the Company&#x2019;s common stock, subject to certain vesting requirements, at an exercise price of $1.65 per share. The stock option expires ten years from the date of grant, on August 9, 2020. Subject to the restrictions and earlier termination provisions set forth in the stock option agreement, the option vests as follows:</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1. as to 166,667 shares or such portion thereof as may be determined by the Board at its sole discretion, when one or more of the following items related to the development, production, manufacturing, and sale of any commercially viable product have been successfully executed: (a) completion of final design and/or engineering; (b) the establishment of manufacturing facilities, whether in-house or outsourced; and (c) the initial filing of any product safety approval applications, if required, in order to allow for the commercial sale of products by the Company;</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2. as to 166,667 shares upon commencing commercial sales of any of the Company&#x2019;s products, as reported in the Company's financial statements, whether to retail customers or wholesale customers;</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3. 33,333 shares for each calendar year of service in an Executive Position for the next five years (166,667 shares in the aggregate), which shall become exercisable as to 33,333 shares on August 9, 2011 and 33,333 shares on each anniversary thereof through August 9, 2015.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4. as to 166,667 shares when, to the Board&#x2019;s satisfaction, the Company enters into a favorable business partnership with a third-party commercial organization in the industry segment related to the Company&#x2019;s product development and sales efforts, under any of the following conditions:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a) a product development relationship whereby the third-party partner makes a significant financial investment, as determined at the Board&#x2019;s discretion, directed towards the development of the Company&#x2019;s products; or</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b) a product development relationship whereby the third-party partner invests significant research and development resources, as determined at the Board&#x2019;s discretion, directed towards the development of the Company&#x2019;s products; or</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(c) a strategic partnership with the third-party partner where, as determined at the Board&#x2019;s discretion, such a partnership provides significant business advantages to the Company which it would otherwise not have, whether related to product development, commercial sales, industry position, or business reputation.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> &#xA0;</div> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The fair market value of the Company&#x2019;s common stock on the date of grant was $1.62 per share. The grant date fair value of the 666,666 stock options was estimated at $1.50 each, for a total of $1,008,814, using the Black-Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, expected volatility of 134.81%, risk-free interest rate of 2.21%, and expected life of 7.2 years. During the three months ended November 30, 2011 and 2010, the Company recorded stock compensation of $26,823 and $235,822, respectively for the amortization of the fair value of this stock option.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes information about stock options outstanding and exercisable at November 30, 2011:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div align="left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> Stock Options Outstanding</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> Stock Options Exercisable</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted Average</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Range of</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractural</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of Options</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> Prices</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> Outstanding</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> Life (years)</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> Price</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> Exercisable</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> Live (Years)</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> Price</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.32</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,001</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.04</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.32</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,001</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.04</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.32</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.65</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">666,667</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.70</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.65</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,334</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.70</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.65</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.50</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,000</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.35</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.50</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,000</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.35</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.50</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.55</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,334</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.78</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.55</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,998</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.78</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.55</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.27</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,334</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.31</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.27</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,334</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.31</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.27</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.98</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,667</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.28</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.98</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,999</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.28</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.98</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.94</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,001</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.14</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.94</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,001</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.14</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.94</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.21</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">83,334</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.05</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.21</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">83,334</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.05</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.21</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.51</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,667</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.15</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.51</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,667</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.15</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.51</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="10%" colspan="2" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 950,005</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 8.38</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 2.48</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 223,668</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 7.76</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 4.16</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition to stock compensation recorded for the stock option grants and forfeitures discussed above, the Company recorded stock compensation of $3,115 and $5,425 during the three months ended November 30, 2011 and 2010, respectively for stock options previously granted and vesting over time.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company does not repurchase shares to fulfill the requirements of options that are exercised. Further, the Company issues new shares when options are exercised.</font></div> </div> </div> -624851 780928 -599776 <div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">NOTE 2 - Net Loss Per Share</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. The Company has not included the effects of stock options on net loss per share for the past two fiscal years because to do so would be antidilutive. The Company has excluded from the computation of diluted net loss per share stock options to acquire 950,005 and 766,667 shares of common stock as of November 30, 2011 and 2010, respectively.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Following is the computation of basic and diluted net loss per share for the three months ended November 30, 2011 and 2010:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div align="left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="80%"> <tr> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three&#xA0;Months&#xA0;Ended</font></div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> November&#xA0;30,</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 2011</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 2010</font></font></div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td valign="bottom" width="76%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Basic and Diluted EPS Computation</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Numerator:</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td valign="bottom" width="76%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss available to common stockholders'</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(624,851</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,196,956</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td valign="bottom" width="76%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Denominator:</font></div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average number of common shares outstanding</font></div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 20,638,360</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> 19,692,018</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="#CCFFCC"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &#xA0;</font></td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic and diluted EPS</font></div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> (0.03</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#xA0;</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"> (0.06</font></font></td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td> </tr> </table> </div> </div> 82675 878 -156640 <div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">NOTE 8 - Subsequent Events</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During December 2011, management initiated a review of the costs associated with start-up operations, financing, and allocation of resources, and suspended all operations associated with Nakoda pending further review.</font></div> </div> -624851 156077 130192 20299 -780928 -32 52422 156109 650736 -620075 -30130 <div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">NOTE 1 - Organization and Summary of Significant Accounting Policies</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline"> Basis of Presentation</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The unaudited financial statements of New Energy Technologies, Inc. as of November 30, 2011, and for the three months ended November 30, 2011 and 2010, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial reporting. Accordingly, they do not include all of the disclosures required by accounting principles generally accepted in the United States for complete financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended August 31, 2011, as filed with the Securities and Exchange Commission as part of the Company's Form 10-K. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the interim financial information have been included. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline"> Organization</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">New Energy Technologies, Inc. (the &#x201C;Company&#x201D;) was incorporated in the State of Nevada on May 5, 1998, under the name &#x201C;Octillion Corp.&#x201D; On December 2, 2008, the Company amended its Articles of Incorporation to effect a change of name to New Energy Technologies, Inc. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Sungen Energy, Inc. (&#x201C;Sungen&#x201D;), Kinetic Energy Corporation (&#x201C;KEC&#x201D;), New Energy Solar Corporation (&#x201C;New Energy Solar&#x201D;) and Nakoda Energy, Inc. (&#x201C;Nakoda&#x201D;).</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Sungen was incorporated on July 11, 2006, in the State of Nevada and is currently inactive.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">KEC was incorporated on June 19, 2008, in the State of Nevada and holds the patents related to the Company&#x2019;s MotionPower&#x2122; technology. The Company&#x2019;s business activities related to the MotionPower&#x2122; technology are conducted through KEC.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">New Energy Solar was incorporated on February 9, 2009, in the State of Florida and has entered into a License Agreement, an Addendum to the License Agreement, an Option Agreement and a Sponsored Research Agreement with the University of South Florida Research Foundation, Inc.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 16, 2011, pursuant to a February 7, 2011, written consent signed by the shareholders owning a majority of the Company&#x2019;s issued and outstanding shares and a February 24, 2011, unanimous written consent of the Company&#x2019;s Board of Directors (the &#x201C;Board&#x201D;) (collectively the &#x201C;Consents&#x201D;), the Company underwent a one-for-three reverse stock split whereby holders of three shares of the Company&#x2019;s common stock as of March 15, 2011, received one share of its common stock after the reverse stock split, with all fractional shares being rounded up to the nearest whole share.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All share and per share amounts have been retrospectively restated to reflect the one-for-three reverse stock split effected March 16, 2011 and declared effective by the Financial Industry Regulatory Authority (&#x201C;FINRA&#x201D;) as of March 21, 2011.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 16, 2011, pursuant to the Consents, the Company filed a Certificate of Amendment to its Certificate of Incorporation increasing its authorized shares of common stock, $0.001 par value, from 100,000,000 to 300,000,000.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On August 19, 2011, the Company established Nakoda, a California corporation and wholly-owned subsidiary of the Company, which began operations in September 2011. Nakoda is an energy savings and management corporation that provides a broad range of energy solutions and savings projects with the goal of implementing energy conservation, load management, and reducing building energy consumption in target markets. During December 2011, management initiated a review of the costs associated with start-up operations, financing, and allocation of resources, and suspended all operations associated with Nakoda pending further review.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is a renewable and alternative energy company, actively developing two novel technologies for generating sustainable electricity, one of which harvests solar energy of the sun and artificial light, and the other harvests the available kinetic energy present in moving vehicles. The Company&#x2019;s proprietary, patent-pending technologies and products, which are the subjects of 43 patent-filings, have been invented, designed, engineered, and prototyped in preparation for further field testing, product development, and commercial deployment.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#x2019;s SolarWindow&#x2122; technology generates electricity when glass surfaces are sprayed with electricity-generating coatings, creating, semi-transparent, see-through solar cells. If successfully developed, SolarWindow&#x2122; could potentially be used on any of the more than 85 million commercial and residential buildings in the United States alone (U.S. Census Bureau, 2007 American Housing Survey &amp; U.S. Energy Information Administration, 2003 Commercial Buildings Energy Consumption Survey).</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#x2019;s MotionPower&#x2122; technology harvests the available kinetic or motion energy of cars, trucks, buses, and heavy commercial vehicles when they slow down before coming to a stop. MotionPower&#x2122; converts this captured energy into electricity. If successfully developed, MotionPower&#x2122; could potentially be used to harvest kinetic energy generated by any of the estimated 250 million vehicles registered in America (U.S. Department of Transportation Federal Highway Administration, 2008 Highway Statistics), which drive approximately six billion miles on our nation&#x2019;s roadways every day (U.S. Environmental Protection Agency).</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#x2019;s product development programs involve ongoing research and development efforts, and the commitment of significant resources to support the extensive invention, design, engineering, testing, prototyping, and intellectual property initiatives carried-out by its contract engineers, scientists, and consultants.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">Going Concern</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is a development stage company, does not have any commercialized products and has not generated any revenue since inception. The Company has an accumulated deficit of $10,972,777 as of November 30, 2011, and does not have positive cash flows from operating activities. The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates continuation of the Company as a going concern, which is dependent upon the Company&#x2019;s ability to establish itself as a profitable business.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In its report with respect to the Company&#x2019;s financial statements for the year ended August 31, 2011, the Company&#x2019;s independent auditors expressed substantial doubt about the Company&#x2019;s ability to continue as a going concern. Because the Company has not yet generated revenues from its operations and does not expect to do so in the near future, its ability to continue as a going concern is wholly dependent upon its ability to obtain additional financing. Currently, the Company is seeking additional financing but has no commitments to obtain any such financing, and there can be no assurance that financing will be available in amounts or on terms acceptable to the Company, if at all.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of November 30, 2011, the Company had cash and cash equivalents of $1,700,110. The Company will remain engaged in research and product development activities at least through November 30, 2012. Based upon its current and near term anticipated level of operations and expenditures, the Company believes that, absent any modification or expansion of its existing research, development and testing activities, cash on hand should be sufficient to enable it to continue operations through August 31, 2012. However, any significant expansion in scope or acceleration in timing of the Company&#x2019;s current research and development activities, or commencement of any marketing and sales activities, will require additional funds.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If adequate funds are not available on reasonable terms or at all, it would result in a material adverse effect on the Company&#x2019;s business, operating results, financial condition and prospects. In particular, the Company may be required to delay, reduce the scope of or terminate one or more of its research programs, sell rights to its SolarWindow&#x2122; technology and/or MotionPower<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TM</font> technology or other technologies or products based upon such technologies, or license the rights to such technologies or products on terms that are less favorable to the Company than might otherwise be available.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon achieving a profitable level of operations and on the ability of the Company to obtain necessary financing to fund ongoing operations. These consolidated financial statements do not give effect to any adjustments which will be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying consolidated financial statements.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline"> Summary of Significant Accounting Policies</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Principles of Consolidation</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">These consolidated financial statements presented are those of the Company and its wholly-owned subsidiaries, Sungen, KEC, New Energy Solar and Nakoda. All significant intercompany balances and transactions have been eliminated.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Estimates</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of the Company&#x2019;s consolidated financial statements requires management to make estimates and use assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. These estimates and assumptions are affected by management&#x2019;s application of accounting policies. On an on-going basis, the Company evaluates its estimates. Actual results and outcomes may differ materially from these estimates and assumptions.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Cash and Cash Equivalents</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash and cash equivalents includes highly liquid investments with original maturities of three months or less. On occasion, the Company has amounts deposited with financial institutions in excess of federally insured limits.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Reclassifications</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain reclassifications have been made to prior fiscal year amounts or balances to conform to the presentation adopted in the current fiscal year.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Fair Value Measurement</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company measures fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The Company utilizes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 1. Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. The Company has no assets or liabilities valued with Level 1 inputs.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 2. Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. The Company has no assets or liabilities valued with Level 2 inputs.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 3. Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company has no assets or liabilities valued with Level 3 inputs.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Fair Value of Financial Instruments</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying value of cash and cash equivalents, accounts payable, and accrued liabilities approximate their fair value because of the short-term nature of these instruments and their liquidity. Management is of the opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Research and Development</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development costs represent costs incurred to develop the Company&#x2019;s technology, including salaries and benefits for research and development personnel, allocated overhead and facility occupancy costs, supplies, equipment purchase and repair and other costs. Research and development costs are expensed when incurred, except for nonrefundable advance payments for future research and development activities which are capitalized and recognized as expense as the related services are performed.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the three months ended November 30, 2011 and 2010, the Company incurred $130,192 and $57,122 on research and development activities. From inception (May 5, 1998) to November 30, 2011, the Company incurred $2,047,888 on research and development activities.</font><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><!--EFPlaceholder--><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Stock-Based Compensation</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company measures all employee stock-based compensation awards using a fair value method on the date of grant and recognizes such expense in its consolidated financial statements over the requisite service period. The Company uses the Black-Scholes pricing model to determine the fair value of stock-based compensation awards on the date of grant. The Black-Scholes pricing model requires management to make assumptions regarding the warrant and option lives, expected volatility, and risk free interest rates. See &#x201C;Note 5 - Capital Stock&#x201D; and &#x201C;Note 6 - Stock Options&#x201D; for additional information on the Company&#x2019;s stock-based compensation plans.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Income Taxes</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accounts for income taxes using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credits and loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carry-forwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized. <!--EFPlaceholder-->The Company reports a liability for unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return. Estimated interest and penalties are recorded as a component of interest expense or other expense, respectively.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Segment Reporting</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#x2019;s business is considered as operating in one segment based upon the Company&#x2019;s organizational structure, the way in which the operations are managed and evaluated, the availability of separate financial results and materiality considerations.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Net Income (Loss) Per Share</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to ASC 260-10-45-10, the computation of basic earnings per share (&#x201C;EPS&#x201D;) is based on the weighted average number of shares that were outstanding during the period, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted EPS is based on the number of basic weighted-average shares outstanding plus the number of common shares that would be issued assuming the exercise of all potentially dilutive common shares outstanding using the treasury stock method. However, pursuant to ASC 260-10-45-17, the computation of diluted net income per share shall not assume conversion, exercise or contingent issuance of securities that would have an antidilutive effect on earnings per share. Therefore, when calculating EPS if the Company experienced a loss, there is no inclusion of dilutive securities as their inclusion in the EPS calculation is antidilutive. Furthermore, pursuant to ASC 260-10-45-25, options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants (they are in the money). See &#x201C;Note 2 - Net Loss Per Share&#x201D; for further discussion.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All share and per share amounts reflect the 1-for-3 reverse stock split declared effective on March 21, 2011 by FINRA.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline"> Recently Adopted Accounting Pronouncements</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company reviews new accounting standards as issued. Although some of these accounting standards issued or effective after the end of the Company&#x2019;s previous fiscal year may be applicable to the Company, it has not identified any standards that it believes merit further discussion. The Company believes that none of the new standards will have a significant impact on its consolidated financial statements.</font></div> </div> <div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">NOTE 7 - Related Party Transactions</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A related party is generally defined as (i) any person that holds 10% or more of the Company&#x2019;s securities and their immediate families, (ii) the Company&#x2019;s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For services rendered in the capacity of a Board member, non-employee Board members received $2,500 during our quarter ended November 30, 2010, and $3,750 per quarter starting in our second quarter ending February 28, 2011. New Board member compensation is pro rated in their first quarter. During the three months ended November 30, 2011 and 2010, the Company incurred $29,100 and $7,500, respectively in cash based Board compensation. Additionally, during the three months ended November 30, 2011 and 2010, the Company incurred $43,392 and $11,331, respectively in stock based compensation related to stock options granted (See &#x201C;Note 6 - Stock Options&#x201D; above) for services rendered by non-employee directors of the Company, which is included in professional fees.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">March 21, 2011, Todd Pitcher was elected to the Board and received $3,750 per quarter for his Board related services. On May 19, 2011, the Company entered into an Advisory Engagement Agreement (the &#x201C;Agreement&#x201D;) with Aspire Clean Tech Communications, Inc., a private corporation wholly owned by Todd Pitcher, Director. Pursuant to the Agreement Mr. Pitcher will provide ongoing corporate advisory and support services - until the parties agree otherwise in writing - in exchange for compensation of $3,500 per month plus reimbursement of business related, out-of-pocket expenses. On July 1, 2011, the Agreement was amended to increase the monthly compensation from $3,500 to $10,000 due to the increased level of time required for Mr. Pitcher to execute his duties. On September 30, 2011 the Agreement was further amended to include the addition of a $1,000 per month health insurance reimbursement retroactively applied to include the month of July 2011.</font><br /> <br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 8, 2011, Mr. Pitcher resigned from the Board and ceased performing services for the Company. The Company paid Mr. Pitcher $30,000 upon receipt of an executed Mutual Termination and Release.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 2, 2011, the Company entered into an employment agreement with Mr. Scott Taper pursuant to which Mr. Taper was appointed the Company&#x2019;s Vice President of Business Development. Pursuant to the terms of the employment agreement, Mr. Taper was entitled to an annual salary of $90,000, which would increase to $100,800 if certain milestone were met, and a stipend of $1,000 per month to cover medical insurance premiums until such time as the Company could provide an alternative medical insurance plan. The employment agreement provides that Mr. Taper&#x2019;s employment by the Company was &#x201C;at-will employment&#x201D; and may be terminated by Mr. Taper or the Company at any time, with or without cause, and for any reason whatsoever, upon written notice to the other. On February 28, 2011, Mr. Taper, resigned as the Company&#x2019;s Vice President of Business Development.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 1, 2011, the Company entered into a consultancy agreement with Mr. Elliot Maza pursuant to which Mr. Maza was appointed the Company&#x2019;s Chief Financial Officer. Pursuant to the terms of the consultancy agreement, Mr. Maza is entitled to a monthly fee of $7,500. The consultancy agreement provides that Mr. Maza&#x2019;s engagement is on a part-time basis and is &#x201C;at-will&#x201D; and may be terminated by Mr. Maza or the Company at any time, with or without cause, and for any reason whatsoever, upon written notice to the other. On August 31, 2011, Mr. Maza, resigned as the Company&#x2019;s CFO.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 17, 2010, the Company entered into an employment agreement with Mr. Farago pursuant to which Mr. Farago was appointed the Company&#x2019;s Chief Operating Officer. Pursuant to the employment agreement, Mr. Farago was entitled to an annual salary of $150,000, to increase to $250,000 if the Company consummates either an equity or debt financing or series of financings with net proceeds of at least $7,000,000 and a stipend of $1,000 per month to cover medical insurance premiums until such time as the Company could provide an alternative medical insurance plan. The employment agreement provides that Mr. Farago&#x2019;s employment by the Company was &#x201C;at-will employment&#x201D; and may be terminated by Mr. Farago or the Company at any time, with or without cause, and for any reason whatsoever, upon written notice to the other. Also on December 17, 2010, the Board approved, and the Company granted, Mr. Farago a stock option to purchase 500,000 shares of the Company&#x2019;s common stock at an exercise price of $6.21 per share, the fair market value of the Company&#x2019;s common stock on the date of grant. The stock option expires ten years from the date of grant and is subject to various vesting terms. Effective as of August 12, 2011, Mr. Andrew Farago resigned as the Chief Operating Officer. On the date of his resignation Mr. Fargo had vested 83,334 options which Mr. Farago has until August 12, 2012 to exercise.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The law firm of Sierchio &amp; Company, LLP, of which Joseph Sierchio, one of our directors, is a principal, has provided counsel to us since the Company's inception. In July 2008, the Company asked Mr. Sierchio to join the Company's Board. During the three months ended November 30, 2011 and 2010, the law firm of Sierchio &amp; Company, LLP provided $62,175 and $21,638, respectively, of legal services. At November 30, 2011, the Company owed S&amp;C LLP $40,800 which is included in accounts payable.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#x2019;s corporate office is located at 9192 Red Branch Road, Suite 110, Columbia, Maryland 21045. On December 1, 2009, the Company entered into a one year sublease agreement with MVP Law Group, P.A., of which the Company's former Chief Executive Officer and President is a founder. Mr. Patel sold this practice and has an &#x201C;Of Counsel&#x201D; relationship with MVP Law Group. Rent for this office space is $1,100 per month through November 30, 2011. The Company&#x2019;s sublease with MVP Law Group, P.A., renewed effective December 1, 2011, for an additional twelve months at $1,100 per month.</font></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <br /></div> <div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All related party transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.</font></div> </div> -0.03 -23853 20638360 <div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">NOTE 4 - MotionPower&#x2122; Technology</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Veryst Agreement</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through KEC the Company is a party to certain agreements with Veryst Engineering LLC, a Boston area engineering and consulting firm with experience in product development and energy harvesting; one dated November 4, 2008, two dated September 9, 2009 and one dated July 6, 2010 (collectively, the &#x201C;Veryst Agreements&#x201D;), all relating to the development of the Company&#x2019;s MotionPower<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TM</font> technologies. Pursuant to SEC Rule 24b-2, the Company submitted a request to the SEC for confidential treatment of certain portions of the November 4, 2008 agreement, relating to the payment terms, scope of work and the milestone terms of the agreement, which has been granted. Accordingly, certain terms and provisions of the November 4, 2008, agreement have not been disclosed.</font><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the three months ended November 30, 2011 and 2010, the Company recorded $2,564 and $10,533, respectively, as research and development expense pursuant to these agreements.<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#xA0;</font>From inception (May 5, 1998) to November 30, 2011, the Company recorded $560,880 as research and development expense pursuant to these agreements.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Veryst Engineering LLC has successfully completed its contracted services associated with the Veryst Agreements.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Sigma Design Agreement</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#xA0;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through KEC the Company continues to be a party to certain consulting agreements with Sigma Design Company, a Middlesex, New Jersey based engineering and design firm, pursuant to which Sigma Design provides ongoing engineering, product development and testing services primarily relating to the development of the Company&#x2019;s MotionPower&#x2122; technology.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the three months ended November 30, 2011 and 2010, the Company recorded $74,137 and $26,422, respectively, as research and development expense pursuant to these agreements. From inception (May 5, 1998) to November 30, 2011, the Company recorded $487,831, respectively, as research and development expense pursuant to these agreements. The Company continues to utilize Sigma Design Company on a consulting basis to further test, calibrate, and develop the Company&#x2019;s MotionPower&#x2122; technology.</font></div> </div> <div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="DISPLAY: inline; TEXT-DECORATION: underline">NOTE 3 - SolarWindow</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">&#x2122; Technology</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> <font style="FONT-STYLE: italic; DISPLAY: inline">Stevenson-Wydler Cooperative Research and Development Agreement with the Alliance for Sustainable Energy</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 18, 2011, in the Company&#x2019;s efforts to advance the commercial development of its SolarWindow&#x2122; technology, it entered into a Stevenson-Wydler Cooperative Research and Development Agreement (the &#x201C;CRADA&#x201D;) with the Alliance for Sustainable Energy, LLC, which is the operator of The National Renewable Energy Laboratory (&#x201C;NREL&#x201D;) under its U.S. Department of Energy contract. Under terms of the CRADA, NREL researchers will make use of the Company&#x2019;s exclusive intellectual property and NREL&#x2019;s background intellectual property in order to work towards specific product development goals.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to SEC Rule 24b-2, the Company submitted a request to the SEC for confidential treatment of certain portions of the CRADA, which has been granted. Accordingly, certain terms of the CRADA have not been disclosed. The disclosure of such confidential information may potentially harm the Company&#x2019;s competitive position and jeopardize its ability to effectively negotiate future development and sublicensing agreements on preferential terms; and, ongoing relationship with NREL and its ability to negotiate favorable terms with NREL in regards to the ongoing development of the Company&#x2019;s technologies.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the CRADA, during the three months ended November 30, 2011 and 2010, the Company recorded $33,668 and $0, respectively, as research and development expense. From inception (May 5, 1998) to November 30, 2011, the Company recorded $159,576 as research and development expense.</font><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> University of South Florida Research Foundation, Inc. License Agreement, Option Agreement and Sponsored Research Agreement</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through New Energy Solar the Company is a party to a License Agreement, an Addendum to the License Agreement, an Option Agreement and a Sponsored Research Agreement with the University of South Florida Research Foundation, Inc. These agreements provide for the Company&#x2019;s support of a project relating to the development of the SolarWindow&#x2122; technology and grant it an exclusive worldwide commercial license under certain patents relating to the SolarWindow&#x2122; technology. Pursuant to SEC Rule 24b-2, the Company has submitted requests to the SEC for confidential treatment of certain portions of these agreements, which have been granted. Accordingly, certain terms of these agreements have not been disclosed.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 5, 2011, the Company entered into a letter agreement pursuant to which the Company agreed to reimburse the University of South Florida (&#x201C;USF&#x201D;) for filing fees associated with USF&#x2019;s Provisional Patent and future PCT Applications (the &#x201C;Applications&#x201D;) for certain identified technologies (the &#x201C;Letter Agreement&#x201D;). Pursuant to the terms of the Letter Agreement, the Company committed to reimburse USF for all documented, out-of-pocket costs directly related to the filing and maintenance of the Applications. In return, USF granted the Company the exclusive right to negotiate a definitive option or license agreement with USF for the technologies underlying the Applications for a period of time after USF files a Provisional Patent for an identified technology (the &#x201C;Negotiation Period&#x201D;). Should the Negotiation Period expire without the Company and USF entering into an agreement, the Company could extend the Negotiation Period for an additional period of time by paying USF a one-time payment of a specified sum. If after this additional time the Company and USF fail to enter into an agreement, USF is free to enter into negotiations and license the underlying technologies to a third-party.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the three months ended November 30, 2011 and 2010, the Company recorded $17,853 and $20,167, respectively, as research and development expense pursuant to these agreements. From inception (May 5, 1998) to November 30, 2011, the Company recorded $308,723 as research and development expense pursuant to these agreements.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> University of Illinois at Urbana-Champaign Sponsored Research Agreement</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through Sungen the Company was a party to a Sponsored Research Agreement with the University of Illinois at Urbana-Champaign (&#x201C;UIUC&#x201D;) that provided for the Company&#x2019;s support of the development of a new technology to integrate films of silicon nanoparticle material on glass substrates. This agreement expired on August 22, 2008. As of such date, the Company had advanced a total of $266,709 to UIUC pursuant to the terms of the agreement. Pursuant to the terms of the agreement, the Company was to advance an additional $156,109 to UIUC, which is included in other accrued liabilities at August 31, 2011. The Company had not made the advance as the advance was contingent on the determination as to whether funds previously paid to UIUC under the terms of the agreement had been fully expended. The Company was of the opinion that to the extent these funds were not expended, they are refundable to the Company.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the three months ended November 30, 2011, The Company evaluated the status of the aforementioned agreement and related contingent liability to UIUC. The Company determined that the $156,109 liability is no longer valid and has been eliminated to other income.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has not recorded any research and development expense pursuant to this agreement since its fiscal year ending August 31, 2008. During the period from inception (May 5, 1998) to August 31, 2011, the Company recorded $422,818 as research and development expense pursuant to this agreement and a $156,109 credit to other income during the three months ended November 30, 2011.</font></div> </div> 8243 -624851 82675 -8243 -624851 82675 -8243 0001071840 nene:StockIssuedReversalMember 2011-09-01 2011-11-30 0001071840 nene:StockIssuedMember 2011-09-01 2011-11-30 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2011-09-01 2011-11-30 0001071840 nene:StockIssuedReversalMemberus-gaap:AdditionalPaidInCapitalMember 2011-09-01 2011-11-30 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMember 2011-09-01 2011-11-30 0001071840 us-gaap:ComprehensiveIncomeMember 2011-09-01 2011-11-30 0001071840 2011-09-01 2011-11-30 0001071840 2010-09-01 2010-11-30 0001071840 1998-05-05 2011-11-30 0001071840 nene:StockIssuedMember 2007-09-01 2008-08-31 0001071840 nene:StockIssuedMembernene:ClassFWarrantsMember 2007-09-01 2008-08-31 0001071840 nene:StockIssuedMembernene:ClassDWarrantsMember 2007-09-01 2008-08-31 0001071840 nene:StockIssuedMembernene:ClassCWarrantsMember 2007-09-01 2008-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2007-09-01 2008-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMember 2007-09-01 2008-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassFWarrantsMember 2007-09-01 2008-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassDWarrantsMember 2007-09-01 2008-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassCWarrantsMember 2007-09-01 2008-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2007-09-01 2008-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2007-09-01 2008-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassFWarrantsMember 2007-09-01 2008-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassDWarrantsMember 2007-09-01 2008-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassCWarrantsMember 2007-09-01 2008-08-31 0001071840 us-gaap:CommonStockMember 2007-09-01 2008-08-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2007-09-01 2008-08-31 0001071840 2007-09-01 2008-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2003-09-01 2004-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2003-09-01 2004-08-31 0001071840 2003-09-01 2004-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 1999-09-01 2000-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 1999-09-01 2000-08-31 0001071840 1999-09-01 2000-08-31 0001071840 nene:StockIssuedReversalMember 2010-09-01 2011-08-31 0001071840 nene:StockIssuedMember 2010-09-01 2011-08-31 0001071840 nene:StockIssuedMembernene:ClassFWarrantsMember 2010-09-01 2011-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2010-09-01 2011-08-31 0001071840 nene:StockIssuedReversalMemberus-gaap:AdditionalPaidInCapitalMember 2010-09-01 2011-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMember 2010-09-01 2011-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassFWarrantsMember 2010-09-01 2011-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2010-09-01 2011-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2010-09-01 2011-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassFWarrantsMember 2010-09-01 2011-08-31 0001071840 us-gaap:CommonStockMember 2010-09-01 2011-08-31 0001071840 2010-09-01 2011-08-31 0001071840 nene:StockIssuedReversalMember 2009-09-01 2010-08-31 0001071840 nene:StockIssuedMember 2009-09-01 2010-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2009-09-01 2010-08-31 0001071840 nene:StockIssuedReversalMemberus-gaap:AdditionalPaidInCapitalMember 2009-09-01 2010-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMember 2009-09-01 2010-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2009-09-01 2010-08-31 0001071840 nene:ASC81540Membernene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2009-09-01 2010-08-31 0001071840 nene:ASC81540Memberus-gaap:AdditionalPaidInCapitalMember 2009-09-01 2010-08-31 0001071840 nene:ASC81540Member 2009-09-01 2010-08-31 0001071840 2009-09-01 2010-08-31 0001071840 nene:StockIssuedReversalMember 2008-09-01 2009-08-31 0001071840 nene:StockIssuedMember 2008-09-01 2009-08-31 0001071840 nene:StockIssuedMembernene:ClassFWarrantsMember 2008-09-01 2009-08-31 0001071840 nene:StockIssuedMembernene:ClassEWarrantsMember 2008-09-01 2009-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2008-09-01 2009-08-31 0001071840 nene:StockIssuedReversalMemberus-gaap:AdditionalPaidInCapitalMember 2008-09-01 2009-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMember 2008-09-01 2009-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassFWarrantsMember 2008-09-01 2009-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassEWarrantsMember 2008-09-01 2009-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2008-09-01 2009-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassFWarrantsMember 2008-09-01 2009-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassEWarrantsMember 2008-09-01 2009-08-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2008-09-01 2009-08-31 0001071840 2008-09-01 2009-08-31 0001071840 nene:StockIssuedMembernene:ClassEWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMembernene:ClassDWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMembernene:ClassCWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMembernene:ClassBWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMembernene:ClassAWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassEWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassDWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassCWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassBWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMemberus-gaap:AdditionalPaidInCapitalMembernene:ClassAWarrantsMember 2006-09-01 2007-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2006-09-01 2007-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassEWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassDWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassCWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassBWarrantsMember 2006-09-01 2007-08-31 0001071840 nene:StockIssuedMemberus-gaap:CommonStockMembernene:ClassAWarrantsMember 2006-09-01 2007-08-31 0001071840 us-gaap:CommonStockMember 2006-09-01 2007-08-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2006-09-01 2007-08-31 0001071840 2006-09-01 2007-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2005-09-01 2006-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2005-09-01 2006-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2005-09-01 2006-08-31 0001071840 us-gaap:CommonStockMember 2005-09-01 2006-08-31 0001071840 2005-09-01 2006-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2004-09-01 2005-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2004-09-01 2005-08-31 0001071840 2004-09-01 2005-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2002-09-01 2003-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2002-09-01 2003-08-31 0001071840 nene:StockIssuedMemberus-gaap:ProfessionalFeesMembernene:RelatedPartyTransactionsMember 2002-09-01 2003-08-31 0001071840 nene:StockIssuedMemberus-gaap:ProfessionalFeesMembernene:RelatedPartyTransactionsMemberus-gaap:AdditionalPaidInCapitalMember 2002-09-01 2003-08-31 0001071840 nene:StockIssuedMemberus-gaap:ProfessionalFeesMembernene:RelatedPartyTransactionsMemberus-gaap:CommonStockMember 2002-09-01 2003-08-31 0001071840 2002-09-01 2003-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2001-09-01 2002-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2001-09-01 2002-08-31 0001071840 2001-09-01 2002-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2000-09-01 2001-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2000-09-01 2001-08-31 0001071840 2000-09-01 2001-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 1998-09-01 1999-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 1998-09-01 1999-08-31 0001071840 1998-09-01 1999-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 1998-05-05 1998-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 1998-05-05 1998-08-31 0001071840 nene:StockIssuedMemberus-gaap:ProfessionalFeesMembernene:RelatedPartyTransactionsMember 1998-05-05 1998-08-31 0001071840 nene:StockIssuedMemberus-gaap:ProfessionalFeesMembernene:RelatedPartyTransactionsMemberus-gaap:CommonStockMember 1998-05-05 1998-08-31 0001071840 nene:StockIssuedMembernene:ThirdPartyMember 1998-05-05 1998-08-31 0001071840 nene:StockIssuedMembernene:ThirdPartyMemberus-gaap:AdditionalPaidInCapitalMember 1998-05-05 1998-08-31 0001071840 nene:StockIssuedMembernene:ThirdPartyMemberus-gaap:CommonStockMember 1998-05-05 1998-08-31 0001071840 1998-05-05 1998-08-31 0001071840 nene:StockIssuedMembernene:ClassFWarrantsMember 2011-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2011-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2011-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2011-08-31 0001071840 us-gaap:CommonStockMember 2011-08-31 0001071840 2011-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2010-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2010-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2010-08-31 0001071840 us-gaap:CommonStockMember 2010-08-31 0001071840 2010-08-31 0001071840 nene:StockIssuedMembernene:ClassFWarrantsMember 2009-08-31 0001071840 nene:StockIssuedMembernene:ClassEWarrantsMember 2009-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2009-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2009-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2009-08-31 0001071840 us-gaap:CommonStockMember 2009-08-31 0001071840 2009-08-31 0001071840 nene:StockIssuedMembernene:ClassFWarrantsMember 2008-08-31 0001071840 nene:StockIssuedMembernene:ClassDWarrantsMember 2008-08-31 0001071840 nene:StockIssuedMembernene:ClassCWarrantsMember 2008-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2008-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2008-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2008-08-31 0001071840 us-gaap:CommonStockMember 2008-08-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2008-08-31 0001071840 2008-08-31 0001071840 nene:StockIssuedMembernene:ClassEWarrantsMember 2007-08-31 0001071840 nene:StockIssuedMembernene:ClassDWarrantsMember 2007-08-31 0001071840 nene:StockIssuedMembernene:ClassCWarrantsMember 2007-08-31 0001071840 nene:StockIssuedMembernene:ClassBWarrantsMember 2007-08-31 0001071840 nene:StockIssuedMembernene:ClassAWarrantsMember 2007-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2007-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2007-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2007-08-31 0001071840 us-gaap:CommonStockMember 2007-08-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2007-08-31 0001071840 2007-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2006-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2006-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2006-08-31 0001071840 us-gaap:CommonStockMember 2006-08-31 0001071840 2006-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2005-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2005-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2005-08-31 0001071840 us-gaap:CommonStockMember 2005-08-31 0001071840 2005-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2004-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2004-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2004-08-31 0001071840 us-gaap:CommonStockMember 2004-08-31 0001071840 2004-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2003-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2003-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2003-08-31 0001071840 us-gaap:CommonStockMember 2003-08-31 0001071840 nene:StockIssuedMemberus-gaap:ProfessionalFeesMembernene:RelatedPartyTransactionsMember 2003-08-31 0001071840 2003-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2002-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2002-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2002-08-31 0001071840 us-gaap:CommonStockMember 2002-08-31 0001071840 2002-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2001-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2001-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2001-08-31 0001071840 us-gaap:CommonStockMember 2001-08-31 0001071840 2001-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2000-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2000-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 2000-08-31 0001071840 us-gaap:CommonStockMember 2000-08-31 0001071840 2000-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 1999-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 1999-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 1999-08-31 0001071840 us-gaap:CommonStockMember 1999-08-31 0001071840 1999-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 1998-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 1998-08-31 0001071840 us-gaap:ComprehensiveIncomeMember 1998-08-31 0001071840 us-gaap:CommonStockMember 1998-08-31 0001071840 nene:StockIssuedMemberus-gaap:ProfessionalFeesMembernene:RelatedPartyTransactionsMember 1998-08-31 0001071840 1998-08-31 0001071840 nene:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember 2011-11-30 0001071840 us-gaap:AdditionalPaidInCapitalMember 2011-11-30 0001071840 us-gaap:ComprehensiveIncomeMember 2011-11-30 0001071840 us-gaap:CommonStockMember 2011-11-30 0001071840 2011-11-30 0001071840 2010-11-30 0001071840 2012-01-11 shares iso4217:USD iso4217:USD shares EX-101.SCH 5 nene-20111130.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - CONSOLIDATED BALANCE SHEETS link:calculationLink link:presentationLink link:definitionLink 104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:calculationLink link:presentationLink link:definitionLink 106 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) link:calculationLink link:presentationLink link:definitionLink 107 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 108 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Organization and Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Net Loss Per Share link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - SolarWindow Technology link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - MotionPower Technology link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Capital Stock link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Stock Options link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Related Party Transactions link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Subsequent Events link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 6 nene-20111130_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 nene-20111130_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 nene-20111130_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 9 nene-20111130_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Loss Per Share
3 Months Ended
Nov. 30, 2011
Net Loss Per Share
NOTE 2 - Net Loss Per Share

Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. The Company has not included the effects of stock options on net loss per share for the past two fiscal years because to do so would be antidilutive. The Company has excluded from the computation of diluted net loss per share stock options to acquire 950,005 and 766,667 shares of common stock as of November 30, 2011 and 2010, respectively.

Following is the computation of basic and diluted net loss per share for the three months ended November 30, 2011 and 2010:

   
Three Months Ended
 
   
November 30,
 
   
2011
   
2010
 
Basic and Diluted EPS Computation
           
Numerator:
           
Loss available to common stockholders'
  $ (624,851 )   $ (1,196,956 )
                 
Denominator:
               
Weighted average number of common shares outstanding
    20,638,360       19,692,018  
                 
Basic and diluted EPS
  $ (0.03 )   $ (0.06 )
EXCEL 12 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C8C0R9C'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E-/3$E$051%1%]35$%414U%3E137T]&7T-! M4SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYE=%],;W-S7U!E#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-O;&%R5VEN9&]W7U1E M8VAN;VQO9WD\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-T;V-K7T]P=&EO;G,\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U8G-E<75E;G1?179E;G1S/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T M/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^9F%L'0^3F]V(#,P+`T*"0DR,#$Q M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^,C`Q,CQS<&%N/CPO'0^43$\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!#;VUM M;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D M/@T*("`@("`@("`\=&0@8VQA3PO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$F5D+"!N;R!S:&%R97,@:7-S=65D(&%N9"!O=71S M=&%N9&EN9R!A="!.;W9E;6)E3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XQ+#`P,"PP,#`\'0^)FYB'0^)FYB'0^)FYB'0^)FYB7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&-H86YG92!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M/B@S,BD\'!E;G-E M*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!787)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!787)R86YT'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!4'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$&5R8VES92!O9B!787)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES M92!O9B!787)R86YT'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!787)R86YT'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$&5R8VES92!O9B!787)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES M92!O9B!787)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!787)R86YT M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&5R8VES92!O9B!787)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!787)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!7 M87)R86YT'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'!E;G-E(&1U92!T;R!F;W)F96ET=7)E(&]F M('-T;V-K(&]P=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5D(&%S3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S2!N;W1E'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!F:6YA M;F-I;F<@86-T:79I=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S('!A:60@:6X@8V%S:#PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)FYB'0^)FYB'0^)FYB3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/&1I=CX-"CQD M:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[(%1%6%0M M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SX-"D)A6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@ M2!A8V-E M<'1E9"!I;B!T:&4@56YI=&5D(%-T871E2!A8V-E<'1E9"!I;@T*=&AE(%5N M:71E9"!3=&%T97,@9F]R(&-O;7!L971E(&9I;F%N8VEA;"!S=&%T96UE;G1S M(&%N9"!S:&]U;&0@8F4-"G)E860@:6X@8V]N:G5N8W1I;VX@=VET:"!T:&4@ M875D:71E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L#0IS=&%T96UE;G1S(&%N M9"!N;W1E65A&-H M86YG92!#;VUM:7-S:6]N(&%S('!A3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.97<-"D5N97)G M>2!496-H;F]L;V=I97,L($EN8RX@*'1H92`F(W@R,#%#.T-O;7!A;GDF(W@R M,#%$.RD@=V%S#0II;F-O#(P,4,[3V-T M:6QL:6]N($-O2!A;F0@:71S#0IW:&]L;'DM;W=N960@#(P,4,[3F5W#0I%;F5R9WD@4V]L87(F(W@R,#%$.RD@86YD($YA:V]D M82!%;F5R9WDL($EN8RX-"B@F(W@R,#%#.TYA:V]D828C>#(P,40[*2X\+V9O M;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@3X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!A6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX- M"CQD:78@2!O9B!3;W5T:"!&;&]R:61A(%)E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/ M;@T*36%R8V@@,38L(#(P,3$L('!U2!O9B!T:&4@0V]M<&%N>28C>#(P,3D[ M#(P M,4,[0V]N2!U;F1E0T* M:&]L9&5R6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@2!T:&4@1FEN86YC:6%L($EN9'5S=')Y M(%)E9W5L871O2`H)B-X,C`Q0SM&24Y2028C>#(P,40[ M*2!A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@ M+SX\+V1I=CX-"CQD:78@2!F:6QE9"!A#0I#97)T:69I8V%T92!O M9B!!;65N9&UE;G0@=&\@:71S($-E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/ M;@T*075G=7-T(#$Y+"`R,#$Q+"!T:&4@0V]M<&%N>2!E2UO M=VYE9"!S=6)S:61I87)Y(&]F('1H92!#;VUP86YY+"!W:&EC:"!B96=A;@T* M;W!E2!S879I;F=S(&%N9`T*;6%N86=E;65N="!C;W)P;W)A=&EO;B!T:&%T M('!R;W9I9&5S(&$@8G)O860@0T*8V]N6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4 M:&4-"D-O;7!A;GD@:7,@82!R96YE=V%B;&4@86YD(&%L=&5R;F%T:79E(&5N M97)G>2!C;VUP86YY+"!A8W1I=F5L>0T*9&5V96QO<&EN9R!T=V\@;F]V96P@ M=&5C:&YO;&]G:65S(&9O2!O M9B!T:&4@2!P6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"D-O;7!A;GDF(W@R M,#$Y.W,@4V]L87)7:6YD;W#(Q,C([(&-O=6QD('!O=&5N=&EA;&QY(&)E#0IU2!O9B!T M:&4@;6]R92!T:&%N(#@U(&UI;&QI;VX@8V]M;65R8VEA;"!A;F0@2`F86UP.R!5+E,N($5N97)G>2!);F9O3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE2!C;VUM97)C:6%L('9E:&EC;&5S('=H96X@=&AE>2!S;&]W(&1O=VX@ M8F5F;W)E(&-O;6EN9R!T;R!A#0IS=&]P+B!-;W1I;VY0;W=E#(Q,C([ M(&-O;G9E#(Q,C([(&-O=6QD#0IP;W1E;G1I86QL>2!B92!U2!O9@T*=&AE(&5S=&EM M871E9"`R-3`@;6EL;&EO;B!V96AI8VQE"!B:6QL:6]N M(&UI;&5S(&]N#0IO=7(@;F%T:6]N)B-X,C`Q.3MS(')O861W87ES(&5V97)Y M(&1A>2`H52Y3+B!%;G9I2DN M/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:R<^/&)R("\^/"]D:78^#0H\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"D-O;7!A;GDF M(W@R,#$Y.W,@<')O9'5C="!D979E;&]P;65N="!P'1E;G-I=F4@:6YV96YT:6]N+"!D97-I9VXL(&5N M9VEN965R:6YG+`T*=&5S=&EN9RP@<')O=&]T>7!I;F6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SY';VEN9PT*0V]N8V5R;CPO M9F]N=#X\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@2!I2!A28C>#(P,3D[6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\ M8G(@+SX\+V1I=CX-"CQD:78@28C>#(P,3D[28C>#(P,3D[2!T;R!C;VYT:6YU92!A65T(&=E;F5R871E9"!R979E;G5E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY! M2!W:6QL(')E;6%I;B!E;F=A9V5D(&EN(')E2!M;V1I9FEC871I;VX@;W(-"F5X<&%N28C>#(P,3D[2!M87)K971I;F<@86YD('-A;&5S(&%C=&EV:71I97,L('=I;&P@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\ M+V1I=CX-"CQD:78@2!B92!R97%U:7)E9"!T;R!D96QA>2P@#(Q,C([('1E8VAN;VQO9WD@86YD+V]R($UO=&EO;E!O=V5R M/&9O;G0@'0M=&]P)SY433PO9F]N=#X-"G1E8VAN M;VQO9WD@;W(@;W1H97(@=&5C:&YO;&]G:65S(&]R('!R;V1U8W1S(&)A6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY);@T*=FEE=R!O9B!T:&5S92!C;VYD:71I;VYS M+"!T:&4@86)I;&ET>2!O9B!T:&4@0V]M<&%N>2!T;R!C;VYT:6YU92!A2!O9@T*=&AE($-O;7!A M;GD@=&\@;V)T86EN(&YE8V5S2!F:6YA;F-I;F<@=&\@9G5N9"!O;F=O M:6YG#0IO<&5R871I;VYS+B!4:&5S92!C;VYS;VQI9&%T960@9FEN86YC:6%L M('-T871E;65N=',@9&\@;F]T(&=I=F4-"F5F9F5C="!T;R!A;GD@861J=7-T M;65N=',@=VAI8V@@=VEL;"!B92!N96-E2!B92!U;F%B;&4@=&\@8V]N=&EN=64@87,@82!G;VEN9R!C;VYC97)N M(&%N9"!T:&5R969OF4@:71S(&%S M6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/@T*4')I;F-I<&QE3XF(WA!,#L\ M+V1I=CX-"CQD:78@0T*4V]L87(@86YD($YA:V]D82X@06QL('-I9VYI9FEC86YT(&EN M=&5R8V]M<&%N>2!B86QA;F-E6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX- M"CQD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1J=7-T:69Y/B8C>$$P.SPO9&EV/@T*/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!M86YA9V5M96YT)B-X,C`Q.3MS(&%P<&QI M8V%T:6]N(&]F#0IA8V-O=6YT:6YG('!O;&EC:65S+B!/;B!A;B!O;BUG;VEN M9R!B87-I6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0G/@T*0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87-H#0IA;F0@8V%S:"!E<75I M=F%L96YT&-E2!I;G-U6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX\+V1I=CX-"CQD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY#97)T86EN#0IR96-L87-S:69I8V%T:6]N65A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI M8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/@T*1F%I6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J M=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4- M"D-O;7!A;GD@;65A&ET('!R:6-E*2!I;B!A M;@T*;W)D97)L>2!T2P@=VAI8V@-"G!R:6]R:71I M>F5S('1H92!I;G!U=',@=7-E9"!I;B!T:&4@=F%L=6%T:6]N(&UE=&AO9&]L M;V=I97,@:6X-"FUE87-U2!T;PT*86-C97-S+B!4:&4@0V]M<&%N>2!H87,@;F\@87-S M971S(&]R(&QI86)I;&ET:65S('9A;'5E9"!W:71H($QE=F5L#0HQ(&EN<'5T M6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@2!H87,@;F\@87-S971S(&]R(&QI M86)I;&ET:65S#0IV86QU960@=VET:"!,979E;"`S(&EN<'5T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"F-A6%B;&4L(&%N9`T*86-C6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@ M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*4F5S96%R8V@@86YD($1E=F5L;W!M96YT M/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3XF(WA!,#L\+V1I=CX-"CQD:78@ M&-E<'0@9F]R(&YO;G)E9G5N9&%B M;&4@861V86YC92!P87EM96YT6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\ M+V1I=CX-"CQD:78@2`U+"`Q.3DX*2!T M;R!.;W9E;6)E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J M=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0G/@T*4W1O8VLM0F%S960@0V]M<&5N3XF(WA!,#L\+V1I=CX-"CQD:78@2!M96%S=7)E#(P,4,[3F]T92`V("T@4W1O8VL@ M3W!T:6]N#(P,40[#0IF;W(@861D:71I;VYA;"!I;F9O28C>#(P,3D[6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`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`T*<&]S:71I;VYS('1A:V5N M(&]R(&5X<&5C=&5D('1O(&)E('1A:V5N(&EN(&%N(&EN8V]M92!T87@@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX\+V1I=CX-"CQD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY4:&4-"D-O;7!A;GDF(W@R,#$Y.W,@8G5S:6YEF%T:6]N86P@3X\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX-"DYE="!);F-O;64@*$QO6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0=7)S=6%N M=`T*=&\@05-#(#(V,"TQ,"TT-2TQ,"P@=&AE(&-O;7!U=&%T:6]N(&]F(&)A M#(P,4,[15!3)B-X,C`Q1#LI M(&ES(&)A&5R8VES92!O M9B!A;&P-"G!O=&5N=&EA;&QY(&1I;'5T:79E(&-O;6UO;B!S:&%R97,@;W5T M&5R8VES92!O2!S=&]C:R!M971H;V0@;VYL>2!W:&5N('1H92!A M=F5R86=E(&UA&-E961S('1H92!E>&5R8VES92!P2DN(%-E92`F(W@R,#%#.TYO=&4@,@T*+2!.970@3&]S3X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L M:6YE)SX-"E)E8V5N=&QY($%D;W!T960@06-C;W5N=&EN9R!06QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD M:78@2!R979I97=S(&YE=R!A8V-O=6YT:6YG('-T86YD87)D7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@ M+SX\+V1I=CX-"CQD:78@2X\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T)SXF(WA!,#L\ M+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/@T* M/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A M<#X-"CQD:78@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X-"CQD:78@$$P.SPO9F]N=#X\+W1D/@T*/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R M87`^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/"]T$$P.SPO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,2PQ.38L.34V/"]F;VYT M/CPO=&0^#0H\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^#0H\+W1R M/@T*/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W-B4^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@$$P M.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*/"]T6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@.7!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY796EG:'1E9`T*879E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^#0HR,"PV,S@L,S8P/"]F;VYT M/CPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^#0HQ M.2PV.3(L,#$X/"]F;VYT/CPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE$$P M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^#0HH,"XP,SPO M9F]N=#X\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T M<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[(%1%6%0M1$5# M3U)!5$E/3CH@=6YD97)L:6YE)SY.3U1%(#,@+0T*4V]L87)7:6YD;W<\+V9O M;G0^/&9O;G0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^#0H\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1) M4U!,05DZ(&EN;&EN92<^4W1E=F5N3PO9F]N=#X\+V9O;G0^ M/"]D:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@#(P,4,[0U)!1$$F(W@R,#%$.RD@=VET M:"!T:&4@06QL:6%N8V4-"F9O2!,86)O6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@F4@:71S(&%B:6QI='D@=&\@ M969F96-T:79E;'D@;F5G;W1I871E(&9U='5R92!D979E;&]P;65N=`T*86YD M('-U8FQI8V5N3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!R96-O2!R96-O6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@ M+SX\+V1I=CX-"CQD:78@2!O9B!3;W5T:"!&;&]R:61A(%)E3X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!O9B!3;W5T:"!& M;&]R:61A#0I297-E87)C:"!&;W5N9&%T:6]N+"!);F,N(%1H97-E(&%G2X@4'5R2!H87,@2P@8V5R=&%I;B!T97)M M6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@#(P,4,[55-&)B-X,C`Q1#LI(&9O#(P,3D[2`H=&AE("8C>#(P,4,[3F5G;W1I871I;VX@4&5R:6]D)B-X,C`Q M1#LI+@T*4VAO=6QD('1H92!.96=O=&EA=&EO;B!097)I;V0@97AP:7)E('=I M=&AO=70@=&AE($-O;7!A;GD@86YD(%531@T*96YT97)I;F<@:6YT;R!A;B!A M9W)E96UE;G0L('1H92!#;VUP86YY(&-O=6QD(&5X=&5N9"!T:&4-"DYE9V]T M:6%T:6]N(%!E2!P87EI;F<@55-&(&$-"F]N92UT:6UE('!A>6UE;G0@;V8@82!S<&5C M:69I960@3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE0T*6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I M=CX-"CQD:78@2!O9B!);&QI;F]I6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY4:')O=6=H#0I3=6YG96X@=&AE($-O;7!A;GD@=V%S M(&$@<&%R='D@=&\@82!3<&]N2!H860@;F]T#0IM861E M('1H92!A9'9A;F-E(&%S('1H92!A9'9A;F-E('=A'1E;G0@=&AE3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE2!E=F%L=6%T960@=&AE#0IS=&%T=7,@;V8@ M=&AE(&%F;W)E;65N=&EO;F5D(&%G3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE'!E;G-E('!U M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3QB3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE3PO M9F]N=#X\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@7-T($%G6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4 M:')O=6=H#0I+14,@=&AE($-O;7!A;GD@:7,@82!P87)T>2!T;R!C97)T86EN M(&%G2`V+`T*,C`Q,"`H8V]L;&5C=&EV96QY+"!T:&4@)B-X,C`Q0SM697)Y#(P,40[*2P@86QL#0IR96QA=&EN9R!T;R!T:&4@9&5V M96QO<&UE;G0@;V8@=&AE($-O;7!A;GDF(W@R,#$Y.W,-"DUO=&EO;E!O=V5R M/&9O;G0@'0M=&]P)SY433PO9F]N=#X-"G1E8VAN M;VQO9VEE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\ M8G(@+SX\+V1I=CX-"CQD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$=7)I;F<- M"G1H92!T:')E92!M;VYT:',@96YD960@3F]V96UB97(@,S`L(#(P,3$@86YD M(#(P,3`L('1H92!#;VUP86YY#0IR96-O2P@87,@3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE7-T($%G6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M5T5)1TA4.B!B;VQD)SX-"E-I9VUA($1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1J=7-T:69Y/B8C>$$P.SPO9&EV/@T*/&1I=B!S='EL M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF M>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE"P@3F5W($IE2!B87-E9`T*96YG M:6YE97)I;F<@86YD(&1E2!R96QA=&EN9R!T;R!T:&4@9&5V96QO<&UE;G0@;V8@=&AE#0I#;VUP M86YY)B-X,C`Q.3MS($UO=&EO;E!O=V5R)B-X,C$R,CL@=&5C:&YO;&]G>2X\ M+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@2P@87,@'!E M;G-E('!U2!R96-O2P@87,@ M28C>#(P,3D[#(Q,C([('1E M8VAN;VQO9WDN/"]F;VYT/CPO9&EV/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C8C0R9C'0O:'1M;#L@ M8VAA'0^/&1I=CX-"CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@5$585"U$14-/4D%4 M24]..B!U;F1E3X\ M9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^#0I06QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C>$$P.SPO9&EV/@T*/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S M=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE2!T;R!I"!T:&4@;G5M8F5R(&]F('-H87)E2!S=6-H('-E'1E;G0@<&5R;6ET=&5D(&)Y('1H90T*;&%W M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI M8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SX-"E)E M=F5R6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C M>$$P.SPO9&EV/@T*/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@3XF(WA!,#L\+V1I=CX-"CQD:78@2`Q M,BP@,C`P."P@=&AE($-O;7!A;GD@8V]N3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE2!A9&]P=&5D(&=U M:61A;F-E('=H:6-H(&ES(&YO=R!P87)T#0IO9B!&:6YA;F-I86P@06-C;W5N M=&EN9R!3=&%N9&%R9',@0F]A#(P,4,[1D%30B8C>#(P,40[*0T* M06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D:69I8V%T:6]N("@F(W@R,#%#.T%3 M0R8C>#(P,40[*2`X,34M-#`L#0H\9F]N="!S='EL93TS1"=&3TY4+5-464Q% M.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^0V]N=')A8W1S(&EN#0I%;G1I M='DF(W@R,#$Y.W,@3W=N($5Q=6ET>2X\+V9O;G0^(%1H92!#;VUP86YY(&1E M=&5R;6EN960@=&AA="!I=',-"D-L87-S($8@0V%L;&%B;&4@5V%R2X@5&AE#0I#;VUP86YY)B-X,C`Q.3MS($-L M87-S($8@0V%L;&%B;&4@5V%R65A M&5R8VES960@ M,2PP-30L-3$R($-L87-S($8-"D-A;&QA8FQE(%=A&5R8VES960@0VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]C8C0R9C'0O:'1M;#L@8VAA'0^/&1I=CX- M"CQD:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^#0H\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SY. M3U1%(#8@+0T*4W1O8VL@3W!T:6]N6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX\+V1I=CX-"CQD:78@#(P,4,[,C`P-B!3=&]C:R!0;&%N M)B-X,C`Q1#LI('1H870@<')O=FED97,-"F9O28C>#(P,3D[2!T:&4@ M<&QA;B!A9&UI;FES=')A=&]R+@T*4W1O8VL@;W!T:6]N'!I65A3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE#(P,4,[3U1#44(F(W@R,#%$ M.RDL(&]R+"!I9B!T:&4@0V]M<&%N>28C>#(P,3D[6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@ M2!M96%S=7)E'!E8W1E9"!V M;VQA=&EL:71Y+"!A;F0@2P@=&AE(&5X<&5NF5D(&]V97(@=&AE(&QI9F4@;V8@=&AE(&]P=&EO;BX\+V9O;G0^ M/"]D:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@6EE;&0@ M8W5R=F4-"FEN(&5F9F5C="!A="!T:&4@=&EM92!O9B!G2!D;V5S(&YO M="!A;G1I8VEP871E(&1E8VQA#(P,4,[ M#(P,40[(&UE=&AO9`T*9F]R(&1E=&5R;6EN:6YG('1H M92!E>'!E8W1E9"!T97)M(&]F(&ET'!E8W1E9"!T;PT*=F5S="X@ M5&AE2!A<'!L:65S(&%N(&5S=&EM871E9"!F M;W)F96ET=7)E(')A=&4-"G1H870@:7,@9&5R:79E9"!F'!E8W1E9"!F=71U3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE65A$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^ M#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^/&9O;G0@$$P.V]F/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/<'1I;VYS/"]F;VYT/CPO M9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X- M"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY796EG:'1E9#PO9F]N=#X\+V1I=CX-"CQD:78@ M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#(S)3X-"CQD:78@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O M;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,"4@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY!9V=R96=A=&4\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,B!N;W=R87`],T1N M;W=R87`^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#(S)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE$$P M.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P M)2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^#0H\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXY,#`L,#`S/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/"]T$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T* M/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXU+CDW/"]F;VYT/CPO=&0^#0H\=&0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\ M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@ M8V]L$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY%>&5R8VES97,\+V9O;G0^/"]D:78^#0H\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX-"B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-S,L,S,T/"]F;VYT/CPO M=&0^#0H\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/@T*/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#(S)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$P)2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^#0H\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CPO='(^ M#0H\='(@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY&;W)F96ET=7)E"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^#0HH-#6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X- M"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0 M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=71S M=&%N9&EN9PT*870@075G=7-T(#,Q+"`R,#$Q/"]F;VYT/CPO9&EV/@T*/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/@T*/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#(S)3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^#0H\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X- M"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY&;W)F96ET=7)E"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^#0HH,3`L,#`P/"]F;VYT/CPO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+C(W M/"]F;VYT/CPO=&0^#0H\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R,R4^ M#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-#$E(&%L:6=N/3-$;&5F=#X-"CQD:78@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C M>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXX+C,X#0IY96%R"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T)SXF M(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-#$E(&%L:6=N/3-$;&5F=#X-"CQD:78@"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C,E/@T* M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW M+C"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-#$E(&%L:6=N/3-$;&5F=#X-"CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`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`Q M,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/"]T3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE#(P,4,[:6XM=&AE+6UO;F5Y)B-X,C`Q1#L@;W!T:6]N28C>#(P,3D[ M2!O9B!I=',@9FER&5R8VES92!P2!T:&4@;G5M8F5R(&]F M('-H87)E&5R M8VES960@=&AE:7(@;W!T:6]N28C M>#(P,3D[6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"F9O;&QO=VEN9R!T86)L M92!S971S(&9O2`U+"`Q.3DX("AI;F-E<'1I;VXI('1O#0I.;W9E;6)E6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@ M86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,"4@8V]L$$P.SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M$$P.SPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,B!N M;W=R87`],T1N;W=R87`^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE$$P.SPO M9F]N=#X\+W1D/@T*/"]T"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/@T*3F]V96UB97(@ M,S`L/"]F;VYT/CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@ M8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH26YC97!T:6]N*0T*=&\\ M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R<'@@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^#0HR+#`Q,#PO9F]N=#X\+V9O;G0^/"]T9#X-"CQT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X- M"CQD:78@"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q,"4@8V]L$$P.SPO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX- M"B0\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B0\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\ M8G(@+SX\+V1I=CX-"CQD:78@'!E8W1E9"!T;R!B92!R96-O9VYI>F5D(&]V97(@ M82!P97)I;V0@;V8@,RXW-0T*>65A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^#0H\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE M)SY3=&]C:PT*3W!T:6]N($%C=&EV:71Y($1U6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1J=7-T:69Y/B8C>$$P.SPO9&EV/@T*/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M0T*6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD M:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@5$585"U$14-/4D%424]..B!U;F1E3XF(WA!,#L\ M+V1I=CX-"CQD:78@2!G&5R8VES90T*<')I8V4@;V8@)#(N-3`@<&5R('-H87)E+"!T:&4@9F%I M65A28C>#(P,3D[6EE;&0@;V8@,"4L#0IV;VQA=&EL:71Y(&]F(#$S,RXP)2P@F5D("0T+#(Q-R!O9B!E>'!E;G-E(')E M;&%T960@=&\@=&AI6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@ M+SX\+V1I=CX-"CQD:78@2X@5&AE(&=R86YT(&1A=&4@9F%I2!O9B`Q,S,N,R4L#0IR:7-K+69R964@65AF%T:6]N(&]F('1H92!F86ER('9A;'5E(&]F#0IH M:7,@#(P,3D[6QE/3-$)U1%6%0M M04Q)1TXZ(&IUB!A&5C=71E9"!B M>2!-65A2`Q.2P-"C(P,3([(&%N9"`H8RD@-2PP M,#`@B!W:6QL(&AA=F4@82!S<&5C:69I960@<&5R:6]D(&]F('1I;64@=&\@97AE MB!W87,@)#DW+#(U,"!E2!O9B`Q,S,N-"4L(')I65A6QE/3-$)U1%6%0M04Q)1TXZ M(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&IU65E#0ID:7)E8W1O&5R8VES92!P M65A$$P.U1H92!S=&]C:PT*;W!T:6]N28C>#(P,3D[65E(&1I2!R96-O9VYI>F5D("0S,"PQ,30@;V8@97AP96YS92!R M96QA=&5D('1O#0IT:&5S92!I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;@T*1&5C M96UB97(@,328C>#(P,3D[28C>#(P,3D[2!O9B`Q,S0N-"4L(')I M'!I65AF5D("0T-SDL-S$R(&%S('-T;V-K(&)A'!E;G-E(')E;&%T960@=&\-"DUR+B!&87)A9V\F(W@R,#$Y M.W,@.#,L,S,T('9E3L@5$58 M5"U)3D1%3E0Z(#$X<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H\8G(@+SX\+V1I=CX-"CQD:78@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SY3=&]C:PT*3W!T M:6]N($=R86YT6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD M:78@3L@5$585"U)3D1%3E0Z M(#$X<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE2!G65E(&1I28C>#(P,3D[28C>#(P,3D['!I65A2X-"E5P;VX@=&5R;6EN871I;VX@;V8@&5R8VES92!V97-T960@6EE;&0L(&5X M<&5C=&5D('9O;&%T:6QI='D@;V8@,30P+C0Q)2P-"G)I2!R96-O$$P.SPO9&EV/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SXF(WA!,#L\+V1I=CX- M"CQD:78@6QE/3-$)U1%6%0M04Q)1TXZ(&IU2!E M;G1E2!P86ED($UR+B!# M;VYK;&EN("0Q,2PP,#`@<&5R#0IC86QE;F1A#(P,3D[&5R8VES92!P6EE;&0L(&5X<&5C=&5D('9O;&%T:6QI='D@;V8@,3,Y+C4S M)2P@3L@5$585"U)3D1% M3E0Z(#$X<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<^#0H\8G(@+SX\+V1I=CX-"CQD:78@3L@5$585"U)3D1%3E0Z(#$X<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE2!A<'!O:6YT960@37(N($-O;FML:6X@=&\-"G-E#(P,3D[6QE/3-$)U1%6%0M M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&IU#(P,3D[28C>#(P,3D[65A3L@5$585"U)3D1%3E0Z(#$X<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H\8G(@ M+SX\+V1I=CX-"CQD:78@3L@ M5$585"U)3D1%3E0Z(#$X<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!B92!D971E2!T:&4@0F]A2!C;VUM97)C:6%L;'D@=FEA8FQE('!R;V1U8W0@:&%V M90T*8F5E;B!S=6-C97-S9G5L;'D@97AE8W5T960Z("AA*2!C;VUP;&5T:6]N M(&]F(&9I;F%L(&1E2!T:&4- M"D-O;7!A;GD[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=415A4+4%, M24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"CQB M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR+@T*87,@=&\@,38V+#8V-R!S:&%R97,@ M=7!O;B!C;VUM96YC:6YG(&-O;6UE28C>#(P,3D[6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&IU&5C=71I=F4-"E!O&5R8VES86)L92!A M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+@T*87,@=&\@,38V+#8V M-R!S:&%R97,@=VAE;BP@=&\@=&AE($)O87)D)B-X,C`Q.3MS('-A=&ES9F%C M=&EO;BP@=&AE#0I#;VUP86YY(&5N=&5R2!O9B!T:&4@9F]L M;&]W:6YG(&-O;F1I=&EO;G,Z/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:R<^/&)R("\^/"]D M:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@-31P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE#(P,3D[2!P M87)T;F5R#0II;G9E#(P,3D[2!W:&EC:"!I=`T*=V]U;&0@;W1H M97)W:7-E(&YO="!H879E+"!W:&5T:&5R(')E;&%T960@=&\@<')O9'5C="!D M979E;&]P;65N="P-"F-O;6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^#0H\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0HF(WA!,#L\+V1I=CX-"CPO9&EV M/@T*/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$:G5S=&EF>3XF(WA!,#L\+V1I=CX-"CQD:78@3L@5$585"U)3D1%3E0Z(#$X<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^ M#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE28C>#(P,3D[65AF%T:6]N(&]F M('1H90T*9F%I6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&IU"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P M86X],T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`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`Q,'!T)SY796EG:'1E9#PO9F]N=#X\+V1I=CX-"CPO=&0^ M#0H\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY796EG:'1E9#PO M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY796EG:'1E9`T*079E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY796EG:'1E9#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY286YG90T* M;V8\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE$$P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C M;VQS<&%N/3-$,CX-"CQD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!=F5R86=E/"]F;VYT M/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L6QE/3-$)U1%6%0M24Y$14Y4.B`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`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY!=F5R86=E/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q,"4@8V]L6QE/3-$)U1%6%0M24Y$14Y4 M.B`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`Q,'!T)SXF(WA!,#L\ M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@ M8V]L6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,"4@8V]L6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O M;G0@$$P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q,"4@8V]L6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@ M$$P.SPO9F]N=#X\ M+W1D/@T*/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN92<^#0I/=71S=&%N9&EN9SPO9F]N=#X\+V9O;G0^ M/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^#0I,:69E M("AY96%R$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4G/@T*4')I8V4\+V9O;G0^/"]F;VYT/CPO9&EV/@T* M/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y' M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T* M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/@T*17AE$$P.SPO9F]N=#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3`E(&-O;'-P86X],T0R/@T*/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/@T*3&EV92`H665A"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M$$P.SPO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`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`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`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`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`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`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T M)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXS+C`T/"]F;VYT/CPO=&0^#0H\=&0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXQ+C,R/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C8U/"]F;VYT/CPO=&0^ M#0H\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`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`Q,'!T M)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXX+C

$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ+C8U/"]F;VYT/CPO=&0^#0H\=&0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X- M"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ,"PP,#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXY+C,U/"]F;VYT/CPO=&0^#0H\=&0@$$P.SPO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX-"B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X- M"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+#`P,#PO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY+C,U M/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS M1&QE9G0^/&9O;G0@$$P M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+C4P M/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^ M/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/@T*/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR+C4U/"]F;VYT/CPO=&0^#0H\=&0@$$P.SPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X- M"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+C4U/"]F;VYT M/CPO=&0^#0H\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`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`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`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`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`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX-"B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY+C,Q/"]F;VYT/CPO=&0^ M#0H\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@ M$$P.SPO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+C(W/"]F;VYT/CPO=&0^ M#0H\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CPO='(^ M#0H\='(@8F=C;VQO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXT+CDX/"]F;VYT/CPO=&0^#0H\=&0@$$P.SPO9F]N=#X\+W1D/@T*/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/@T*/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+CDX/"]F;VYT/CPO=&0^#0H\=&0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`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`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T)SXU M+CDT/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/@T*/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXU+CDT/"]F;VYT/CPO=&0^#0H\=&0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T* M/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/"]T$$P.SPO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX-"B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX,RPS,S0\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C M>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY+C`U/"]F;VYT/CPO=&0^#0H\=&0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX-"B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXX,RPS,S0\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@$$P M.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B0\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+C4Q/"]F;VYT/CPO M=&0^#0H\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Y)3X-"CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXV+C4Q/"]F;VYT/CPO=&0^#0H\=&0@$$P.SPO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N M/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX-"B0\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@ M5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@$$P M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@ M5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@$$P M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/@T*.34P+#`P-3PO9F]N=#X\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@ M-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@$$P.SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D$$P M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/CPO=&0^#0H\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4G/@T*,BXT.#PO9F]N=#X\+V9O;G0^/"]T9#X-"CQT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1&QE9G0^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^#0HW+C6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D M:78^#0H\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@3L@5$585"U)3D1%3E0Z(#$X<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&IU2!D;V5S(&YO="!R97!U2!I&5R8VES960N/"]F M;VYT/CPO9&EV/@T*/"]D:78^#0H\+V1I=CX\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2!46QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SY.3U1%(#<@+0T* M4F5L871E9"!087)T>2!46QE/3-$)U1%6%0M04Q)1TXZ M(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE M/3-$)U1%6%0M04Q)1TXZ(&IU2!I;F-U2P@9'5R:6YG#0IT:&4@=&AR964@;6]N=&AS(&5N9&5D($YO=F5M8F5R M(#,P+"`R,#$Q(&%N9"`R,#$P+"!T:&4@0V]M<&%N>0T*:6YC=7)R960@)#0S M+#,Y,B!A;F0@)#$Q+#,S,2P@2!N;VXM96UP;&]Y M964-"F1I2P@=VAI8V@@:7,@:6YC;'5D M960@:6X@<')O9F5S3L@5$585"U)3D1%3E0Z(#$X M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<^#0H\8G(@+SX\+V1I=CX-"CQD:78@3L@5$585"U)3D1%3E0Z(#$X<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^ M#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE#(P,4,[06=R965M96YT)B-X,C`Q1#LI('=I=&@@ M07-P:7)E($-L96%N(%1E8V@@0V]M;75N:6-A=&EO;G,L#0I);F,N+"!A('!R M:79A=&4@8V]R<&]R871I;VX@=VAO;&QY(&]W;F5D(&)Y(%1O9&0@4&ET8VAE M&-H86YG92!F;W(@ M8V]M<&5N'!E;G-E2`Q+"`R,#$Q+"!T:&4@06=R965M96YT('=A2!C;VUP96YS871I;VX@ M9G)O;2`D,RPU,#`@=&\@)#$P+#`P,"!D=64@=&\@=&AE#0II;F-R96%S960@ M;&5V96P@;V8@=&EM92!R97%U:7)E9"!F;W(@37(N(%!I=&-H97(@=&\@97AE M8W5T92!H:7,-"F1U=&EE2!A<'!L:65D('1O(&EN M8VQU9&4@=&AE(&UO;G1H(&]F($IU;'D-"C(P,3$N/"]F;VYT/CQB6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@2X@5&AE($-O;7!A;GD@<&%I9"!-6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD M:78@3L@5$585"U)3D1%3E0Z M(#$X<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE2!O9B`D.3`L,#`P+"!W:&EC M:"!W;W5L9"!I;F-R96%S92!T;R`D,3`P+#@P,"!I9@T*8V5R=&%I;B!M:6QE M#(P,4,[ M870M=VEL;"!E;7!L;WEM96YT)B-X,C`Q1#L@86YD(&UA>2!B92!T97)M:6YA M=&5D(&)Y($UR+@T*5&%P97(@;W(@=&AE($-O;7!A;GD@870@86YY('1I;64L M('=I=&@@;W(@=VET:&]U="!C875S92P@86YD(&9O<@T*86YY(')E87-O;B!W M:&%T6QE/3-$ M)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ M(&IU2`Q+"`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`Q1#L@86YD(&UA>2!B92!T97)M M:6YA=&5D(&)Y($UR+@T*1F%R86=O(&]R('1H92!#;VUP86YY(&%T(&%N>2!T M:6UE+"!W:71H(&]R('=I=&AO=70@8V%U2!R96%S M;VX@=VAA='-O979E2!G&5R8VES92X\+V9O;G0^/"]D:78^#0H\9&EV M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1% M6%0M04Q)1TXZ(&IU2P@3$Q0+"!O9B!W:&EC M:"!*;W-E<&@@4VEE2=S(&EN8V5P=&EO;BX@26X@2G5L>2`R,#`X+"!T:&4@ M0V]M<&%N>2!A2P-"DQ,4"!P6QE/3-$)U1%6%0M04Q) M1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&IU28C>#(P,3D[2=S(&9O&5C=71I=F4@3V9F:6-E<@T*86YD(%!R97-I9&5N="!I6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!;&P-"G)E;&%T960@<&%R='D@=')A M;G-A8W1I;VYS(&%R92!R96-O7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/&1I=CX-"CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@5$585"U$14-/ M4D%424]..B!U;F1E6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX-"CQD:78@ M3L@5$585"U)3D1%3E0Z(#$X M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<^#0H\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE ZIP 13 0001144204-12-002550-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-12-002550-xbrl.zip M4$L#!!0````(`*5N,4!FQ$";/W\``+.@!@`1`!P`;F5N92TR,#$Q,3$S,"YX M;6Q55`D``Y7#%4^5PQ5/=7@+``$$)0X```0Y`0``[%UM5?T?V-Q; M4[M5[43BG?3T;*43IS=UN^-LDMF9V2\I@N68'0Q>P$D\O_X>@9T`QC82(.-, M3]5N=QLA/>?HO.E(.OSX]^>))SV2,'(#_],!/D0'$O&=8.CZ#Y\.9E'/CAS7 M/9"BV/:'MA?XY-/!G$0'?__I_;L?_]+K2?VS+R?7TL#W7)](%[UO)`[=9^E7 MAW@DM&/XR:>O.D0Z"YS9A/CQ!^G>CLA0"GSIU\_77R7Y$$O2.(ZGQT='3T]/ MAV3X8(>](.GPT`DF1U*OMQSL7RG.8TG2#[%\:&8>70`-G./!!Z#8.91./$^ZIDTCZ9I$)'PDP\-% M3\_WH2A?Z=\?6E/?\BU M?U*2UMBRK*/DZ;*I&P6JC(U-8-(6+WU';EG/T!0?_?KMZXTS)A.[5Z3`@0F* MP_G+F\D0$7$.'X+'H\7#(\I..@$*7KXV)&[Y*_"@I+GK/Y(H+G\C?5;RDD^H M6&Z?L8*^CE[<#W9Y-R]@WC\"B>3\D1 M-.I!*Q*ZSLM[VU_*OP#:^&#;TY>71G9TG[RP>%!"&3RA/46E[R1/2EZB0(8% MKB\F6#]*'^::QJ5-M;1I?``R+TF)U'O'42(;UV0D)2)X3"%\.HCQMYR;L1V2:#"+$ZL)EE1R`C\FS_$UQ4D"[^ZJ+RLRDM5>#]"BWC\10NK= MS>W9';JC-H@2<0<"-O/=])THZ?%`&A+'G=@>S.?%Y?G!3S+2%5/1T8]'U7"D MF!?B;GH"^,Q]W/ M-V=9_`C0ZP:\K/UXQ`0H3\-7U[YW/3<&_3R=A2&T9P2,&0!C0].$\[(4"A&5=$S"-]X%(<%3Z+V&;4IC)S'=49&!)@V'(S@ M3U"BTR!JE5E@)Q%Z!5@U*\ MF/`2-M8UX*LXMAKP*BA6E#9E;:;QR2P>!Z'[!\37+2'&".4G>#.,,DT58%%, M`QNF65384NMQ1AZ)%TRI^-W$]@,!+TK":>A&!$37==P8;.AL,O-@@3`\FU$1 M+K[1)B'(,F3#,++Z5!?N=BEJ0_"WZ%X+H0B;9X?%"T:U0I&,YE[9X2`$9L,< M)`VO2)APMDD*[J8DO%M54N7@)W0(Q)1:E'6X"EHZ'+IT46Q[5^"'+_Q3>^K& MMMJKF'M2K?KO&5D:*:6>3K46R1D?:# M9`6A8IB\`<5:4[F;5,:*`Z.YV>C*GMOW'A&19)%E"^4<4@F`@I%J)FR]4S48 M6GM6554S,8\YV+)D:\J8K@5:.6>PS;`VCE1#AFE40MK39=74\"ZQ*KIE<@:N MPL$"6V6]&F-75Y/MHL6692)3P54U7T6ZH6X'1Q/]Q]_L\'<27X6N0]W4PKJR MNM%7@'PE0)D\NRI.V2V89NB[2PZY` MK6S)Z.$:662,583*8,EDW92Q)1"KRF+)%%QI(Z4IA5?W1>&W`>V.PA>1LJQ4 M+*.*&VL/:G<5O@B51>%-$R&1Z1Z-*7115)-I%[JFQFO[HO';@'9'XXM(630> M*5@5Z>-7L'97Y8M0&51>L3!618J`SJ#R,C*@(W$:KW-JO"I:X[V8"D.!-4H]*O#NYX)2@>M2H7=A+N2Z M5)B5YJ(Q4\1R.%NV5*R9(C.>*Z>#*T8$U1Q$4?_.>M M$ZP[G'N6G5L#64C=*=CJ>[<8R1K:J58QA!\0TBL@,T+##_--N+PR*O;/Y951 MH=2C0CDT*E'1F/BS'.27-=DT+)9U3$U'PGF4'UO@180Z$OZS_`E6@>:._S`_ M($6JT!P;_VE^4]>Q)NY"3`E6!C="HXX4U;"R2\".%PI=*T8[*!3*(C#0#S;KU2QOH5#H M)@HZ7RB41*8V=(B(XU,;CODLA.HH2H36D9@8F#6M%_6 MVD@$80=4;HKOU>7Q!2;LU2?UFD0Q=!$O%@TG3W8X_!+6,*V;BZ34M5V5IW\M M70S&K(N\V;Q*J6CKZC%G%W*S>TEI).YHH#;UABBD68C\A9Z;AZCH&FN!YV*9 MW[9!-5")6!A$AJD5`I&QP&>QS&/;H!JH1"D,(I/6BH'(5,VQ4-*O;5`-5!T4 M!I'MBKP0B$R5^PHUSCB7TPT$'GGPK0:L&"DKQR"[';$VSIRU)T^`,_*>A:P< MS.%=S%NRM7*)O!7)V05O^/2H>$)[)P%]D)'2\G&VB3Q7$3A MG:BV]CLJ4E3UP"[/ID8C:MU$1;1=*3G'[K!J674EJ5FVLUA\1K;G-I$O@YC< M3%T_&(UN0]N/;(<>%62&SU)$K:>6"7D%5"4'2D^#R30D8^)'[B-)J3X/0N(^ M^.GQ$V>>>?_$'R;_\I+CD"?#_\RB>'$0:3"ZM9_3.89>0F+3(]KIG^WR(E^D M311-34HN&[FJ*AO9B\?";00+W&X'`ALIJ51[HT8@T'7MJU\P<3>ZV*K0(KLE`ITY/9K_%D1@,P/6V7]9U_4M M#-@G">#9M))I7<:W(@',&U-`?1(!O!4)J%1!Z2U+P'H&M"H!>[<.8LGC=6`= MU$A.@K-R>C:^F98P!O; MJJ:E&VVZ-K$LX`GN5!-8UV:$+Y8%/-&-)AOU62!JPX1GOZ>9[9-F'2S+=E4% M!RM>`NOY'ZU"9J&#:E?3XVA[3#2WC['VG&@^KZ+N-]%\?L2L3W3GEXE,EVX* M'_78QY4A"[W8TC$VJIVT[_H$<^V'[G*Z19F+TCKZM8W'WB39ZY"_)L&V3RGV M[>17*H!13+"^%+UX`_._G@'K$JR&]F=(L-:X&?IV_"C71SVV>]5=J7\S&0B, MK59W6,1R@,<`8J3(LES7"+X4%GN1[^@V6%-L-#$H]R#D0ZI(H$6)9ER3_\[< MR(W)#0D?TT-M,/`U<8('/^F%L4;C9J:QL\E4%)PYN=LVH7O-5I!%M6+@JF@6 M1ED+*Y:QS5K6ZJFU;EK6FK94WI_,`_>W@4JLI]98ZJ&[:O[=7C;+R#^)A<0L M'W]:^?[/QON03XL:IE3+PL"'OSJ$\F00GHYM_P'B\FP#UW?<*2UTFA3AAK"] M/QH1!R+PM/'`3W=C!B&,R?K=DSRI8%*`")AB2\9Z5<*Q3-4E2WG;Y.TG.SD. M6O2P86I:MI[L=^9N82[##B%8,`V8)V:^%;9!EO5-6>T2C;GFDC7,5+1 M=Q]?B:T,'A\4T,HJU1XZ?!Y;\B94ZKL2-K9S_0NZU0]DC!*J;N9>BY'E,3Y!8.JEQ97$3*0UZA( ML5*H(047OWO`!'1'JL-QJ7;EDPGL6B0HIU5.9`,9+FU?=DAK<6#M340-%DER M4UNDC5C21K[_P7E7HAU]K+Z<5]#J5TSV1R6;V;)3Z">]Y;>:=%['-/:C'33O MHWP/K:OQE2'0Q@H"$=[3!6J-.LU5;*AXRU+;EJA*[3-0W9?Y[]:C84[^">R% M?I=\=)VI'K[:=I'^+"B^>OB[@:1]+1J8Y0K')9E.*&.K4L]3E5ENYT.%-:H&5J)H7;I.EOD_-2E@[;:> MMMK77??A'E-M\O?['E-%\GGN_;ZAV6 M$@>X;F9C4[>V;+SOY<;$)IZQ[]_H]/MB^W<[I)0)+!_6KQ MT5J:N>QG!W%]ILB^ MD6%?W=5Y&$Q.`WHE:@;S.9B2,!'BMN4,3*]N6,C*SM8V2'D23H,HCF!YV'^F MFM>V8F!9570MNQXJCE])H1?$"%1HC&1%,RQYJTZ70,N3!"\XA`R3Z:%.P_8= M,@AO;(\,1NE5N;:G0-$-QZD MY7E10/J@SX7?5"[X&$6(`C)Y@9*0>2!GI%I")T(@`=.(./(L^/F M$7VQ79_:FX&?B@R($^A`/+_R@/-4?J;4=[2LGV!3,H<2JD%:L>6YY%=RRQ6, M_O"K:]^[G@`C`Z8Q;\BWXBE2D#KFA2EMW8QD*QH4QFYDB/LI:/ MEG&&T&5NWWMMLT[+;W"N0U%@8N`'2]^2TB-DGL%;F+JO?S.XC=^C:X7P0IC'`-Q*/Z18!70R0EF=0 MLXSL?@EL&; MNHHR>5(&8!5"'%K(0XS?@XYD"VV)<+)P2O9U5[U/R[[:U'%V>;T&1&$Q03P/ M'GTA/C3R0(=/AA/7=\$"IP52A,1G2#%!;C(+UFJH"MD!6.%"2_H'M4./8'[I M]-3<#^>BQT#T!D,F<<``;9L:7(5D:KO@+D<$=&J9BX#>D^EFK=##94\M69,W MJ485B.7+@5;2<576`G3@W?4=@P@EC MJY"EJ8YL4X[RS(V<-"=(AJ\IP>4QD+:=L"XCRUB7J]P,K;BZF+[,Y.X6;NM0 M;#,W2R4^'=OA0^N2I,BJK&\R+04XF1TY&KE!M)$&U_UG)ZGHU;K?4I3EF8'2 M\3/X"F%G^EQ$^-O+P=P`(P/V-3N9R4I^#H/?D[-<$S>*VM\P@(#`,I?[EM4` M92A(RYW8'JS`2K?L6EX4*J9LOAR3W(:E_8U!"R?5CIBD1K&V6_0*NX*<6VV5 M$#>]T=;`H$UNL_',&OAB2]-WLMK5M&PZL&FYWRZ8) MZ[KITG/]/1`.A+J%D*7N:@>$PP486)8[N_O!,P&FI:@;ES!\>Q]M;`EPV+E< M4,B['U`KI;&_?#GUX'"UK M0T`L[SK4\[O>+&8Y,%^!AO4%+'KH,'L"9PNHUM*E'(9)1H;*ERO]!1S)&*@Y M>00;]D`N9Y-[$B:4+LA,;[`.9G$4V_X0^%&?D%7FIQ^FLJ#U,E'&CBLE:DC< MX[/`2>*F?P&_,<+/-\/_T3E')CSZ^#@S.F:&[FD_O`XQ[PLG_9 M3X?,]?*]H3H`IPX0QGLTL("\P1B`+)!TNUV&1ZG/7(^&I'9.'(&1. MC;R,=@.B!_U(UV0:A#0$E&CRP/;G68)S0ZV3L-]@H5)/ON#OH@J83WP>8!"^I0AZ%)CWJ*M;T7)_D4&D!4=>$/R?/_$?YI MAM\Q,K"IHNR\%GI_'3R-J3/LKTM\KX?,GK*P'^MZ+[D-/@Z\(0FC-.%&M^GH M1J,71#,(ZP''9P_:<(/ZP8L_#MW''Q[BC^_?+?XA1?'<(Y\.;ON_WO8N+L_Z ME[?'$IK&'Z6SBYNKKR>_'4OW=-"/TK>3ZR\7E[VO_?-EB\4OUQ=?_I'^="#9 M'JQ0/AW0>U3N:'Y`AZ(#C0#Q<+:^Y#Z:AV;\W- M3LKNV]^^`K\I$UPG,U;#,P;Q>!J@K./T#MAA3Z8?_^?Y!'5E/NKQ/NGR)'[_ M[C)X)#26DA3T0:(VX8-$USQ$>J+_AS^`R:#_D](@30I&TO1E_?_75J MA])CB:QM)8R MJ?WD@HBFA`0$.#@D*[_^?8YNH$&"%"6+%$AVU>S&DH!&=S_WS9S(HODHAA]M MAA^=!?7:;^CDMUI]Q8QF:80AQP0IQ[$^B*LH=4#+'ZB_WT5(.Q3"BX&:@!/` M3C-:8LJ4NI,5WJ$!#\M,G3^9BT@BDYJ^O%-8>/1#O(PMZ8Q#VU"[JW:4!D[@ M3<,45IC;W*K/,:.S];^S&G)'IW*0L1U-PN@HN8D$,B;&2N9[,6(E,%=@2W#N M[+CX-7R8=UROK?K\.)Q.PT"NY]#+$A0]=;!(C`7P0A<6"N2B^!A/--+?G@`+ ME>QS89<`,2\!A@W&EC6)V$L-&I6\U"N!-QR%>'+72F>*7P;"H8KQ.S@;,$AZ M^@#XW'/(>-^7]\7"2XEFRYF2;QU$*XBW*P%8&HDD"N.90*><\.\MO'$G(:%5 MKX'0\^$O!(V'45'0]$QX-2/G>@V1J&%]^/CI\S&Z>GP'58@E6"(70,FKX2*L MT6)D/`#8;U/&G3#Y&F5[P\(MDQ:M-N)Q,MNMWMS:ODB&P9R/_&=.+8^6"?`;C&$5J^I)$GDK"!;QS<86&)& MBY_)>IN4?H.TTX?%!_"&?,/6=811W)G,(B)]]77'[@]X<5V^XYE1^Z9O.=:% M&*<1!RW.U4Z/854:XUNON71/V94.^49)O%AC$24.6`->`#!-4GDDDN1HW8#X M&8^!_7BX@D>9BF$4L\$Q?V56=F-LK`AN?T-_HH,B3_5"-Q>W]R"L8A!NX91. MY$H%WI.Y4_#Q!._:PP8P#IH!W$\'KL@;TY.O.XU!+V?5!\#LGHF^+L0L86N6 MY$1S5*0OQPUG"/'KU',1$M(<]6*P2.\LL&(3HBX9G@+0Y!.BT0X+7-#0I*)F MOU8+D9F4(0KS$C6)S\-/KBYK\-',0/@^LCW+!UQ[^U?)FP=D_4O81[K:9YXLL>J-2H^KI9 M0HXUR?#$UY+TD,G06^1&P;0+.!'EP)#U?X7T3^VD^.>)XRGGB7``&?\#S`P. MT+"X"1?S1&(KP%^3F]@2J!HO^FV:?(EWA8WK'X*_PI?RSZ%*AY>/'P%.Z5BO M^\.1W>GVX1+A,@`*881*..A?%`6W9%1@VK1*SBM]&\2(/\NTLAC`Q]1L`I7`8>B"J,4H*$! M:^9P`)ED?H*2@LV#N2UD'[0*WT,I@H;.PC/4:H?YRW]_\F:XY@]&_MY"+6P`Q>/D.Q!T%2FZ5A8-2.F:# MZ@[M%TU5E-[7F4\V998%&48-!>>R.RD^APY0WF MCDAI@]5K=#_&H%J'L$E=SOV%A"X#!COB??.BTF#>$@`QV994S(@'&^1SJM_/O9Y0EZ!__"'-)?HC"= MVX!2>$I`*7=?"/*SJ=] M,@><>!'0C^M0H,%A?V;""5S(H'RX`:7C%]XV"+HV@BJK<2H<5)YCTOP)3$=4 M38N0RXO0G#NRP].8XT"HS==KK,Y/J>M2*3`)=2/NV?LWQG0QOBMD@CE:U^Q[ M"^+0]]@KE9N&Y$+GXA+FHS?2'L2FP!@DQG:.1&=>Z+*(X6_2#C1S8T&"`:V- M'7^<(NL#@Y#/1'+7=^#T%V.,E<2*,I&F\(%IZ`I?.CZD70K8#'?L7`MEZDR= MO]#O'J=3^2FTQ"(*?LG5$H`/R1ADP'2U-AE2[/2_#3%JCD:WS5?GQ7\=3="& M]53K7W@)Y2X"2Z4%P#4"*&6(H7AP"CKPEV$]VT([#=VD_CW3F80%""C4`>X\ M6/5*Y!!S\ZOWO^,",#DBBKRW[CWA`QFF$2IY M8%IS:,=R&-"$21FAL4/U*D0?"OIQ'2OVII[O1.07+KIP+#<4,4D35+C&W@RW MPH$EQ%0WZ\TBS7ETQ<1"L!M\DB;`+1K6OS-4+=)3\4`W'OHQ//BS=2?$7_Y] MO8;&^IS$RG7`&+-OI5M89JYDQ"$Q$'$U0\&"QRW%VNIYS1>N8>:32TP77))I ML;*K!*]B`]D7R1\FW6?ZFJ"=(?.Z=Q@=UULKDCPP1]Q(& MOM0`,9<6;G%1_T9*9;U";1,43-0WZ7/L.9MSW\[@"LC#ABDU'L=)X+&)\!"8 MA(N2!9`>$F&PFOWP&@"56FSQ;;%<`&9+J36:;XX4'+4W1A?MW30*B*<0'VM8 M'YFC`/=*'1^4@RS+*-\>[,@#S,\C`R'<57X.J3'+L]JXD2P4DSNB2%\N2#1U MZZA976FN1H2LW#4C8FP8W5KQ MP*U'Y;=NC87OQR#Y@7&ACY%^GB'ZRY_O/#>Y^>G5J/D/_8.1]F\7507:UE68 M).$T>Z?;^L<3$.7!+9?$J`L@2-QU-E?IO<%E`Z-!N`18#(41LLB9_?2*__MJ M"X2.CB$1;>J*N((HOZAP\E*)#YL]YU*_9C%*,8<5^D&/?_WXRZ?O+2+X%:A< MAB'51&U#=B^'CJJ.;S^)358G[N?AU-RG_3P=S:+/"?C-Z^\,R\SVVN[\P["> M:I]NKUG/9S%UR+&QG\=3J5JIX^_G`2]%-'TD.S7*6_7`>*QRLO832S\"%7I! M[(WW\WC46>RP-9RW!:^1\2!5@QN^W-9W'Z,-;AC<>+H]5\G-&<0]=,2=$]/6 MU35<>1C]].J_3DX^?#@Y>;4.J%!P+PE6;4R!R[ZS"4=^7H).%63%4&%SC\RK M)R#PQN@NRQQ\XL:I;\C2G8\VN/,1911W#H!=&'0^`'1N-0:M@\9EH[,9G:W" MB+M49[N[\1)QD!K;+U1@:A0S(\D*.^^W4#%K'P!/,.A\`.C<:XP&!XW+1C$S MBEF%$=F!]TU=^Y!7T3Y287O" MY6U2HCP>R=^=?7Y_^CG;^!7V=L#M6]1L0K:Y>H2@W+E#K25$-W&JU4M*''G3 M'?3M?K^_>/(G,+`?K$?B:64TRITGL_W1-Q^'1)NCGUZC-]HW0G@\>!YSCF*5 MU4YMO5K$_*B=KZ'O5N)0^T8CQB_YZ"2_$I/>>"NK(G=?)LFOC['DW@%8S`:= M#P"=VXWNDW7&O=JMJZ\:BWQ*?Z+.SN`42M&+O;!X+;9R5Y%10V M1T?M1G=H*.(QY]B+!JK#1F?($U^?R9UE>,CA\I!!N?_I,)C(,Q7+OSPKW`'- M='](]T5"L@<5WS(8;3#Z4##:I!H8XV,_++_;R!E,_ MKJ\C<>TD`A9*(B^(O3&"/,6?K>1&6'21EG,%BK\5B5DD8A$D,?\I3!R_7H/? M)<[7A??1;G!\WY+P`V/AY`I.)B$0P%M:52.Z$X/VZM<&)Y<(*)%\$?_I,Z40+V#/QRXL5CQT>KI@WW$KCTMI`#*RQ: MT[:FJ9]X,]\3KG5U3T\$*1E$L$!\X\#U?`>_=9)Z[2Y,?=>Z<6YQ_[#Y2(R% M=YN_QT>V;D+?%5$,#[IT7?SK>DW]7FV`MN-%ZJ;P=`O&6,,"F.:`J-<8$K`U M[8/C&R>X!NRX+`XE,G^DLDEOY:O59^X^$4H,@7WE@@S!<@EKD8 MJ]K!`I/?SFZ>:)NO3[>3T/?#.T1I)M!8($J'47)#T"14/&(0`ZAF(H@=AGX8 M`VX"FB(>P]L3X+P,184?9.O'-FQP[*=$-,E-2`0@;KTPC?W[>HV>@:612FY% M3"L!,D;$T6TB`.L.B!>1/HQ<>)*YR1)DNDB``4V)KP#2GJNQ-,3W2JGG_!C<,;NPU;NQHYMI)"NHTB/I;\;0PP@YCY%Q$RLC? M38;4VSH=]?>/CBY1/:[7?F/]^!3UXX,CJ-U$S;UG\6"`U6O2`CLXG%S%Y)?X M\%=U95,"H"+ZX.YV_%O=3W9Y^&??Y<@#2\H#ZGZ3Q1O_9OK>]4Z%^T`@S]T2 MIXLW'S&]8KR6AP7(CVJI+N:;_>Z6ST]IV:<[DLX3K=XN!&&(SQ+8%8MOO M40N&V!XTVO9>/7V\T;8D<=_HM,\Q&1,UV7VJ!+G@E*H3/8GD]"O^6SR4+[%+ M_MF]2TPU164''G$P&%W]"S<8;5)H=@0WOF$$Y:(.P[\9S99?P$;4J-$+JE'" M]VD4S[4(1.3XE*+JN%,O\.(DHAP82[!:9;2J#@9=N]MI'P!K,4B\ MOTC<[@[L5J]CL/BE]V:P^%NP&(>FV*WF(7!C4T?YR'JLX[A>"R>+U7BV7J]( M]7VOVZ.6W1H.J;2.BR?3`$NDK@/O[[)*+2L2OH.%5DEHI0%66@FW4*T%GP;] M>WQC>3&ICV/Y\!677LEUJ33+L68B\D(7/]YI#'JR9>AB\9Z!<0'&\A=_G/)' MKT+?79?1T!'?GYZ;P'-ZK7'>O*W<_\O47&Y82(_"^JU]V+,5S]4!/Y;U+#.O61\`[^, M1`P;$;+P$*'W+G0BMZ$_5*\A&Y!TC%UJ!D5JYL+%,)H(#Y_@8?%SE`_,AA]N MZ)B"M,R5D=9Q>@UW875:)6P(2S]E129_N,!R@#.\;@_LP;";55XZTS!*O+^S MOU,1)]4*9T7"-\![]%,TK`NLM.0Z5+VR],Z)J9V4/-T,N%&$S$H>4]V!+"BU MK==#N]WM%`I/-::&.RPY`WP$0`$,#TM?YXJDF5YL*R]_Q;)49,1E*TES7.?! M`,IZ3<*R6,*Z6$)+M]D:V;UNJX`#(`EBY/N)YUMS&-6Q\2-9R3E>+"-).?P- MYZXNY_X_I,?3.7HT_'JK_/H8.(R/Y=^+VEA6P%XD7*"^61J-@4*%ETO[6Y@NJS86+/3S@+3H9\1'\ M_G3FA_=8&P1<<>8`)P=65V!RQ$5%=`N[B[E]1%$@`1/T(N#E(I#Z8B[>YKZ( MA)!?>+N5-0<`J1:KA@7Q]]8;YSNK7;C3(.>#F!P& MKB?[;$SFD`1[IH!6ANT*RAJ36%GG$'GW#>MWY!W:%\))O;8@'+-%[47!F7_P MSO/!:,!EO`"O7WX,((1_0;4_"+/C99T9)O,V@YA,Q)A\SDZ&TP1.ZMR@=FZ- M!1!"+.V),'@`*[4#4U,1N4FI.,0IP$UBFLVK9-^AO5.G%+AJ,&*\"?97R0"KX)Z!SC*8#E545[+;58(T8P:H.KQN=^Q>IV];>'=3 MDOLIM99QK'>8<71T,;X)?;B4:>@*``5@2N)X@6+[>5L.)X[3*6_L>PNXJ.>" M=F;=>\*G(S7_`=+@-L3J5Q]%!_RJU>DTX-=6Y,5_'4U0\8\DA;4;HW\P4CMT MK?B[0:,_4":<+G@66V4\8)D6E*K77;O=&N#Z)=I/@@J)!^=R0+TSVL>Z8N@W M!R2*U2ZHXV0:6,YL%GJ$>J@?7H:NFRF)"&Q2&D6"9L.'-':B$*G5!78\3L*( M&95"75ASRJQQ0:*![%$BK25-CJ?(,B#70BLDDF6=1GNP:5FF\?!,]=7$DO6@ M5-+OO]WBUDY*+ED%L52\GN*;K=8/))!Z*)"`\Y0_U/Z!)==8/KALL0[8$8O" M%AY]C&PBMY.S3%0LDTU*@.JV3(9NC&=E(FM!*FER\$&192V36/7:>B++6B:Q M4)*BR/+H==W,"B/M1(\491F1K2/+"A=9_.J:@DVCK3(?WWJ"#1:1D)T'1IRS MB;!P146HLWW^NCNTA[WFF@+0*LH_O2_5PP+06I1_'12+90*PN2``>XU!SY+R M[RS036EEYC_6.V/ESIEZ[8G>&?4LH,3CO3-6T3F#VL6CO3/S2/$8[XRUZ)S) M#*"'O3-6F7-F[@RKO#/B$TPI?VW,PMCV%AA1XA<\DYA@9#X&4`JG"[U0,4Y[BGHN"(>1]X5 M6K;8L?$A)6U!R5K#';`M%4]&SZ2")ETRZA.MX5,5OZ?$"-=6]?[I!*D3W5NM MP4/*WC^=6P\`_$]8.1!_HU!SZC4E=@JJW8TW7>6F*.ATI!$\Q4&AZ73]1@^4 MI#65NE4?RLPS3:E;I2 MU`J+"\ZY*PIJ828+,E5N?C.:9EC^%/&-%;KAW(*=$D\,J%N/TPZ?YKD@W.1+ MWSW'A;;YC2M\ZCL5\5U(^9?M"ET9HX'=[C47%;EZ[6%-[B%/1KWV@";77>+) MR!0YQH9Y3>[Y9#'H+:-N:X4K`UV!3_-E;%PT[;>4S%3U-CMLFW-B,@(HNW;F M2)WSV=N(.O/B4#=]2@FDU_2*\QZF[>'W**ARVR M@7+95Y2[<+.^-Y:]93]5J9^V1>&UHI)L'0&#SD0IE; ML-/(5=42']'3Y65VK6MZ4Q0B:1*3N5NIXV0]B5FOK729:;+H#AB5:K6RZ`"1KP&R6!'YW,8$3P\XA@R4H?*X))!3X.W`@^]<&)G.O0 M+I(..S@F832%CYS<>"+KZP[(=3:9`%>(2B5Y)H=[S74C[^1C6LNR!3.O1#K7 M:X^T;$NEL^R*OZX&;Y4J\/4:WZ:,1=K#P=!N#[HO$HUM-JX9P9KR5B),@Z?[Z%(0_(*YCR7G,:L@1:8@$59$MU#;7V,GWI-\4_)6LW1>HEQ.+H/4WNV[JMIIFLTL+!3+KPUHO9`'CVA(96H]-^40-^@L+JP90& M'7Y$#]WE[FN28^&"<9XOT:PQ_/J-TH\]@43 M'3#J*3YMW6!6-GK!)I]'XM6Y#8N6_R-S&\BP>9Q7>]Y$UR(6#]CH3O[[(NZ# M'KE6#EZI20Z06-^/O<0DY^R6U39Y:S'$S@XHI>N"*I0@239[](+-(^5DPCY1 MZ\!&*T'JQ,3!=*TX`R;2-S[!=O:=)X=DY>KQG<#20M3Y;D'-NZ9\64UA;OYC M3F>V\V*K.:VYVVQT6\4D!@SZ`5$DF0(-3&8H->AL&=^;"*[,:BM3O)!!L$Y: MGS8`2V=/UD,E'RU[U!]Q_+EGCYK(#V"_,\9)_W[];`.+C?I'ERE\@ZA>$:O^ M1B6@:DGQ+,LO_^]7$.8>4(`WUK[US(H=*6;6F>1/O^0F*B+)ARQ)Y.K>^F=X M$UC'#42VX"_8PZ[5,^RB]B93WW7'C2)UZC1(UC,""R6GRJ;1A59RP]:9!)XE M80.^9EL&=@G?0)+#B-D:4B MSMP(?X;O."KMB$Q5$"*8VN,*8#'AC-]:Y7[%KX=^>.V)PFS"JS0!&0O"/P!] M(XX=N)E[8*933R(L:J$7P**C/[S`#>_4HJTVAQEP:`HB^7EXEV<-T1_U#S:L MCP'=)5Q$E+$_C;@M#@R$`]* M]2*+![?*S@V*0^G!E8M+/_NJ-&6JO%%N@L?K]NA&*G/_M1K]+>CV\TIN/BQ3 M/SYKZMGP579C"44%4O\:8Q!)$IV-A.BFH!YK%$-T]Q:`>X4:$*"_I3N_+O$8 M*QV1ZHH+VFA!!:/KA)L#)"($6M#`6B-[-.@M5<&R2WBT"F;-:6#S@8_E*EAG MU.AU"IY+I8&!7I/Y,'NC92I8;H(]:P9,9B;$V73A;[`3LMA<,?M%X5=N)DC^ MK8L"1:4XS6#.-%HG]R47%Y33\_C_)V1HM`.+,*<`[HXQ>9 MG.;#+O+Q8@:CP@)DW8@>(G.8EW'.147M)?SO++9QJBY>-.\K#'3M\CAGF5* M+_C7Z[4R!WMS5:+WO$F&++=CMSJMQYE>A;-I;0(>E?"-E,CN.XZZ4ZXWOJNV M]$#"=^$L]=I\PG<92)0$E9M)43AG:>#`'5!;"$!`OVY:'EQ?[B)"GH;-OPG8 M$^!9`2N5<39/VO"4K?$41:TD5=8@5^L!:F5!RR[I=[F"65*W]F":5L')J]]'NPFVQD7108H:#7P[ M+TV!!7U,*M<%>.XMQQ'QU'X#5"^>QKY2BY&_72S@-A2U+8IJ-:AN'SND](ON M^XBULAD*!38A(H&N<3``G'M4)UW!2(!.5##HM>!.0B8QL$UT_L;C2+"*G8E([F5T#;TH'-O*_>:2R[CHWK!0 M.^#Z*P?O/U,$\FO+;E-^(+88T)GI^MBPJ*'4)U-J>QFEDH7/J1ED_LZ!+U;4 ML-+KH`!L6Z1,(=5S@DQ9QE69%D3D37@,.P2*=T"='/);^9P4R*0.3&F[$_$"N";KS(/<*_Z`H" M<*AK)U#6KT1;+W#A>@&-8G%-@EPJ)O-.K5)6JJLMF69"#C;@K<`N*4T)W73W MF;&=J4%Y-L)C5>&7:H'2ZVZD[_U:J$7UDT[IO1/`\!X)`V3HB6/=.19(+$%U M\B^!29.HWZ%O'/U"F;"##:*A(GWBL:;^6IQ`4:^58*^N_W(B!.FU=_!@/*_< MKB>A?P!4W5@$]$7!>/5,8&1`Q04P`J<1U!P%*;&X-"O:I/E@K'`.JF4LZ2&@ MKA]RW'^@C@FH-']"7'OC19:\!(P,YB<"A2Q71_^6S.D#VZV`%IFDH-AQXEQS M0$-WH\K>QU@L%::8RHXZQ1UZ98*0S%J<2D&!1_ MN'BE7LM M_-"F\,E:^7OSO9R3A79!Q@K;+I5G>)UPI78Z!9KW_B9['H#10K3SYXV37EN3-WCE;HMC839]3&^!SSLNM/5<:S5?):I M>>MKH)NXNM5+EN8KG^5\\#%E8H8\#'D<`GF=+3]`PF5.&V=PP3=EK2_"'=+,\C)0S^&?PS^'=@^&. M.0)A6-1.(N;>(.+!X=\SV>P[#?S/3G!-T=V#@[[A/I5`P$\I-X8U&&@P\&4P MT*A?!OT,^E4)Q`;]MBU_#?89['L1\T-,N?&X04"#@$;Z&M_'-F$O,UH.#_B& M]U0"_V1FE4$_@WXO@7XGL%Q$_4L6%(>\!R[FI:(TH.O#SK@\KD#)0533FKHP=!# M3@^_8J^3-]3EY#M#$(8@#IX@2%`IP;06,/1@Z$%7E6Y!5?H_HRH9 M@C`$850ETW6FXF#8GS"&P02#"083#"883#"88##!8(+!!(,)!A.V:,)95]=P MP6'TTZO_.CGY\.'DY-6WGG=C3H]Z[?53X!-AMYFE&QYM<,.M1J=]`!A5<=Y2 M+13^MHV_'"[WFG:SV3+8_-)[,]C\'#OO-)I=@\LOO;=JX;)1+@P*[S@*[RP[ M[AGEXA_?.DO3H'8E4=MH&@:QC=JQ:_B\U$MV=^,EXI7!I^?#IW[O`/#)J+$' M(.MYY/#`H/-+[\V@\W/L?-@8-`TNO_3>JH7+1KLP*+SC*+RK[+C3L3L=XTLP MOH3]0VVC:1C$-FK'SN&S227;&D:U&[V#YY`OO[=JH?"N2OL6II(9;'[QO1EL M?HZ=CQJ=0Y#U!I>-%?9<=OH%L:7L)>8;10-@]A&Z]@Y?#:99-O# MIX/GCR^_MVJA\*[*>A/K-=B\/]C<;PR&!I=?>F_5PF6C7!@4WG$4WE5VW!K9 MH]'!,V3C2MA#U#::AD%LHW;L'#Z;1+(MUJ.W38':B^^M6BB\J]*^;;QD!IOW M!IM'C<[!M\!Y^;U5"Y>-,=1>%?9<?F_50N%=E?4MTY+,8//>8'._T3:<^<7W5BU<-LJ%0>$=1^%= M9<>82#8Z=&0VGH0]Q&RC:!C$-EK'SN&S223;&D;U&J.#CXZ]_-ZJA<*[*NW- M<$N#S?N#S:-&RW#F%]];M7#9*!<&A7<5';>-32+:]*,+!"_Z7WUNU4'A79?W0U$,8;-X;;!XUFH?06,'@LE$N#`H?#@KO M*CLVRH5Q)>PI:AM-PR"V43MV#I]-)MD6,:IW"!AE%-D#D/:FW-)@\_Y@\ZC1 M.GC=]>7W5BU<-LJ%0>$=1^%=9<=&MS"^A/W$;*-H&,0V6L?.X?,S))+]8)T? MOW__\=,O1^_.+B_/?OO>:L^^/H1DE:,,PK3''654T:,\"2@5P\O\9$]`KHTP MA,?O_-W9Y_>GG[.-7_G.^"__.FUR_LC=54=NPIEA MS7CFP!_;BU$37MSU;@M7_/'3^]-/E]];<)X?K.P^KOQP_-+XB_<+9]$O^(EXM/)2*X='3T2.JD;12ID7 MG,1RP_3*%_O$DI>=ZL5X\NHE)<\840O`DACTL_!P0WN[@J6&]K9/>\-&IZ0W ML2$\0WB;)[RU\TKVB-[:C:ZA-T-O1M!MG?#:';O?-[1G:,_0WK9I;]`8]`WA M&<(S2N9VZ*W;:!EZ6_"(OTT<@*/V<\&W^PBG=7:JJ\AZ6^XIGE]-WNF?:9QX MDWN)2^H3K>%3'>/Y!]>_X$NZX$]PP9^77_#'H%YS7-=+O#"PDA!6ACU9XW`Z M$T'LT&\C,0XC5[C6)(RLY$;(9\(9_?4ZF`BO"2-X+NN%X_3.(;7 MG*OP5MCTY@FLZP3W^9*T5+U6^%XXL5YW[%:K9^&:KWMVM]VSW#3R@FM:)+F) MA+"F<`\WL24"6*9>^P2?F%Z)R.HT;:O=;+7H7?@'_`B[F8EQXMT*_Y[.H.\? M=CZ+Q*T7IC'\E0Z#6X:7;P6`$#X)*T>$K(T'@@8OB%C=7N40Z_)&U&L*WFZ( MI!XF`(M9&HUOG!BPZ,9!/`&X!8#>M#&L$[41&WO#A.)6/A3]1K=S6^,!F);_]./;-#ZZ M=IS9]R<:XAX'[NETYH?W0KP3@9AXR;GO!/&E^)J\0X#\7*]9UH_JS8\!(+WX M-8SC#\#_3F`'7I`"OIW-1.3P3L?P2WCYLYC\]$J$_I?STW:GW6QWCXY:K5;S MZ'^;S6;WR\7E^R^CUA?$^5:KT_S2?&6E@<7'8;;<&7WZ_>/_*L(9(I(+"0("Z[>HKM_0-7:HC38 M`1#1DN^:H``I1#+) M"\9^BLH(?EI,)J`KH.B95Q/@(R7'4#K1S(D3*[D#809ZC^-;]\*)8/]B[*0@ MZT#(N6&]%H?679CZ<&`!*D8"!_93U$L6]R6^RCU-@!OS$?BV,A6)WH4'2O94 MV#A^VQF34,T"L*3?#/I4Z9[=7'Z5]+I#OUK0JUC16U2L7E8YVA5R^!#Z?G@' M6%FO>3'AS1Q4KY!>"#PKX"MQKEY;U(07`98IPM]O'4+E24-DG*DO/8;FB_Q9VJ?#IIXI6$B66EH;/NA7P25897?EDKVUVWJN6+_4 M,[!AJAV#M2"BC26,(97E]_0;D5O^\RG2W4-FQ+X7I:_C^5R58ZFHKR*YO?N: ME;ST$'M/Q.OY4Y7TS.\=Q.ACM/[#3$`VU%^1G3^1^A?2O0^3^E%=-L1N",,0 MQB)A-`UA/"0%'RC#62'[]J2\9KE3]EWFUG@OW1JGYQ?D\)*^CTNS MDA=GECMLEAK<,+CQ:'9=TD=O_YDU![O2*88?P^@AY[`A,D-DA@$;W-A3?7GT M?6\7P*C"5A(0Y[`TJTB.+_=F9A_%BSJ\J$^`1LWA@1[ESCXS?] M=M<>[G3SX^]V6HP8[/T6[&W9K5'?'O5*4M?W!7^?R=9X>4PW5+CO4R$.2@4U M&&TP>K\PNKI&U0OZM=Z+()QZP;YYM@Q[J/Z%5XP]&(PV&+U?&/V$<4B/S47; M)__B'[)T!GV,:]?./%)F[GEZ4"7:&^QI+]_52V;Y1W:_,[0[_8>RD`XC[\A0 MG*&X#5-<:V3W1VV[V=I4'ZW=HKAG,[)?'E5W@(R,-5#A"Z\891J,-AB]7QC] M#/;MJMY=^^;JE1TF])+YT_.+YS%@'^B!5B%\-PWZJJE'OVDVFIT-J=#5Z-#W M<"*/(2Y#7!LCKOUN?_F8+*/572\76]_!#-ZYIA:CL#;@OD.=Y2QL`POKA1/9F"NF MMK9Q'([YB3LON8'-.5%RE,ZL,&N,:5L3+W`";$IE4XVKX\/954NO>BT2<9A& M8Q'S7^,TGG&O+GA.6\::_]0GYZ_0=;!W'?>SFW"W4[G/=3N7:HQT&4DO],_, MFX%NM0=IX/V+".`A'Q#_V)V"Y(H3?.5V&ZRP MWVL..EHWX_5V--%_D'#!N$+B/J?.K/.`V[#<:39U"^,Q&WL(]\\C M,7,\X+<3`82D6E3#Z@3HXS@6R6:9$'D,UH:Q)[9@3[30 MGM"A1PKH13J=.M$]*KH7<#YOXHU!G%HYC.HU!:7JF!X[`,SUEGP`;MPKAWHO MZV1E`/%80-#\B31P4M=#BTJ::(Z/%ER2S9>@54Y!B%W?6Y=B?!.$?GCMH:D& MC+,!)EF]5M8%FRTYU?O[@3;,W%A.&TARX]P*ZTJ(P)HA+P8F#.>TG#'.1(%- M"C;_'(T>9V#'CKV9#\>^9I'KW^,#8I;PR[B-WP,ZZ06>+Z;->=@ZS)O6:_GI MX8-AA(LVB.`CM"S]>YJ@@6,Z](;H;)].N-4TCG/QPYA&N\@9'=2W/=^E]=`F ML5]UV2ZQ!;8O$E$.(S*9;V37=#2F'3HP2(T_TX#T4[XN7%L!>YP)*1WR]=K< MLG!605VX(X%32"0TL7.[A.)Q>@U(:G5:&=1CO$M?6>CX^(48IQ%[]'#-TZ_C M&R>XIF[N4R^.B>G&%D`YR>Y2-GKGFO[8`LU["GA[]*\&(!VM&P&H$9]@6];_7WOB.;L8#?H/YP($8@Z!& M28!'=ZR)XT6(D1G34:X0B4;Z37K!!+]#3^7HK#KIF!1*M95\39P,4UB4NO<#)D8,0M.0?COB2EN.%,198?1%\Z`]X*-AZ\<@+K-O0O6F>! ME;M4D3LKR9;(=U.I!>CSHY"+>PE-C0I!@AV%=P$. M*DNO@'%ZP)=P`QU6[BXO0!PFEO6P5WM51BAXM(@L>CSW+J[;/3Q3>-`QU'8)FN`/R.(1M.4D" MF/Z9@DQKD3+1[-O+B)3P#]!O3)ZXA,2@0U-6#`36@0#0SK+K#P0P/L6O5EP_ M-EV*65V=P5^1243"IW6`96G,(B>0$2AROX5(C>?A7=9`OMUJM^$Z$\6][@N3 M?HIO7TG/B>7D`\J*7ZW7EGS!RC]`>A1P0C<=TXLW49A>W]1K<"L&?1XKD9G3 MEN'2!W$5I:@Z,SJ-%M"I7OO@AY&G$`I'.J&^2[(9)S)9OWIC7X/Q*/7[ MP#IV71"8 M,U!_OP/S$9@,Z2\`)S!38:=L7=.T5J3T63!)R--MJ%V5^TH!=7)FX8I*D'%S:WZG/4N="(7GW@/1M@X"6&_ M;XAMZ9H%/5142<",]?UL0NNBRDM?CN<4(MV29D7VC@@!J%,<@3UXQ%Z92""J MJYEH\2ST)8>D&`J-_$G$D#I59WN&50#A&2*/PF726\8M`X-_QC*$OOVTH M=QW*/?;1042P0KK(IZTY4S83 MS9B&YBUTQ=@G[R`_A6X0R1,^9,;-1Y`6<0+4^UE7P9?GX/3,0)AU%0<4LP/1`>XEP#+&Z`LKH,=H,Y.D MAM>16U(-\N/$`_:[$M1,4O*&@BEZ@TSU+>6LHB]]#H6\) MUFYCYQ;S?_&3]9J6$U?PT.#4[1G/+(8GK:LH=%PK4JX:7@D'F^(@4TIB0W>] M7!C>^Y.&J6::YW7H4$C!0X\_?@RQ5RU"*D9TRSJGY>.'"MYO6!F888IY=F`L M>;X[_W(Z9;4857$GNA8)O!_])9*X87$FH+4T$1#):64FX$)VGDH$U&]^=2:@ MM2P1L%Y;*Q/0FDL$)*UAC4S`'2'2;<0#\QGQ!.5`W%&"$H,*E+&`@PV20,:* MT!PIZ>LUE_/H:*[P'4;+X,?<^O9D1(O#7X3<`.3$`:2`S]1K`C6#R!N#9+9) M-P2D8"(&CGTK$,UB,CGE!B0"QFG`1.JP/$"Y[V-E!N,1:1J4&9JM0O[-K*7T M7^QVA._SLC+&@W0R#9%4K5MQ0R[:%>X)(.99Y`G`^GN0&^P6.5(86;@!4I^B M$#T0L6)2J$CQ4:[^E/.5Z[5N1[I7CD`D(L>P"[$D3%(5K@UJ$!M$-ES+-1P% MK6B;+P0^DX3)_8Q=WAQ-97)#,*B$V8DG?+@F08$R6^TM`V;.7E!XX=TR#YBD/OB*1F_HS@>LNO:!MP(61A-GC*B* MT[)GD7.O.*WVQE%.Q2A>Z!^`H:AT,1[%8NH=)9@GB3%\Q*%8B"/I<9.$3`.+ M&]9'P/8X'6-D8]"Y%`/(JE8_P[C=D!A5Q,LH=I2,0% M@GW8LZ8R:*.A,@M.#/O20O6:$IYQ>>:`XR-K>O-[XZ(!*BB(5;#L4SAU2JZN M`:@[L#+F#%G_$Z:D?UZDP'?NV6K'_[/H7>E$^YB'BN%5+4T0I3PLV*%0N=SK MNVQK68PDD^M8&H'?,9&(;Z2A-;S(NB31IQ-(46(!=YW2*IJH&CL16CI1.OX+ M_GL%F!I+-GTCG-M['265O+&(*"GW)/;#.PMH(``TQSQC?)Q$2XBF$E@PL\;2 MC8/R!Z8U[18D^]B9)2F9S;PU=+@69"_2H[6,')=_`\@1)$Z!'BTB1]BBO*_L M?N2G%2OB5!DB67;3H"R:TA_:O69&M-FU1.(:B$2ZBRU);TR26,V"V213Z8VC M1&W,Z6&Y]T&XF'EC_0_H!W?.O55"<,-Z3?T5*1[S1\;Q=TI2NQ%J0,X,I.17 MVB(<-/:^6E=RC[!7M"W1XD@C*^"X?P&]T$2`Q8']`E#@;N$[;R1#N/6B,,"= M(QLZ!^$MQM*1C3GGAK"_D;"E9F-IB@W^[CIRILCK;T,?,VF"ZY!D6J1<_>QK MRE\1$R#`),ZU2Z1<+\.X.$\:U8J;D`KB=(:8R*DX7X%08L0EUN0(^UB5RQ4Y ME*,8'LLU,U+G,OL)3*]&CVF MV6?@*/'8PTW$B>))9##Z"1PB-FCW8FG*OS`J@I0?@_5E\H>^W:K5"1E,SVN1 MF[%NB!7G8<)6%N7IY#*9/(?*;,N"EOAT+L3P(^C%#E)0FST`&7DA!6EG!=.1 MWG4HIS6=IAS#=@6:KL1!7K>:]FC0M@>#P0,IML4MS\+8(P-][,0WU@0T!K"W MHW":^6`P-)9%SQ]($5J2&%J>G`LOHA:++G6R$Q837$%+*DV%+56QV=N+0EV* M7>)'L(693W_''[P@+61A9OE)"&5BX?@8DDVV!B``V*WH4P+@I[,P6![&XK+O M>TK!4@Y*9)["GV#1*WP"<&'B44^!+#7!,,IU:/(C.N$+B,D91856 MI(^49:S5:^ND)2]=$JQ*A0\`5H%@ZEU$$DL2"05)1C9L-Z)L0/*<0%S)4.IU^Z%SE4D1V%2)@&NNT)U)@`;YTNLUUS0 M-D)%7!CTM"8I:OTV!T-6[I*(#;>)').=[?-T,[=(>(5./,MQX08I#IOE%V(B M_8G*U"HZ_F'Q6(B_.`=;O9A[B-$.3^2=:!I6K'\/5@$[Y6;>K4PIZ\`$`=&N M,&L:'<9I1*4#Y+#/'@?D\WVT4W(+#I>5$4W`+-3CP!VAO[7BB0OE6A%8G!9C)'C$?\A\MI#LA-?M^Q!LVFW6LVB;"681F**&`(: M+HAX$E$%=;[,QZDGE@$\?>'$B4H06]AM&T@8>Z[4:QD]R(1$+IU`BD/$L9![ M@*@C2O;Q8W/Y_J1L(^$&0`)8/E*\ABOA>_!63(@+V'T5\R?NK6GH)0\8Y9LB(&,1U4:35:W>$IES_0DS< M0N=,1`Y>EQ-+9"[]"K4/90ZK>J03RPK#P,J?+CR?'OZH> M.%BR?)2$W/GK\K<"*>@)OR1D*0I5B)&%46YK72&?9;4#A;WVMB1>RY=)H%0! M1:=G;PO.+F2-+ M3Z_!N@=)SXP,7?]H\.8%C-)'K;3:?#=2BA>20M$]'^0SE9<:*[E*37$'KC+- M61@P9G2.L$G`_1NXV6P\OL$L$_J#KS5VPTI72?)(4F2@<%'F.$R13\/]Y\G^ MF'J09"HYJ#P3$9&Y1M90[1L!0T?->7__'*+*(P%O.VD2K:7)(ZJ=5LVM:_3D_T'HR<2*4IUOMK@OXT=?[*\QU8X4F1\-%GR8D]RD216A^U>4#7.5+\ M-*O19MW+KM`F^'D7?MH6<2:$&UX\FJ^F1G)G2D8!`3J34< MP[D\I%BO90HRNUTP;T+Y&@O=I1PWU-N7R8@&1E:S=0W=/)%N/F`OKW]CD9_U MFW"0%9%F8XAG\UE84[[OF/NI4:$E.AT9_3T5HK]34<>L5AS#C!3?P+PIU'4I M2.!XW/T#S4Q4`YW,U7AOO<%:OJ]>PNM^1U$A]#U&Z$JZMS33%#Z4W#$%8\3/ MX@B.-W.H%9ZN5<%+Y#Y\-U1C5MV>=_O"`]H#U[.W_@K M^O7KM5:#:%[R;8XKP3W_)PT32N[SQIR0QO5LJCH2:Z7`*J'R$&2\TLE-<:?< MJ\TF6D`M]A+6E/20`6*O0QGUBXF`G*!2LB;!5^I7Z@@297:%\U<`ZNUUH(YI M9#'HHN3J4L"8LZ47WW@(*8AF)19E848*;1.&V7GT4S*"[*'PBFI]*?B-V0D. M\B@L/8["JS`KF=">`I[D\"GR`)CL%H(U')S&I%P8I;M=C9B%NUC$3*MM$/.Q MB-DI1\QY5)!5`PQQN/^$<`*`HW!+Y:3D_ST$K]4A.YRD/\!%30GZS7 M%E&ALV.H4&7M%,"D-S.)DRB=&F?+AE55K)FAT'%&*DLS$>V\3^:,1VC(^AF' M!X@5Q(%6-8;$!T#6"/)*9@0KPHQO@.B/B&L'Z+01><*$E^.!"LY[D73^8/T> M=E[)1SAE_9I4VV3B$'.9N#)].(R5ICT?WL'J/6Q&'0GXA!5Y\5_H(_:HOE7S MMQ9Z(&>[W!-.L`KW-NCBT3(8M3E%A@-LA@/DK0'G4T:YT4DD5'\(_MD+R#,C MT_GHZ15YJ7GFFRV]M]0%P_$I"DLPOA*!F'C*[EB:P#H341P&@?!MU48%U8=; M$=U@"WCJO^^,R?@`DW<\3F$OXWO>LTTZA4]*K<@&5\U2^`S.EN&"^!FR)HJV M<#,5>K-A?5ZV']D&)A(JRN1R];*Z'QLSE#&'GK34(`PB@6E1W&#$O:7L_)F< M:"7;4Q#7TR]@:;YVWD5C[,R(_/Z6??TB,0Z!E=&/L MP,VB4VYO8M,;)A@U13!Y>-2#-3?IH=`3.R.DURUXM#5JTX.O>P.[U6YS"G`Y MZNG9ZPWK`U7)J+([ZXW6T?L[I-'RN@.M2C#;1MMN=@?V<#A<^^,+^/("T!Y3 M(]4,V/_OZ.CTP[GOC&6/S*.C9]U;5?%Z8^+X`GO%'5'MAZ4/W#7B>)N^8VP( MAM6@X;V0#2./V'X>ZT.8G3LG]C8LL-Z_VZER$EH"MA(7#TA7Q-]G13C)4B M3F#E47D*_%U6-Q,X9:@14P@HX,7F$Z<.8Y>%,'*P3[)^?^S\TG>=V7KR4,-2=4`OUC'""^;.),=EH8^+ M3`K.CZ*..WA7!&N.WQYKH5:TH._(!/5BO2.M;(N7%])0P0L5ZY6=`BMR)/84 MX$`WPT9IPUJNE>OJ`(>;8SV@S:(I#;3CX[S*I%(0W5@[/PY!_3\%R[4WLZIU&02-//'9S"`04AV'` ME;5RLAF^IG2J+`HF?V%KY.3?[XGD?!EK15P3QG]6R0M&@FY>@BZ96^/%VGA! MZBR?51A[`8]"8&BQ]'`?Z%`3:H/E2))%Z9@[?+#J?4_19\79"Y7Y)$A(DVZQAS#KPN./5T;)5Z32Q*'='9IRSK%Z'=3Z`Z2>7W#=7M'REV)HBS-YW]B*@3U";N2!2DY*8G\>%X!Y\5A9QM] M5HW+^6"YZE.(*ZA)!]S?(INLDN4(X``<]L#+KH2!FX\2E2)#>2OJM M3]HV''#A3-D1^):`&*;ULJP6/'QZ86A!($[F)Y/NIND8?&`HX(0"O' MEHV8*+PLE?%8OP77WPX`'->1':5@?N)/;Z-64GZ$*06C4#JE(T_0E_OPH@C M&E*KSR/"M#`:762`LYW>`Y_%F`>/'LL*#;WK0!0&82K[2.UC[X%M>B)Y?@M( M#WA'JRLE.J%C*?ZQ)!T[,@P6F&;>-1?E[4FE`WT=&5]FT.:D$%5J\S/>1 MAHV%:5PH\9'=G60];-Y`*#L.]JG*FL9RYO#$DUUC\ZV1=@,/9HW?L`\J5OTL M\N)"^*C0*`[3*[*9\`%.[,P_H`NZ0I87K,/:P'Q\JWQ8]$/<1OWTX]LT/KIV MG-GW^BCT0@N)=U@/?#8YUZJ?WDFK^;V(QY%'$N\X<'-"4]T]+L77Y!UB\<_U MFF7]J#[UF?,ZSITHN;_46A"\A]L#U03,Y.Q%TJ3@A\]B\M,K$?I?SD_;G7:S MW3TZ:K5`:?C?9K/9_7)Q^?[+J/4%^6VKU6E^:;[Z69+92P9=JMJV^M/9Y:DU ML(Z05W*"#4'"TD%1'=XH6Y9)SB8/IS[1&CX5>FM>Y1/4"\P*XVN=T;6"-IPW M7,8^T@$[F-YXWQ%WX50QY@PTNQG6^@<60F7]Y)9'-37U/`MV>-.I<''^%G`& M9^IQ(MD;#[ZV=!U]4AD\"8\BGPX#(C#\EZL?O!E M[4.$OR.\RZQ;^40^4"UCO?#T&^^6K@,_>G<3S"EZ4$AA3T*O*BAX_]JX[5@%VA0XIF0G!1I.3E[7IT]'(77X%G(%= M;!A=X-"6OG!I-M(+D\'^4N0'CG;)',(($]\BK7+7`DI7H.^OF%_BT70-*Y)Q(2(+S&_WHCA1 MJV=C!M?(%-3&O"ZD"NHI>B.[!3=#AQW@)=F4,9O/GL7>])BRSXXIWK^^\0:. M%)>I'MB@VGWV9,9NQ^ZH7,96R^YT6L7P%C4M))NO+'=$FW#/#RGKGS)WX`]O M2BW\/LK>I3DNV,7\5GS'Y6(+6`N\M8B5;C:NNGS"II.'/K&&$799D02,N5-LAMB&_6:SC<0 M57!X%#\^GS9-/4,PT;8PXC4WY"@EE0/&V+,2:.[6BT-@+Z?4GYM"E,?70&WT MK\6AZ-G?BDYT$O/'\0SPTSKQ!2Q\*0`?<5Y:&JC^##:E$#5LZO3IW6(82Y_@ M*OO;1Y01H-'%EHW/CL$68I;#GY';SF+^1JHD@$C/9+]53A-8A+.,64<)=(AT3%# M)8DX&3O8(^%-K[#9IFIWG44I)6AM=(@?A9.C&>"T2++\1P;U/U.XLL)XA?PV M[JA'#+-+;$',8Y@%LU3:@G]?W"9E*\B-PALX_:1)XBXWH=4J6@_U!,@A[Z6, M9]?A@!W*OX+N"E<.:`L\+$U4)ZI\]F_&Q!=/H,SM_"19-@G[>*748)G^ND4[ M1H+A2[X1C@__H2XW#@V"*=XXC4A78U/99Y!=5_8-7@H^@-?-`G%YAOEC&=MA MNI=P&G4VY'BH$%A'G$A.4\V*VC0..18LH66!"/F4%.FJU+3,%-"=,]2F0OM* MO?:ZPTA.,7[BO#/9=E[A+;R04N>S2]D$7'8;)YL:-_*R[MY=$XP(^5RK+1U$ M/B>D6`'B2B/%&^HUDCD(RHMQF"36I8-$KP><6"?")_AOQ`^!SWNDKBVO#/LW MQGC.U2!2Q`7E`].K_@"%\F])-97;X;-J5K9I>VXWU*+"9WZ#-K`3!(AG5(1& M1LKK$4^X5^VD*82H6+!DT4U[".CK86199IG1Y,.$K&M!F8IR:K`#4/1F,K*\ MP"EY>@3FRJ-/8D] MSAK^DR[R&^H=#+NL`QE36-N0R92PC9E8[C$P"@ M3A*''+HFUH.:1((9CF%"O7=8MR%E`X5EB26H89.=<\LB1!8Q&UL(/X3:QDIX M$698-B9KCAE:V33(\7TI,SS%X:=`*L[?SA)F2']:EQ>>W'A";WQPAI-G$"/G ME7#%^Y@3EN[2SC_OS?&^3!T%(Y5'"I$/@5E#Z6(EK`%7GALB(G*KQJ.:&X>T M^2/B7=3\E!LREW*)>=:`73[*>0,?:@W.P(!:9`W6^IR!,J(*K&%QS)K:T@); M6`;E#V>&YK=*\YGJB\E)BWZU1VI`'YS(N0Z7T+O\X^,H_BSSL2^E^%*);<]_ MLJCB6(L:3JO'*@Z/R=%5FS;_93Z]B=C!E%L)"X]MPX"JYZG`/K)<<:5/EF/7 MFBQER'[-_5@I]PLX":?ZH-8/A^%Y8\"!<%M-Z=1\2'>R"JH3]=QXG.YDS:M. M<*N/UIUT[%ADD`R6-94GA%[1]_--RI-$B1?1GH[].*0!@DNH3MJ5V!/F%ATN M:IJTVJ7T\-J%DS@%-S`U&U5M&WH2;[*DSQ7D5LA"DXWKYK/-K-?]1KO%KB-: MT\X+3F5JF]Y*:EE?=.U#(<<%K)+JT\*IQ-<959OBU7*-4F:,NQ1U+)3JXAS) M].I/.1'GUHDH->.6)]NQA@`*2I[GP?J"E%ZMMBZ]C@,W`BXJ[WI!N2WRJ'HM M8U)GQ3+B&ZI1PI?9:I=4`$OB5$/<&2PZ[-B=3A>G`;%#?X%U8JH($V]QKVVR MF12XC`3=F@2EW"3?N<.HUI0GSP`,;KR0U3C\OSPT\NNOYS8^PV#]9QB+V4WV M`H@=F:"#,;@LOF)SU%=.1W9\FW!`@]O+ MS_VZW[9;@QZ'T-HMN]\9%D-H=-&^N$81KR(20.')0S-&PSM8_2+[_@D"S7K= M9=>&BFUE?E^76X,6NWT9\MLN^2T1,BJ\$A)'1C)2'9%`N(VPE\QG#/^B"G-3 MKWT.'1<'WGCP1@MQ\R3TT^F5!Y;+;Z`@^H2TK6:W1YP]%]^(0\W1RM@6U7%1 M/B#()'+3:L8C:\[_/K=^=>[JM5^B,)W9UGGCN*%QBA+:HV9$D10_I^0=1D$F MI0_7">?>%6(ADY`28QKL=(:+`,H(:0`HQ\C`6V11[U/ITE>L,1SP1KRFH M6A0:0EEUX\T*9['H*-@;*DA8::+O2&#$,X=!`OIKJZB_+AFNVY*U)N492>I> M%W>@+C,2@;A#?I1G=Q:!B(R`[5^]TT-R)_S;C*6A3CZ_8T/MVTMRPQSZ8II; M8994L0%&4F5FG.%#^5E5'4:TLG$SX^_?41.:G% M9-9369US+B*JT\!TV3&HJN]E)=$3$UA!N?3X)2\.N^W6X,OO%^^_`*Y_80OB M%26ZP>GCGUZU7_U\U&PT._EI'MA4\00?I8$-5$C__1BHA@.R;3[)X^W"( M=A.TGDZ_^>/;)^Y+.Y3F

`74B-*8M_[U)F].;"Q1M.CNYB@I8^<%D?S7R9 M-8FL3I+TCM92+P?COT5T'VMI1Z:F>E,5/:3DU6O_.CTI9G'&,B["HYUE%#G3 MEJ6KE,%4KYT&U[`!0>;GK[^>V)1)B^%F%-<.:.'YGRE5@Z,WU`P%#4X>@Y77 MJ,I$11P%7NAB2NT0:/`E:,:1="+]0%J]K(7)E-6NKC:^'S"%I(X?S.YLIFULEYRC2YH+2SK/#+%7G/ M6D#_]F'OE("E^_,O`",^I[ZPVMVKHW;1-@7D9\]#3XX3S=RF[T;(+$8`6C\,9Z8!W8?17 MYJ[-TQX*B1C:NFS8W3B4J@\ZIW3L-JAND+KE(?C5EGD5JAM%!X@J-&!U=!'Y M29S]52-S.0L(*@WY5)Z$V[U^G,>]"< M>$6G9=6H:58,QNG.#3:(UF4C>35N$7H*2TN:^-9K#W?QU;IGJ8/W^DU[.&Q2 M\^>EO;27GD^+,1Y"+YMG0-TE\IK\3'%*$Y!P'@VG`/N"RD426=O%O>R4"Y=F MDX1CS\EF3"*$%Z3B`8!EFVKQA7<]=:SW%+TRRO&+*ZH*Z(KSSB_9_8<>)>%1[-Z]`NOX[ZLUV2Y:%_0XO[ MRZ('72.WEZK:"2O86O'<+/*F3N3Y]POJV*)JNR03 M)$LI&*/&>3)F-DD=7U/U*DA0-K9J\JXP(&;K^]LHR>3^[D?YWI)HL@D[D M_.W=[-BPLW[)#A6.AKX3_>$%;GBW`/5O^8*.6O7:P7HYMX4`:ZB-].9%`N06 MQ&%P],<]:`<1\@C9[>!6%`?^:(2I%\PIY?S8]STN=T/WS`7<`2@JU`OGE'QJ M!M!/R=KE=E^MK/YB/D.GD%@YF5#;:,Q%D$.5$MF$<(H)8XX_KT>A]:43?#G[ MQ^9%J"$68`UF&.&_F?9XGGX_?'Y<4^:Z#7#;[A;.:]"1K>AM2 M`PT4N9]DNUPLH@O$G?:V]:M#@U6Q-K?0NO/3Y]-?BSOB;H!X;[\W+AIX-M3- MU7W*Y91!F[7#UYV#=$Q0P6'IW"N!+1\HTY6F:N2C`)<`^BOU2+P5W$^;',F8 MXPR:-IQ9S@(M[IVZ$3OCOZXCS`ZQ]-=(?^?WL#%$Y'()+3DZDY#;O:,&A*U2 MRI3Y>NTZ=/Q#L,6?N\OLFCYPJ]P%3OU!U_2!SR'?4[S2^@K+_^>WJ/UQHFF*W.*9R+QB,NH=O;,9?X4X0SGSX#^3.,6LN'; M>9\W6#T0UZ#N4C]KGB-1'.=%A?E7("V!M9$IG-O6.,PE$C03@>\;;X5RT.V\ MV'\Q30K)D%.5BYO2-N+<`O.AIG&XI"RRH/>\0$[5B;/\#`NY*LW&6;:?5&=F_0 M7\L(WXFH4E4Q=)L.W=\#CQI(<_^IBS`%QO+!#R//=7(=[0-J!,2U;.PYW[!^ M)?8'#.4XCV-R)R%-?4.4O)AA)T=4"O/!J1MP&U<5DL_I`\;GI/9("OF*;`E' M`7$SV>RKO-&RK@;7:PN^AU_Y%LM[C2UO/]43N%44Q%4NR_NT4T+8M85/%""15S84:^50?Y^ MT>7T29X+3W%.GRL"'MCX#=5(4_K8PL.R6#4K'R[0&>`S;%;ZS;CKIBQ(7X8G M^"'Q-1&!+)8O^>!BX$RF@C62K].9AQD4X!-299 M"W34-;2R&&\J"FUNU;FP%)BJ$>EX96?#A[R8Q[E2T6K^8)`?3$W_8]F*'](Q M0\<8FFF(&XS<(]*%C#!YF4!N:V`/>QT9R&W:K?Z@TH'<3G-H#]H=S"CZULCM M_B/ZZ?8JE-F&5USWE"'9H8H@E]ZO&2 MB&LYQ-"7/:-B4)W`8+)`80JI`'#LBVR:(3I[KWW08]'JBA,YA/R2A&-^$2S] M:>29[-+0;G-J-AA,<>;Z=BD70[_P&P=XH@S1H7\_"7&".7;=:/?[]J`YPDWC M)\3529'S+DBR;MC$GLG@T?0?B:@1N3# M6GS9AE-=JS;3J_Q":6]DNW+"*LD'5\4W=,*15QS.0"GF'B=.WJ_H*RFE+-UX M1]0>$0,G:D4""8WO0AF+#VGS8[*.HH;';4#5L0O`S`:A,BK@L)LTIR`( M`3`6KF9M<_-L-LIR%*W7\IGG$N>*F*-P5_"T:OJ&(CC]91J?9_DAK!IAQQW/ MS0KW"3N%[ZFV1_`=(D7J61%.7[A%[*[@S.6\FPUI,Z\M)TURM"96V-%.B.(IF%KN"I],>OS;:TX M$#F6&X=KI@(<40E17'/YM0?33E/9_HK<@W6(8^ M;'<[V=97;Z-8//]))#P&F*8U/FV'7[J]]JC9^]KM-0?#P7IE\_UV=]AKY77S MA7T4MWCL(HF2@709Y@,USD'>?@Q.G!F:$>5'_8P=]$!]%#)%E'T=->]@V.X/>OD-;/J8NWRI@TZGVUX/L9@2 M7N92GY68@)3:_<,A)D,^SWF-%2<8>3K+<[_A=+04+$;M6._E3_!SYIJ/K'A\ M`UK%3Z]NDF3V_=NW=W=WC5B,&]?A[=N3C_]Z]3-\I]4O&KG^GOVF^5E.:5?GQ;^H&??WRK=B#/^K9PV!]9A]/VBP.XWH.V_C/>VE%S M=-0$MI#_-GL0U*3\,?A?IXE+N]I#/[[5%O_QK838LX"/:7RGP7=08"L(I$J! M37&M"S4X]I1:)B-;`C,:>)@&/4V/A\>OQ2F&BV:1A[V:)KC\\7B<3E.RM-E, MFG_C$(%>IH=5"@4VQ'B?"_5RN5HJ2@U*[;\P,*BT.50BAT.ED.>1P,3?1^(& MW[X5;+0=$"`W#KK=O)UF%6^GN=[M-#=X.]U1;UA-[$%W^5&S!_][2>SI]/M? MT,_?''9:QMY:#Z^;@[7PN@G@'1YU6EN!6P_$6Y^T[4'G@*#X>-EZ,18!CN30 M/G>"614?_G`BS#Z-#Q9O6@9OGH`W[P\>;PY):CP?WIP<*-X8Q^"&'8,5AKIQ MX^R8&Z?ZN&3TWA?$+*-];PJ7C2Z^N[A\J!;!,EPV]L'NXO)A6RF$R]7"5Z,Q M/AV:)O*W)Y#L=GO#EM']GP^KIF%`WS?Z_@OAK]'W=PM_#UO'7\1?H^/O%OX> MMEY/^%LM'-T8SNPI!#NC8<6RBA]KF>41HC,L4SUPW;Y"B5F5NIZN"9QN+7#: M60_JW>U#W;@N=AR2U6)OU;F>IF%OVV%OK=%HM![4F]N'NF%O.P[)"K&WJEQ/ MCZH.YM+J#Z<8\EM*CM8L&VEM'W[[[]S:,[B9$%'U`S65Q!NCCFZZ?T%UH6X: M&.QH\LG.X)210`:7OAF7C&ZS%RF6AZUAF13+O8*F<>3M"21-BN6NI_@,XV7G(=GJ]($/C-JM_DYH&]K8CP]A]$G<@>80I@%. MFSN/P@#^.>81M1JS.+XX&;9ZW>:6.(71>)X+#ROLIM\!/#02:PE^'1Q&[14L M*^6JJ\[U-$?&5?<$^`W7R]H>;1]^^V^:[1G<3-2R^K'#BN--V^#-$_#F]$#Q MIO+&^LX;RM6%N@D-[*IQO"LX9220P:5OQB6C$YML\3W$9:.G[RXN'[:U8$*V M^P))DRMOX99*L56*[.]0Q,H&*'&&9_/;P9O`S> MF(D#5>W[7VV\.:2TB.?#FVWTVZ\NWO2'PV;/X,T3\.;=P>--U^#-$_#F^$#Q MQB1B;#H1H[I0-\$A$QS:7UPV]MKNXO*A6HUF(O3^X?*A6K)EN&SLVMW&Y4.U MKI?ALK&U=Q>7#]OBKW!]>F53EBL,39,:MR>0-*E%)K5HO_#7^&%V"W\/V_>R MB+_&][);^'O8_I8B_AI_R^[A[V'[6!;QU_A8=@M_#]NO8L8H[#P$37'$?D&V M6L41U;F>ODD"VUH26&\]J/>W#W43"-@K:)I`P)Y`TBB2.PK!:JD;U;F>GE$W MMJ9N=->#>F_[4#<":LUGV M@D%\A?BFS:XA@VHGAA\>,MI&RMW:U9N:SVH MM[JG,]+ML;>FNM!O;5]J!OVMN.0K!9[J\CUM$8C,W]M M2^P-[GJ=)L@(DNU#W;"W'8=DA=A;-:ZGU1KA]0P->]LF>^O!_QZ"^G#[4#?L M;>P:$OKSQ(O[E(2.229]Y M*;3:\>24'4)NHYCL/'(?J-BOG#_MI:^G^:7=;.51,3.F]]LZHFQH6*X7`(;` MTP@KA0SJ=YM#!N-:W8!K]25!:1H`5!]$QJ5=9?"84OTJ@>7%M;EMGKEIY/*6 MY')SVZ`T])F;(^,\V17G27/T$LA@IGI4:+;& MRR"#T=@WJK%O'Y1&8Z\^B(S&7F7P&(V]2F"ID,:^^3,/C<:^,QK[\"60P>2V M5&B:V$LC@QD*5J'17"^##,9\VZSYMG50&O.M^B`RYEN5P6/,MVJ"Q4RTV@%P M51\<-5&3S&#U=-L!@_W`Z`JTI^N(V? MVJ# MR,CE*H/'R.4J@:5*K#!XCEZL$EBK) MYN34:F1D46Y'+>-/;!J61R]4'D9'+50:/D#^CSK-[8'2:)G5!Y'1,JL,'J-E5@DLE9'+VSASLWIG;F[ZS`3J:IVY M?=1$4#_FS&G@\8'C&R<2<7::J7#B-!(_\Z]_?*M^YB7PK;GWO3CLMEN#+[]? MO%]81/[M>_C;XU;Z`AO_,KL&SALKO)UUQ\^<>WVMZSHS./@W_\?U!+`P04````"`"E;C%`Z:?*#1,* M``!M?0``%0`<`&YE;F4M,C`Q,3$Q,S!?8V%L+GAM;%54"0`#E<,53Y7#%4]U M>`L``00E#@``!#D!``#M75MSXC@6?I^J^0]>YF6W:@PA='V0#QF`9.4"$T_O2:=RGK']9^?;H-A];[7;E]]]^_NG3/US7N;G^W'QP.BR@ M#)RV^P5"0:?.=P\"$"0$YXE,.>/#F=,B@3<.2(C=.G>4_=4E$GYUU+^^@Y>^ M7SW<.:?5NN,,PG!T4:L]/S]7P>\3X?*H\ZK'AS7'=1<#_Q%#O'`^5.NGU8\K MWSSP,?,OG'>G'^OG7N_4/?.Z7??=&3EW/Y*/X/8:]<;Y^5GC0_W$6VG5$A"# M\Q'VA7-Z4C]U3^INO?%4KU\TWE^\._O/JC0?S03M#T+GG]Z_4/CDO8LMZBEU M_.JTF5=UFD'@/"A1Z3R`!#$!OSKO*9CKP4&=,WE96:$^[8J@RD6_AGTW:@O! MRL\_.;'PQ5325(/GQD*\7OO^Y>[1&\"0N)3)D#`OU5!UEM6T?GY^7HN^C:4E MO9!1+W?ZYI&J(5D"DI#T*_LZ,#(=Y34[W1,#N/U6!L<(!A-0C MP?Y9XNKG0V@&(0B&DV,"^Z2UV?E^\'O471GE<8`J&O#`Q\WVYN\QSO4F\SNH M,M'BPQ%^!4SBV#&8?=(K-K!UZGN?M<5'/]P\;A$YN`WXLVPSGPKPPGT2W>Q\ M/_B_\A#D$U^N_N60LB/ZA-'_1MMUBS/)`^I''ZZ(I++3NQ=X2N/N'ET:(P.0 M\AJD)^A(7<+?H>EY:&*$:!'=8V,/:3[!-+P*N/?7SJJQA?O06K\A@N'`\AY$ M-+=?0V/Z,0_-5AEZ1'@#5/HU3"#@H\APH-(+N!R_#GMS#(?6QLKP".8136#J M@6SV!43?OX8RC"$<6A>/(8Z2VMB5[.O.#',,A]:&.LSP)"/S#>H&N^0S@"OL MIT?#^X"P5]E:"\$X_-Z!7G)DG(:S)X%#$T_ADJ^]>YBC./B:&7=LO22>H<(9*=8H"\Q7#EI\58UU4*\SAE1;P_2Z0`V=R0@4PD)= MIJ`$*LC`17JJS)%$D80>D=THG#"6;I^044U-H1H$H5Q`UE@H>WDQ4D"Z$%Q6M@C7[.`68_#O*.G2`/4([BVS(&4C`V4RJ/#0U3]4<;% MA`1J_VR&+2+$#,WQ/T@P!@UZL[966/'AD+/(D[>[K#A&39&&3H2WZ!#_N^$5I3.;RD5W;`U8Y&QK""?GZ&R*O.9\2LJ=OB*S&X$[(-MX06:,3,:'^KCS4 M,RSN5>)9)F+"\[R4/'/M=@WY%=:X8[UIUEE2"?D2G:FS?ZF*O&V(VPB"W7.`D9?&) MY:WFZ3\3RNZXE%?00YDG,M70*-*##88+%!WVB.ZS*G);B2,L@P@:JR#H)-JVVTR&(BI6R?DM7]JA'?YX).&2F6_V6E)I*3M(U=)6 MFHHGU0*3%K)&W`9VG.+)2M``3LM808FV2[PJ63^&DC\K]/)6TH9I*#F:SI*T MENC<5&)>JC-#V@;R[`+L_-F2W\8.BPG@4:2;)LNOK:0!(<`^^Y^5KT$"=8># M/Z2,XF$1'1OYJC9L;-7YU3DCJ1BEH1)*F7HQ4<"6=5;*+(RYE9Q*NF7M[J7, M)+^,?\[97,K85Z9%M$K81$V:L-:;8K[-[2IESF:KI9G6A\[P+V5Q14'N:^Z9 M)E]E&LDM`V?3P%@IDU@[:<(XE%;*W'TAU12*#Y8$.M*^P\*[+649GB'+32]*4Y]5OEQGL0>%E!G\4:=N-Q_C<31WGMWC MAJZ._?3>KTOK%NG"SEU2."\\.G^B52:'E,@Q)#?M)VTW;SE75Z*QI!H,<+B; MJ3<@K(]#7D-W'=U6<5MZ7L&CSH$QE8-X16:0,&]G/Y'Z_\1P.1/#:R6DQOG? M]79'PV:M.K0(H?6FQ\%I>5,&&A_]`H36VQT'FQ^M$&$=[OQNC,6/DWE7AC%W MH\ZL\)9RK!YC.H_N(*)_$R'0()"W7"R>YM01K8#0H99NH3XL%4`HPQ,MG@E% M$_UJ]DT"6IWS5J"_PMPG8K6%X0E$K5-!0X5$J9YCZ0@C*MBD1!);J1\4`*RC0K MEPHZ+5&NI[C=O/9HBJUG:#)ORI1%WTDM^N,L4<9YF:HK]C9)--HX+5/:?#=E M9/D!B1[JY9\5.2YIEB),W(MDU7PHOWYR7-H7ER>6*>^^3[48URZ6J6Y[-P6E MDYRE+.#>30$ZKZ>4C]5YF2H,W5A-=?M;WU9WKV,[^7&.H>*ULJ4J&]Y9-UMJ M"#0EQ&]:+0433N4L)7[YOIQ;.*,I)'[;\V5[FEU30?R#J<4L7ZTI.?[!=+51 M2U/6F]CVK96-FIS=[G&S7$9KZY5OQ\U=__*VX\9M_MJUX^9A_,:TXZ9A_JZS MX^91Z!5EQTVER*O%CIN)_B5A6MR?EJ_*Q@__`U!+`P04````"`"E;C%`V<[2 MS+(7``"RH0$`%0`<`&YE;F4M,C`Q,3$Q,S!?9&5F+GAM;%54"0`#E<,53Y7# M%4]U>`L``00E#@``!#D!``#M75MSVSJ2?I^J^0]:S\MNU'27^/2C49W MX\,_GQ=N;XT(Q;[W\61P>G[20Y[M.]B;?3SY]M`?/HS&XY-__N.O?_GP'_U^ M[^;ZT_"^-_%<[*'>N/\%!00_]WZWD8N(%:#>H_7L>_[BI7>-IMC#`;3:^XR] M'T\617_OL?^='GST^]7]Y][%Z:#7FP?!\OW9V<^?/T^1,[-(W^=MG]K^XJS7 M[T?]_BND\'WOM]/!Q>G;G6_N_97GO.^]NG@[>&=/+_IO[*>G_JLWUKO^6^LM MZD\O!Y?OWKVY_&UP;N_4&A%D<>(S1P/+L1$766%;5P;MW[\[XM[NE@0XGV!;?)>OU6?AE6)KB]Y3W M^=FW.2,EX/2$)=A?_:A8GWW4A_&X')P^4^?D'ZS##\1WT3V:]CC%[X.7)?IX M0O%BZ:*3S6=S@J8?3SSD(3XX@\'E.:O_MVO?7BV0%T0_+<^Y\0(?840QC#*;G,%FII^QFF=2G9P="N4> M:GY_"&#*LCXFTUOLP7!CR[WS*5]K(]>B%$\Q<@Y&)-E-DYCN+((.'RJ%OH(Y M"K!MN=6CA+W"7Z"A&R#BP>18HRIA[3=>#?TV[N_T\C`'%LU]UX&M^>:/%=,@&5DY"^6\!7R*/0=$E,E/+6.M4.O?-:J]U[?/!Y9='[K^C_IV',P0790 M)=#]QJNA_ZL?(/KH;U?_MDLZ(3/+PW_R[7KD>]1WLD.*ML`\Q$]!U>N;_\XF#6ZZ*Z;ZS<6 M\:!C>H<(G]M-<$S<9]UHF5IH$7L.3+]&:^3Z2ZXX8&J[/ETU@UZ>AKJYL=,] M$/,`"C.V$1W.".+?-\$,:1+JYL5#`+TD-G96MMF9(4]#W=Q@P@PDF;79H&Z@ M2?\%H2MH9XJ#.]?R&ME:EFG`8OCP2ZMFQ&%VUZ]Y"GHO8ULWJB MZ(\5_'JS9G\WLD:$?6[0PM8J"UAP)HY.V^PP_)KSP7+=D]ZFX5U4VUK8"\X< MO#C;E#EC%6JD![IB>J;O]1TTM59NH$;=?O5F:/47%O9*DQK6KI-2WD-_@19/ MB"B2F:A:(XUS:(+8JR?4WW)&C=*L!C;T.ENS(;,:)FB&188\AUDVPD]94[6: M:SA%0!.L[`0A+C-Y^223>QPS1?;IS%^?.0B?L;V,_<(W-69B#*U:?X./O@^A M:X=U?^M:LZ@YUWI"[L>3_>_/:J=GM"+LL'@+V[CE_@\HB#>@'L*FET&:L&C] M5$9C%O8-^COVG5OXC&:0*2[;-)V,1W)4QB6;HW%GVL.Z0V,0='F$9A9OCMIP M',63,[M<<_0]0K,Y9/&OZZ>&;VCL'&\]N5GD)+]OB)Z7$3"`6.X8=O+G_T8O M(KKVRC5&G[]8^!X_!7&[`)VL`G:IPB[$Q,3F56J*\NN-:B.@\7I7=ZF?FEOL M(C*"=3?SB7B4DZ6:HNT>S3"%V>4%7ZV%<&FDB]5/W6@[_H#17<=^STRMR/IX$9(7B#WTO`-WSQN6'/]"=T8S] MBL*.'QN3;5JXT/J='`(1Y*R*F+(Z?F`L:/5R%):=0SM MHO70!`I0#/'R:"#N:30I.IM$TC3KSR![!W#L= MQ)-4UQCNF=73@`0GFN3(10=753P?SI+6XD8MR)+N<:7/9U.+/G&FKVA_9EG+ M\)"&W(!&GZ1/:YN/OV\\.>B=]<*FT6:32QW="@J7/U<>1#<>P'\P996VY[+Y]&(PL0EY`L/_+JK=.::!JS!"H2HB`2D01BZRQ<0#B;[58<4>KC(^8I$I&>7U4'U'=E04:@&9)741/$2CELWS\RA M%T5!,S+ZNTQ-/8C\)2+!"W-#9L[K;//@@EH\@7*KZ,"PM:3L&?A2E&<4U$IO MEF.-H)`>.B7EJR$255F&RDC-QHS6^58+9O`L.(G'%FKS[H[DP>5O2#%&\RZ/ M5`=P%XUYET129I]=4)*6EBWF"_/NC90Q"_2N&*-YSC#*&`76CQBC>5XQRABE M]+H8L7E.,LJ(A=AT^<;HO0G4,5:J!H#=X:5-=G.K>)8+3)TF>\/)&]820DG@>&"R5UQII")7!9/]X\J!S4>IZ>BS M%Q%0;$U*;DU)&\X1!@2H,21]ZC79/U`-F?PN;KZ/8+X)TF!'09G!5!&OF7-<#-5<]5@-:A4^'3%7S%6<#STF[**44XY; MX`J<3,2GQ[]V.[G0DB`@DU$(O[LH2@*W\$FP22,GM.2+G`:K:EZS/QN,TX3P M(77XGALEB"MV<1/6U(PH#(<8KH(Y+*(_XSDO1K)7PP@$8TI7\M1O2AM!N3B' M@%257\W?3H&:[Q>=_U^F3JRXC4E6UH]+"*?07;VQ%M3J/ MHYH]CFJ[Z(NR_K7\IJ_*FTN01OH1=:;1BDVCE9V;VG"U*\<365VC#?>[91#O M:R%MN,PMCS324]IP;5L>97;&`(/O9^6@2ADWVG!)JPPW;YF:>SU;$N;^&C77 M+;4D1$%*#TV*EBG7=:88O_>?'=)B>Z/RA&9L])X+=52`T:135,LJVJ(6OMSY!>.:%GC;V[O,*GX"DSSZE5V@* M91ZM9P&/55K0@3"B8N(]6"YB;Q/M')B*;IDD*YN`B\NML<<>B\`.MLC+A(37 MFU\0Z"/.V%LC&B"1.:=L:SJ0AQL_H_86Y%[HY;J"93Y9LD=!8>*)=F&)BOKQ ML%=-0LJ0$Q/V%8'$$R]"I28T823(8IX'X<^Q=VMAP@\%D^DW;XZ<&;-W$+SF MHGSL@:SA&=ERQK)L@WKP@YH"2V8C3(6@DJ7T4,J6=I@,CTVJB"8AR8+BW3U9 MR"!8=O'J%#`Q648+E:!CASN%-PM)R9^IXO)&45^@XA;7TY*?(4E2SKS)*JDM MH\0^,T54"TKKH#S[9<+\N9]?1P^*-0)A+YHFVZ^UW"8B%]JJ:D$=B_S$]]LGW?R/V/CURAFL8PQGZNF)V.GX2WQS# MB^[VR[:BS]Y89&E)7(!*K@_MX0(5XR[8>=O@7:\"=]]0J-^W_M>+HI96%'>' M3GPB:D/,0$G(J>-J&^(`2B&5-0^JA@BTE@'2=L0V9!`JQ1$EFW@;<@R5W`+* M6^S:D*JH%%.$!]TV)"HJA3C',*0]<5'G>EBM`T1L1C@>UT&QCGX\SH*9!L/C M\1"4V+>.QU%0YG+S>'P%U:X^C\=I,'4I=#QN@H5^.NUW%RQMU.P\"`WS(.1C ME$P&7D36E\0\%@?)%]0WZ`VK?$2Y=?2@^+]5 M:!VDMS[YBGYN\I+!DK\C,.]6GHW"C'S[/@KEVM",\M$7#`)?3D\69W/PM6>E\J_]FXKN>$:/HS>#EZ_.L^HHN)&D M(%VN.@IN)2E(E].<,2-7VNR7TT3MTO>XQL*E^/:XSVP;L6DCND$6BYD2#1F, ME[V!G>E87[X=76A5=#JS=+@,:J+S>F%X27'-2G:GP].@B7>TRMJN!BE>8W:H MBR[Q>(1>QGY04+@^6C*7:V'Q+DHG/)QN][/<72^[;"NI[K(MMC9&)%TZ+"1R)@]QWHQOH6)M?=8:@ M%'LH@%K#_W+Y(3@^/D>B-3P&I^_V!5QMK'L]^:7\*:*4VQ-N$O6R^TW.J46A@4HT%U%_8BVPH(86;V\;>1:LM6\> M72*;9X3-G2SB\EJHE\SV9EA^MY02DV?QS:_3Q3,HT!M-71EN)\H>9Q1&7:]C M"FDU]#7/KWZ`'I;8\Z?3G3U9&H6@NC9LFQ,QMR&$6E2X^8'FR[\23WVIRL;A MND4?SGAG@'T MYAD1&U-A(I<2#56B"Q;W&]UFB!"4;L:@\>)7I24WFE1=TU!5M,T4M&4:Z@J6 M7DX[=:Z\N-M#%EY>*U53+SXV[A>JNN]0#`A<:@H*5T++XQR3\%PL)F&OC([5 M\@@=3*9#)_14R[4%919M(#:F8U%5ND&3IHO/+-"Y,Z!%]:SXUQFAL@ ME>L=D19Q`@>Q.`+7W&`:%9QII\QX',U;C\KX"L(=8JSF"A1YK/*!*S%N39/:#?(6NGIL!S8[8J@5>1#4,.[%)+4B&8(:QKVHIU;D0%##N!=7U8K,!VH8]R*W M6I'E0`WC7FR8_H0'N1/Z#;$U1OQR1$J#5P#7""-WEAJHVL8>L$Y+^ MK*8U(TX[0[0A!Z@"8"D?NC9D`Y5^\ZW81-Z&3)>20YR7E:;MN8>R?%;;D(FR M@@TXQXVI#9DI#]^0I1A@KF%5(N-4*5?$&+NYQM7RV'.=P6+H;5=$ZL^]$_.J M[3I,$Q&H,;?:KOTH>Z+'T`VVOQP.7>`?&Z-OO1ZH[AP<@]=OLI$Q862%A258 M(#9A:3=>F)*HT41@DK:J#=2+8X"JZ"JZ@7[99NA%7ET;C*_:C+%@R]I`?'T, M$,LX^V[P_W8,^%5NIC>XWYA\YYP7>K!=ONFTF*J/"K0R33`,)%2:HP#;`*3+ M\]GE^>SR?':9,\W">T29,[6@5!/9)FY(]@&52S: M;+-X(RK:_MR*`MY\L<@/%'"X=UQ)8W$%3(G+XHZX<)>5[M?(2J=([T'[29=' MK\NCUT+J-:QD&;RWD7'GQ0>+"YGM:'A0=K MBWN64T:.,3Y82V"TZ9ML]:'1!KM/5Q8:;;"?=&6AT0;[-U<6&FVP5W)EH=$& MNQ]7%AJMRQ01`@?X5[%6/+#J_=?V? M=.PYF"`[4'.6KN;J,Q%:R^)B/1N[*)$`^=%GE-X1?XV!"5JU(0NC&S)?86Y![^.O36B?&)YSBWV+)B0NY/L&E-V1EL15/22^Z'-5N,P MBIZ"6Y^$`1HWSS:/W\ZZ(<\NJ&,\KM$2-CYL!5CX,%VB2)O=6*OAV"?HF.V4 M$^\!5M=D"GLE[([!RYUKA8&@R]!@NFF23*9M[67,R MK[@N/N_0PU;S"M-Y*+DS0,C7TX$FEK"WH'2-?!8YNP+2-I(5S@<".!(5]>-A M&VI(&7)BPJ(L5E+("IK0AQ%Z1Y0E.LF%$9?21&E"M&\3C`!)+SD>=<7UC$%# M8%Y\QM83=KD(5P&4KFH&IFLT180@9S2WR$P!4+J>&6AN+4RXYCR9?O/FR)DA MYQJTSC5/:#/V0,M:\7.'-$SI!LW`'UL[PF1(!?JJ0@-FX+LC:`F[6S3Y-L:< M*`@Y2DLDB56J,3VX`T3@Y)"[W>\4T4(CI2LXT*"-'0:X%EG^X42Q2;)%)V3D M6ECHJZ[61B7::-SE3E=7Q/\17DEA[AR9Z6$M6;/]H635S`]0F;),.!G'8,'D M4&C`;'P%>W")A@S"&YLX2HYG5@-FXRLWGGD-&80WP\2JAC.K`;/QE1M/TVS1 M<%+BBNADRFY('.0YHH'+*JF3XD=_:/^QP@0EK%#LJJ[`BJ70@*8`9ALAAYL5 MMLH#"0UN45+F;%S%%77C8>G0"P[UPN)Z0H:7VUDO0;NP>$7AP.$;C9M\2GNY M:K.TS\(Z6L(E&2E7!>07%.Z":4T(2ZV(SM5R&?HK6FYT%3;VICY9A$\*YPM: MV=KZO.'JO"/?]>%(WH:U(7%_4YP1[3AM2.U?-X\D94L;'@%H:CH=8D!NPX," M3?%1]C*Z#2\1-,FS@HOE-CQ&T-A25;,WM^%E@D8$0J[[11L>,=`G"\27:6UX M_J`J%[>=1[TSW@-B2#J($)>YY$)N6.^%5RF92_Q4VE52JT]+*U^1HAX8*[9H"(>9-U(ZL\TUA1\%0<8_6FL2G-%PD$B:U+(7/JV(5=)-5Q1 M<:YI0W:3\LX7*;6I,%BA#>]OU\&-HE"'F"_FGKFJX4L]]J$V/'1>#?]4',&T MOY#>9>2I)G/+(5-(__.G-://%=XQ>G-OXP]"GZOFQO9, M7`_!O9>S(`9L[C%5:%*KCS;%D\P@J[G1)0\) MNY%CK4C:>@C85&"T:@)7K0F`N%GPT=\L2,O=3F0Z(3/+PW]R_'#JI;Z+'?[' ME44Q9=XUB#)^\8]6T#RB]!I1FV`.#U;YSJO84-D&&AZ!]"O7MW^4SRUD5N:, MXXJ6JW?(DYB;Z;/SZZ[9K[N[^^L,!#!R-$IC M7($Z47[;%!.3O8.*RQ]+&K'C4H8Z,=Z)\4Z,UR+&<[;.3@2;+8+O0<$"5C'C M[35:(]?G7A*Q\:X[X3?[M+K\>"0)4JS<">!.`'<"N/4"6'7+Z*2QV=)X9_Q@ M-*/XP^&,H)`7Y82Q,*&W9&<9DD:Z;G<6[L["G2CN1/&O(8KEM]1.$ILMB7DZ M@+GO`A@:!ENQLMVYN!-PY@FX1NF4718B"++U._'=B6\=?IWR$[P3X6:+\-T$ M92P$<+%T_1>$KJ#E*0Y89&`5_FL'O!:F0E_V=JK41'<4[S25[BC>R?)?1I:K M;;"=.#=;G(N>GN[.Y"V1="H#F"U65%KH9'DGRSM9?C2R7&GSZ$2YV:+\8?5$ MT1\K^/5FS?[N!+?1@ON7$FN-/FPA6@8"DH7E.Z'<"64M21"$$[@3P6(1_.&, M=<$>T8`__A]02P,$%`````@`I6XQ0,05=(/B(```2:X!`!4`'`!N96YE+3(P M,3$Q,3,P7VQA8BYX;6Q55`D``Y7#%4^5PQ5/=7@+``$$)0X```0Y`0``U5WK M<^,VDO^^5?L_X.92M4F595OC23+Q)KLEO[*N]8Q\EF>S>U-7*9J$)&PH4@M2 M?N2O/SQ(BJ2(!V4)C?F0C"QU-_OQ:P#$H_'C7Y\7,7K$-"-I\M.;X>'Q&X23 M,(U(,OOIS:?)8#0YO[Y^\]>__/$//_[78(`N+WX>W:%Q$I,$H^O!!YQ3\HS^ M&>(8TR#'Z#YX3I-T\8)N@@<<9^B&)+\]!!D^0/S_$4H3],^SNQOT]G"(T#S/ MEZ='1T]/3X_> MOA_^$$[?#KX/'QX&[[X/?AB\#][CP?1D>/+##]^??#<\#FMG[[[_WSIUNGRA9#;/T=?A-XSX^-L!XQ@V/'&` MKI/P$(WB&-UQT@S=X0S31QP=%I+BP@^(N3O)?GI3,_WY@<:'*9T=,=DG1R7A MFS_^`4GBT^>,-!B>3DKRX=$_/]Q,PCE>!`.29'F0A`U&+JR+=?C##S\@)!OPKP;,PR?#P^O,7_L`?:1KC.SQ%0H?3 M_&6)?WJ3D<4RQF^*[^843[NUB"D]XOQ'"9ZQ`$;\">\'["'R"?]=?/T&<:)/ M=]>5%"%AE1VMLL$L")922,QQ6HIZ&(B/*KTY>4-SBK-T14/`0#$+K"T0T)'DA, MPHO&5B#(K!:KF#>4%WA)<4A$7\$^QYA_&"71:)'2G/PNOK^EZ1+3_.66A21G MOUW^9T66"RW"=B/>+2!WHK,"O]7O!RA8/PE%M4>!,)M.VBI\"NA9=`P!E%A*=-$-\&)+I.SH,ER0-EU!74+H'7K8(*9A4UXN2( M)*A@Z,+4JQ5GK\\/:89O]J'_DI&S=SL4JO5WEA-ZT#0R0&.N1WC7-\!:'GCL MZQO:9@8,]!D`C"!-2VHT'09-_UYE.1]=9%>Q,-FQ%UL4"37)T_"W8@H]K`GU)&GVBB9%GNW/_>"IR;5*0A+CCSB7KPO\ M?>@^/0^R.6M.'DF$H[.73\S"ZV2\Y`LOK)T9A3EY%/-$HXQ!_%O^.62/0RN>G6R@E9;/04'U(&\2=M#N[T=8M3G7[ M!3:,`D>I5=O4IH5"K:&E.O<3">:&J\L\"&3P%[]1$O%_^.+\8Q"+^=#\/*#T MA;W[Z680[7@=(L=*(162^%Q!D$1RT@"OV??2&"[%/-=E$ND:Q+V8@X(R%`(0*\*>G62P'0D@Q]'16$WR"Q9=>Y20C6NX:1HA$IBH!GH5V@,-ANM@T0U)ZTT;'>H M/+-$99L.!)5G/6)\Y@4JM],8%I4*2#11V678[E!Y;HG*-AT(*L][Q/C<"U1N MIS$L*A60:**RR[#=H?+"$I5M.A!47O2(\847J-Q.8UA4*B#11&678;M#Y:4E M*MMT(*B\[!'C2R]0N9W&L*A40**)RB[#=H?**TM4MNE`4'G5(\977J!R.XUA M4:F`1!.578:!S$NEBP616Q'Y'%HJ=N+C)"18M3E'Q^%R-DFMA@HE:PXY!UKG M`9T4,L>@,=]CL!P*1FDB-M]KCXIMTCF&3./A&J"D"1*$T+CH=&H;#9M&`6/@ M-J!C.LGYN5ZQ'':+J3AL8`Z,DA,&)RIU],C)..L!6@84/7(N3T!DBHH"5EH? M``--*)*-5OD\I>3W=<4A=40W.&"`U5;#"E"98$)!Q>4)L%114`"JTW8O@'2= M92M[$!74D`"2*O0!#Q$<7@&GZ74M:&KV>@&8\2KGQ>1X$4#;D-59(*%3TZ,/ M?M(UFU<@ZHB$%DEM\X'AI-W4UR:#@8UVYU<-*J?HJ^/#X^/A>OSS9W1R?'QP M+/_;[,4.T-OC@^].WA^UH-<7P?VEITL5>11?^**G9H]!$SQ-\'SZ;]SA:84/\UG:X_8KJOE8$D.=#IEYSJ[PW@W()J` M[K#.!_0:&T8%.2":#4W@V&=LZ!L]C9W[+\%4G%.^(ED8Q/_"`;U,HHL@;\\> M:DD=%692/=]P=%S2(\Z`&`?B+%`5FTS>+HLW:4W=R7ZS"_R07Z64GW'+7RZ? MPSES73OH&D+7.\XZM5`$GM.*^J=84+,&09(?NMURUD?E\L:,19`$,W'\#$TQ MSOBNHD=,>=GV/"W,`=N.ID5,M1]-;35$OW>!IYAE4C2>LG^+]U[5T*V;UF&/ MUZF`$N.2%J4%,8-*!GOR5NOK>H^GMA,&(NMK+I2!J9$X!<3ZN4H<^'$G29<7 MFS%OF;*C3NP1QZFX<(2-H(H2L]EH1K%H0U5K3?UXW7=U=HHI$5&Q(\:/2@&H MDH`^+=AI`_Q:;2V25-"AM>@#5`A' M]6M[I'BTP?BZ_!7^T-_-Z-PSTO;&Q5O2]GR.452S/U/9[Z[3VU66-+O*G;AV MUQWLEKJH3S+M3#9@!_TJQ??>-@"=M=J[?Y0>X"V$50OI>GBPD^3I&CZ\WL&[ M:2?((^&718^G8I.3W%C;L:?&0.P\DU6:J*!7T*/Q5![H09)%LPMFCVFV?^7= MI(D).VO<:RW>'Y`[=]$8R;T`LW9OC!H1F@TPC@&]>P/@0+VY4Q>%>S/[QSZ/9130:E@10-4?10[PX0<5!/$VLM" ME.O\\,A*-TFT!6;76=776_M?:RU5D8TT+&MNZX= MTLH&B)6XRX#R:PZRLD[&69"1<,3@1>*5>GG&Q.5P#8\JMW MQ7E@SL[>7!ZX!/':$DD9D&M`EO&I+_#8>,0'J)F.ZJKI`>%EVD+`@<5/W/#. M!0D.G]"C/7:K-W7_W8QX?28XNP\>XJY^IOF[HXZF\5!%S$L:]%E0@0TL.QU8 M]C:;ACB*Z,LYZ^-H$%\G$7[^.WY1.7F#SF6$VP_71?H%%<1(4"-&#AIQE8,; MD>\TT!D"["O16#*YQ4;_:C0E4&K%^0YD=Y"A,6Q1FGYA:8%H?X5I^B&J<\EL MXV>G*-&N)!5X@%PW4CFO&>&=G-/N%\LK$F-ZSEYG9RE5]PY-*J>1;3Q:'V!! MBDI:V#!W^K49[4W+7`7]#L\(7QQ)?K8_[FE:4>(`-?+=O MFY'O,`[DG5"!966[F2S MP.4SIB')\"TE(1Y/R^KB78O2*E+76P`4>JBB7U`C0\%M*_1.EWK M>R!FR#*HB0P;N%1+\CIK(1JWJY1B,DOD8=OPY7Y]K]_/+)WX+-$9GC*:^^!9 MT>+TD>"P(>RAE@)JA83J[*R8C(5L&K>(5;W![.L1"#B6FHR321"S_+BEO.!% M_L(+ZN6\Q1?[=Q4AMV1V"$([C13X$U.T[,T\(MDRS7CMCRF:DF=>Q%-Y$[R] M-5L?>W%NDZOTZH>]>F;U<(D/226W6":3U4-&(A+0EW%Q5OT#SN?\BE]^WRE6 M'5_;5AI@VEFJJ,`LEU9@-DOCE=BCP6%;=`]9)=4G\/:,L0[-?;RWDZ$W5R#C M&F"F0UD_83SE916Z!I`ZSK[A."O9.,@XH]OA>'\+ZJ6J MRS+3O/1(Q&N0L$8]EY=).^ZNW!OCY#W#(C>J=PV3]5!]44TG7JUJ1;(Y]VEG MAMOS.>Y?M,HHP'4;O/"53?1$29YCWHM,`0=Q>[3`9:]GA:9V_V:V'2(Y9+U' MKMH5,U->1+9BZA6%W=)$5;?'@M%A>IBUT;T=\`@75\EQIK+BH:)>_*L-,99G M=&F-J[RQ!UH]<2P]`9\Y%R0K7(ZCM7)E'56K.!M$@&637B]5:;4H.I5;"04< MHYJ,O:<7IAFV3Z^MS+O9QC*85+-#ICKI+/P#EW[B2CM1T$=?6E5%[3RI-E10 M`*PH4UZ1`Q\,M/3Z)HJZ[84##(,LSFX#HAJEMJF<`Z1ZM!X8.2=#2T:'2(+" M()O#PV+#MYMP:%H'!`.*`UZS0_Y[G8S",%TE>5:\:*BC8^!S"Q6],FKP"'KT M=51P?L/A$Q3,#$^"&QA*=O%I@=O2'!`XG%WN,^06ZS0H.NI4]O MW(GZN_%:@'?04\3*B+XNQ_@!P+(0[/D\H+,>Z&OS@4*OI8RR:%6).Y+45 M97R9GI@!9"Z/-=5*6"G+^CJ8*//'6+C$4V!4GW5=;O(CY:X"0L4=D>/IIV2. MHQF.+C`EC^Q=BE^YPD;&8HW'/A>M!8(FJ:V6JH41N2;%,#QE@N0UI'R%ZDGN M8*JZC!V2C+M]V,EQBJH]B/?>+9@4[ M*/*V"5X#CKT=M)/]W^O'UAYW1M/?,.7N9E[NV`K7A]/UKG`[M51-6<%L!3NPXIW30=^S1\?1LS3.,(TDV?(S('H9H-!;ZU M.YEU^A#0WW`NZC+=RM?U-!$%1+OF/M3$KN>6E)JH[@\7]$71K]MB_HC7?U65 MS]K?!%)?U>\PBSD)^66GX>:TJP]5P(P8JF:*]+9#-(0?<7X>9/-;FCZ2"$=G M+Y\R'%TG5R0)DI`DLU&8DT?=Y$(/`0X;2GNM--7R^:HB6A8BT,,+FI;L**CX M888+L/:YZB[Z@[/>??3TD=_99QB>;"'(RVPT#6T7]%]=`F`!VR'5J;F=<48^0X54K*62`6:_X.R##@#-8"TR#R5=_S. MN.VZ#)T@+S.P9Y?QI<)UBP[#Y"R/X%MMX-^VP^@2``_7#JULF]7:^0T_WS4< MV`:@0UYMA;D&V90@,&I^*XB8L2UCZ).QC*$HLC:D\@EE5/Q$$ MA+VV+V-\OEJL8G&&]G(ZQ6$^GDKB<2+7>,>4F:<]">C@P4[S9M_6*%?%2@DH MB/Z]DGOOT6J9)NSO=%G6^AY-SM'[X;>#=\>P.>$*;,U$[;`63Z:X--((ZW17J'?-/(W M\OF0#89Q_?C+09-VX&YE_D[V1WQ,FP2>UX MO+'P,G21]MWK[*K9U\"BWM"K#`1!,IT%"?E=^.ZU]@S"%A.8N?\S.F\V^J`._UF2ZS:Y^&J`8[ MM6>*XQJ3U6(1T!?^:CLALX1,2&Y!TY4-=?D\N MQ7,V-!2%VW@;HKX/DADB_HJ%I:-J8J2L,W^+*>$7?S5K\J@`[^KQ+I/8D4V& MFTG#XCDH7XNNS6/!)J]CU#7RV&5XP%*ZJK#**\8R1758W:!UG2QM!935SKRO MCZOU_08*.^T&@\SF=($N9AW4KF&SJ8*Q6JN\'V6&?2G1:G#\!F(4)D-@YC9X M$?W(>'I!^,)P$JE>6;LH'6*EX_&J!J;X710,`ZIGMT-M78%8@X0Z@%6608+W M/AV%_UD1BANW,K,.WW2=>`\!`%`W:Z6ZPI%I,^<%1?VX3MRI/:[3Q1Y[75ED MZ1*0Y*+%N$:<3[\-Z)B*J=9(%`MGH^6NDY,]F5TFE95&*@"6S/(XX@%KK(MR M\:`0[!6A!OSLG0$//:%+-EKE\Y22W]6MC)X)#&IM36PA)HZY9BBH&/V!FBHB M:HAU.L$7:%V+P\4]@EDP`$-*:M$33O(@M6]0:D;`!*.:X;Y`:+S*LSQ((O9" MUR."=2Y@,-54Z8FH=,WI&ZPZHF+"5ML/\``37;)5)"4E&)#$X^W`+4 M@IJ55V"@EX881^)&[*KD+IT$,1Y/M64E+1B=`L^DC1)WDE'N8V%Q$2V?*!*= M3ANU<0X8-C$-25:_NJQ6LA')/>X9:T5Q#HM2VY`V06KE06B,BEUI^AN-E>1` M>*SK8(7")?L?0V%*7UB'G,-N'#'Y7@6A#:.!@#/%HE!X$%]AG'T0`Q=UR+J( MW8*F0P-E\;$DF(G]F&CBP04)>E>W4**R$@@CW1/"ZFT`6A:W>%'JH4!-12)Z M*=Z1!6$HCQ=AOCE@27%(@O*LUE?#@Y-W0]'%??7NNY/NT3__U:OAOSF>+3CJ MG0@!RCLL`G(;,,4NTD5`VKOO-80.`;CY=&6Y00DP08D^2UJ0W?!F#]?!H3`0 M&A*UW5;9V4O]EX[;*;80``0AO596T*J+..#5]UK(`[O[8OLPJO!HX2V?<'I! MLC!.LQ7%IOWI?21X@-0.M7I#%:V%H,]<#!)R]G/\Z1'3AS3#-T"V^IA]&G#: MI)_*+3LY+*AZ:.?+C`V'ZT.">G7ZY\IGR>CX;.".K0`["6@'I^H4H(79,+W, MLMH?9S$EI"1WVG]TZZ"$3D'.7\1:,T)`^\OV;(&[3D"/G6:+KS%Y1\V[W)W/ M7CTOUGOSS:.EGLSN&WU+S=0%ZN6A!28`U20X'2EI.H/763=)XX#^0I(H?4+W M.)PG:9S.0+;6;X?!6O?0QQ$P/467AOKB-'H>IWV&1A%3YK2.^\`VN19!:+:[ M)L-AL/2(DY6RBFKULU.$R&TWU%WREYOLR`>3\4^HX<@ MXP?&%APWFK[*P..^\]0KI`DV9Q-GT3GC0'"B.JOK?O+5ALBU=6E(6&,M=XJ@ M:(5YY95I2J>8Y'Q<4'$5*_*.A\N>6^YH1&&7AK6!A(6_(-K\28B3@)+T4Y(M M<4BF!$?:%1DUO<->0:F$:CQ:T!^@&H<7ZS1&]]>[$[W9(.C!,9,Y^YE!G`8Q MKVH1+4A">/TD4<]1.PRU9':)*RN-5""3S`=H)MG%`#5H"`!%6J]0-6!G[Q40 M#/(&]`)#:9##`6!RU`#U<87N<0M(=H+'^ M^,2K=5V*LB:72:1;5[-5^E+NMC\+8K$3]6N2%/OR0,5`X`!E15?_3V#W#&6"F`IW<,,`#%*]8\C2-,,]D1VR-0PPL#0;5"-ABL<_^I'&-YAT)S MP!0P-#@'%(?EU)[-V+U!"X&SN@+FL7I)[=,0O:/6`M(@A< MW&MV2]6&X8+,#QS=I=X*CPWDZ_32#\2T#@Z]&-(V'L1"C\0M>ANCHT:;S@C_@FRQ)DDZGM6,.O<+F4O_9^(#1,>57PA-E0;5`NL0-K64B]FJ9.S)[+HS,&JT)2:]V8[0*V8;;;Z=>[P# MXQUF`W<2YD7APA$+3O0S5=^`N*4P7\"JU%!]^J6@;Q1O^Y*@:XRP-93USO,0 MVGP/.)958I,?H@#G\-OU.78K)WP-9'A;\$-WB2["K,]\CR3G=ZE][BQ[$\F')9 ME-+<"C_=@GQ)\D[M5#/FM8JBC8,[7T1'I0VH-7S5_MKGVW;MV;\4PUL5)K<6 MX\F;MTY'U7WF*U'CCZ.R40X\DJ_BO$RN7#I"088"?L/@*A8[)/@O765R#[UX M-=_"$_4,+7F@D_.UN#:]FQO=Y%'7(@JW;_F"WN*%[T":"FWY>NYA=]$=)(L> MHL,AOF%O1^_C!EF>8'.W;^.^(G47+^`6[O(-R3L8GVOD>(+@G8S.?07N:P?D M!@_M;L&GMEQ1&,0K+44!C#+92Q.501Q>1CU.IFF=!'8G/RTY'8*)BN5E-!: M57\S&CQU/F31$UN).8:'7*W9-(-I[:2>]\/V<4%G26]WY;M"X[G/; M"JC.<7"R\GH/D`ZVOZ)@O:DJ\%4GVFG+]DUAAL/#6?IX%&$B6T'VH=WXL:]^ MO:?O"P>TK:/-W]WT(!M/%055$F#)!%$7)7NXS'M-@.B:[MG#QA/1Y&< M0=->Q-=)ZK#3ZGJ^*OR,E'=');$7)1-UKJYW.TH[=]+'_(+);)[C:,2&XL$, MRQ7ELR`CX06)5WQ*W%!E;%LIKONI_BHJP%0*0H4DM%Z%ER+J-([#P5"2?!]8);Y\953>]I3-E:A2&WS")[&_V%_O`*RBR/_X? M4$L#!!0````(`*5N,4!GGGEI[1<```RT`0`5`!P`;F5N92TR,#$Q,3$S,%]P M&UL550)``.5PQ5/E<,53W5X"P`!!"4.```$.0$``.U=6W/;.I)^GZKY M#UK/RV[5R([LY.12R4S)LIUR;1*Y;&?F[+ZD:!*2L*%('8!2K//KMP&*HG@! M"5"4`-+,0VQ+#:"_QJW1Z&Y\_.?SW.VM$*'8]SZ=#$Y?G?209_L.]J:?3KX_ M](O#1[Y?W7WKGIX->;Q8$BP]G M9[]^_3I%SM0B?9_7?FK[\[->OQ^U_*^0QP^]WTX'YZ?O=KZY]Y>>\Z'W^OS= MX+T].>^_M9^>^J_?6N_[[ZQWJ#^Y&%R\?__VXK?!*WNGU(B@D#D'^/[0.W\U M..^_&O0'%X^#P8>+-Q]>O_W?76I_L29X.@MZ_VG_%Q"_>M.'$H.$//[>N_7L MT][0=7OWC)3V[D$&9(6/+7 MO_1"X@_/%"<*_+J(R`=GOW_]\F#/T-SJ8X\&EFD(+]U8_(^NRC/DCX8G#Z3)V3?[`&/Q+?1?=HTN,\?`C6 M"_3IA.+YPD4GF\]F!$T^G7C(0US<@\'%*U;^;U>^O9S#\(I^6IYS[04X6-]Z M$Y_,.?J$E:V\'OYMW-]IY6$&(IKYK@.+[?4? M2QCK0\\9@\C(R)\OX"OD46@[9*9.>&H-:X=>^ZA5;_UPXWADT=F-Z_^BMYZ# M";*#.H%F*Z^'_V]^@.BCOYW]VR;IF$PM#__)E^N1[U'?Q0[_X]*BF(XGNYK* MY1(0($JO$+4)7K"/H!^&M@TJ1@`JT1T4M@'F(WH.+EW?_KFW:'3Q?6BI7UO$ M@X;I'2)\;!]#8N(V#XV6*7H6L6<@]"NT0JZ_X(H#IK;KT^5QT,OS<&AI[#0/ MS#R`"HQM1(=3@OCWQQ"&-`N'EL5#`*TD%G9&>]R1(<_#H:7!-C/8R:S-`G4- M5?IKA"ZAG@D.[ES+.\K2JL3&X=<.%WYERFFP?B30M&4SONBQ5P]Y+@X^9Y9/ M%/VQA%^O5^SOH\P189L;M(N=[9;9,Q*P@1AY#CNAA9^RQ@YZ[.0\`5?`88(1 MEQW=?9+L@`T?_'Q.D7TZ]5=G#L)GK$_8+[QSF/$C/)W_#3[Z,82F'=;\C6M- MH^I?EL"8D5>,R.VS9)S]D MNF?X1`-B,<4YP9QZ^VQ^62]*L=E3'D\'G=Z M$E8*=`M+3!&CN>3'XS;L1_%TRJ<['G^/4&T!6_SKPW/#YR@[05E/;AX[R>^/ MQ,]Z!`(@E@MG:?3\WV@MXBM#=S3^_/G<][C^R4]D=+P,F(&:72^(F2TJ="S. MK_RYA3TACYNOC\7-#781&<&\F_I$W,M)JF/Q=H^FF&U77O#-F@NG1IKL\-Q] M05/+#=L>/N.\!3A-<7B>0+-FH_AA/7_RW1R.DM]O^=G5/8, MXIF\E-E0G"VX!;%OS["[U5DGQ)]7T5$B;OR\A;#G$SAU\HM%^'?26\`>0J"B M3R?G)[TE!5Y];JVR]*"5W;4C<,D]*<8V:`&VE,8?@SMO`3B!LA.#O&@1R(R. M',-\W3J8B2-+#/1-"X"F=HL8W&\M`)>O/,08W[8&8T9)CT&^:P%(L64FQOF^ M!3AS-?$MQ$$;U!N90UN,V%2E)_>H'D',G`K,5U`+\11W;P3NU2MSX0G.:@T2?I<^CFXQ\; M[P!Z9ZW9P-HLXZE#:0EQ]1/S7GR3)7*^8.L)NWQBE+(NH-?"O>/@<(3>6=BY M]4;6`@=6VA901JV% M94//83^8@\/*$V7$$+QGNMG.W\8B9B*=EBI8MKQE:LUABB>V?9D)>^"5H.CP>(MAZ^Y7Q# M(M;S:75P?4P''K^IDYB:(H$$-&?Y1OT`D6#/75N80 MS18/OE&+!U!A$1T8MI:4C/DRQ7D.H59^N.5%&MF/+OB4U!D, MT1*4]0(93>"(=MQB6PPSY9;8%^);!1/O_>3A%2^T,4H3+_Y4.W$7S^:";[-_ M?PD'JY`7SDC@!Y;+*0V7A$!7W!6(I/UI*Z]S$R]CE%$+]-$8I8DWA,HH!7:A M&*6)_E'***5TWABSB>Y2RIB%Z%ZW:C4[^"6KGFY6M:SL]GR1):T>>X M0+9DU-)KM$UK%()O?(M.W6A5!U>'Q%,OT38%,.9[E]O(FE"B_B#GS8/T,F(=X*T1:>+@9 M'/IPTQ`?_63613V.[]MQC4`XP";C$'YW493Q;^Z38),S4'@5)?+FK:MZS8ZF MT$]CPKO4X=M%E`VPW/=46%(SHC`*:[@,9C"1_HS'O!A)IH01"&XI79GQO#R`P]:F"E3M3-N-M5!EPT74V^U:T(-#M73!T%)35JHM!M/J?Y/@,+'WQ*;U$$Z!YM)X%,E:I00?" MB(NQ]V"YB+UGM7,8+KNLDBQL`BZN@]QZ[($1[&"+K,75R& M`H(%(UY7!$),TFCA$DX'X1KG34-6BD>JF-XH[DM6R/)R6C+')%DJ&#=YE-IR MW62%*>):0*V#\_QW.(O'?G$9/2A6"-04T3#9?JWE*A2Y4.?T,[--6"Z[4W/F MV.-YY-G&7"QJR<+=-;L)V6`$;_#]&PZVLP`YPQ7TX11]6\Z?$.$VA(T!H25'UN;>A+34 M=49:E=[M.?&9,1,/TR;0J2-]Z^-4*HE)UG*<"6%IKPBDCV)VNJ(JFR*^V,>Z^2S!`Q/_&`U&1*7K=E M7(%?Y$`J]?MJ@S-Q96-SP_R+.X_;9GO<\A&8S/:Q2>`[\N?`T`RV?G[2XP<> MO:DK1&Q]16Q>"2Z1Y,MK>3,O/W5/,:+",GI0_-\RM+C2&Y]\0[\V"1UA0;LC M,.Z6GHW"5*A9SYAJ=6A&^>@+.H%/IR>+LJ3FG, MTN%RN(GL(*7A6.4E:UF=]D]\*%[1:JN['J1X!2J/[T7WFCP^.6<]*"$^'"^Y MT[64O(MJ"P^GV_6L<-7+I^UB`!H5`R`\`8[):&9Y4U@P=PFP9^,%>SN`+S7, M4W$R038LIB'QV`L'Q1B.ED'T")D`^L$;UN85G[/AB%T?0#W@?[FA#6Y[#(VV MJ/`XF789$$CU:,WK2=?F3Q"E_%Q^@U"^^E]"K,=3G^_*=Q81K/P%A+KYW1DI M]'*]^TV!]J]002T:@*@]L3954D*+K[Z-/`OFVG>/+I#-$QH7#A8QO1;N)9,G M&I8N,:7"%%E.B\MTT2A*21\K/*/YGL[#32*`3%M6';G)>YA2'4#<,E'?1Y_I5XZ$L5-@[7/8*U!=O!)J?@ M\)=%G,]$?*2K6)F!N%?,/2C,S[9PL?`@IUJ+<4CYEV/N.T"OGQ&Q,16F1:I0 M42T:;GF[T5V'"$'E:@SJ+WZ16G&A294U#55-RTQ)7::AKF'J%=1SR)D7-[O/ MQ"NJI6[NQ8?A+%'=;8?;@,#AIH2X%EX>9YB$IWTQ"QD:';/E$1H83X9.Z,M6 M:.'*)=7IV%?)/VG7[R\??#.\&JM?G:>2XJI>2+=*/-F;]F1Z[WP#\%8$%R8' M'"M<8&>BXHYRH]"47!.5Q"B*$3`RS83<'?O6`;[P!MSL]4'V!G^+-4>CB:>_ MB8%2^R!,ZTTQ4I/CY0M]"-*[G<`A*0Y^-3DX105IV@TP[DL3YZ4RPA(7^QBM MR7N+/%KY<(D8N8D[C33RFAW<8JF8&.;$;0^77:4W(VA0`FC6(M", MD$!UYXQD-H6L8)HQ=DO=([8]FQ^MTI"\"FHH,Q$Q#7FT3`UE)NJF(9D1U%!F M(GL:\E:9&LI,]%!#'BA30YF)4&K8ZV1%;E&)'`/Y6F-#=A2I-`JR3@^9G)[M MPYR^?FU&GD<%R%)^.YF,CPU&+32*&KWCR#XO6&XF;D:N1>TX9D.'ENA)E,BB];.A4_P25=B:35?63Q&T&0LK^:KFA: MH-*JNX[&\!MA:)&)A&KN&(S6\.0OM"$C?F&PPW,-TV'J>C@NDU9 MV53<96YH$<#VC-_D`A7A.V\ZOBK.R1'XBZ:#5[DQCT"_;CKH>E+HZD%7%`.Q M79;2F3!57X=H;';@.RZ_&0JP#6"Z])Y=>L\NO6>7,-,LO-H39G9I"YN2ME`@ MGP#UW?*<398RI4$'CDW+LEPC#W,0! M75Z%0^95,-*GN0N2KQ0D;Z2S=A=P61YP:;)#PWX!EXV))>T"+JL$7!KM&UI; MP*6)6V3]`9?%VGFQMM&+M8*CV$OV#&R\8V"QU^=O384GZ;7[MJGXZG5Q M-,D/<&31V8WK_Z*WGH,)@LU3PU5.(A20Q?%Y-G91(E/`H\\XO2/^"H,0+M?? M*7)NO>W2,81E0IK2X10&/L%BR'TS[65DNCP((1J#1K8'-HH?G MYG M2X+*GE+>M]IZ7.?04W#CD_"@Y7$(=_7&%8$.QL17FD,F5;8*D MR2Y]]4CL,S3,=H"Q]P"S:SR!/0!6_6!]YUIAG!E/*BJ0I63A6D8C:XNRQA`T M%PVR\82-O;PQ642N2\X[_+#9O,1T%FHD.2#DR^E`$VL.-Z!.CGP6G+<$UC8: M`YSF!'`D"NK'PQ;4D#/DQ(Q%>8VDD)54H0\CM(XH2SA1"".FTL1I8FO?IGD` MEM8%GD_EY8Q!0V!TFIUU**-QDWN-'5)_)_AY2'F;GZYGK"2)9L?5E//^`"5 M*<\TE7,,%@P.A0K,QE>R!E>HR""\L8FC8G_F56`VOFK]652107AS3,=J./,J M,!M?M?XTS<8.)R6NB(XG[&[+09XCZK@\2IT[6F_AD'KIWE(A=LK1.UY%#>C#L.J`D[_0RZ>2-=*LYEFQ$*VZ&?RZG<"KR[PDIO]3%;^ M3M855QBUVX)F9/<_RC98Z#[3^H<`].V`XIO49CPA4)>'X\[CUKE>A?%+U2;' M2]8N#=E[Q%@\)@\6=4>"XLF3<2K)1-6V;:&J6X)RC@Z9,-Y.K,5BS?BC-2-_ MR`'$D'%D,SO=2$LSX%3W(D@EJ"J]:6I&-'P]\A#?]F1BX]NV8-8_H$0"-#GT MOB8IY%VI9Y*^=2,H3W8J[E^9W&LJ+\T&/NQ^9K\R6]VU*&\TRKA+9!(2O9!! MJBA2%9^V3/:CES%(U>THI?%%S7@A_A#R*(M/:L8#\_5(YC"6O6:\6%^/!%4\ M./=ZZKX!JY?LP\3J`O5&UC`Z[)YV8Y_&J9'6+D M16?EMJ\9DED^8F$5N4$(A+4(WZT.+!*\&)'].-\56M%9NE!HUY[3!I%)>QW& M(C,ZU:ST.-GO4BZ6ALE'"1GWW1;E?WQ961&;_)*LHJ]S\F"[&Z+!036RN/8\>-^,_^IN%U7*WXY:.R=3R\)^N>==RAL`P^/P/JEZ]L_JZ?H,RM1DRG!V8*0(G'O"@(6 M9$OI",$X[(!,RN$X;79!3@<.$.H\$?9Z/$E^^6B1GEIX-CGP&M00A:E3Z1N< M.5D\J:\MXL&XI-'C$35H:]77?3$S^5N`F+XM24$[7;/3DCHMR:C-H].261'2PZ3\H4[ M_:;3;PS=.CK])OO\H,*JT"D[!H)Z,==G2@\`SY,=QI2`:">C$:TFZ"9)828KYP_35"EU#S M!`?HH9D2NFTK%9I60_+)XK^6,*OUROV=Z=3=3I5IW&8 M=DLGG*0"EH7TG;[4Z4N'2I(F'*.='L=;8VZ#PQ_\#4$L#!!0` M```(`*5N,4!-#CM`WP@``)A#```1`!P`;F5N92TR,#$Q,3$S,"YXR<;7PN6_5^O56J_#GA]]_N_F;9:%F MXV.MASK,HXR@EG5/E*`S]-4A'A%8$33`,\ZX/T=]9T)\_!X-L20NX@Q]O>VU MT6G11FBBU+12*CT]/16).\;"XL9=T>%^"5E6W-5?85`5=%&T3XM7B98>#YA; M06>G5_:U,SJU+IWAT#J[Q-?6%;XBUJALEZ^O+\L7]HF30-4%P0H<(A<"K:#3 M$_O4.K$MNSRP[4KYO')V^>^D-9_.!1U/%'KG_`'&)^<6(.RE`7B/6LPIHIKG MH9XVE:A')!&/Q"U&GJ09!01CS&2UD"#^5"YR,2Z!7[OT];X=CE;A]]]0:%N9 M#85'EQ#Z2HPIERB3"C.')"`0T?<,A&[68B0[68-$8=G7U]T;*]C%+S*9&I,-.2CF.$D:70&'F"2V(\5\29,.[Q,262 MPOCKM-$N;+M\DG3`&0O\]`%QE2CIODM@9($5$=1)0E_&K6&TC:L6L.38GY?" MQH2U`QFLQ'S97!*G..:/I:@Q?5Q<0M-1T)".H.R12)4."MM6<0J+,5$/V"=R MBIU=98`IP2=,W7'A-\@(!Q[$\"/`'AU1XA805C!U#`-%E@P"]FSR07NYP8QQ M96Y<4C7AT"A=THE8$]\@`M$'ZX'.OE3]J%@3^&;2`J(NM5"+LM%E'&<+AE11@T?^\1&%HKAR4-PA4)?*.'LIK3J M8=5Y`)-MAWTPQP[VG,`SP#:<1^#((@LX%3"+,;4#\CFRS;CH:BS73U*Q#^&; M].N,[BB#F9)BK\NEB:WN82FC+-0Z]@#P+2<@6\XR:+AP!,?USD._TVXU:H-F M`]W6VK6'>A/U/S6;@_Y1RSUKV<4"3"9$41BLK84UZ!?4/U9C;@=M"U+D/7">$21`L5#"AKD.MG;UDBW^17_S^ MH%/_QZ=.N]'L]?^.FO_\W!K\"[UK-.]:]=;@>$O__(38-*6_(CORS/.7^TJ1 MXRJPCY2I8SFY\_B3;#&7"N*H]%5@W2Q;Y:O\*M=K_4_HKMWY2(Y?%4%VWEWKYSPJ'8_+0!`X209C'OSZ@>]C M,4=\A/ITS&!_ZF!(T>R3U31X M(`JUN90(/"'CZJCN'M35;V2Q<"9PSS;((_'XU+RR68S\=FKG]Y:MOKVJ?I][ M6'RAS.5/:!#3G1\S8`\9D!`*9.L3\4@=(FMC04S[=@F0VUFV_J>K^M]SW=+E M3W#S'_7?J_Y]!7HL/1]HVUUG@/S>LC.@O)H!=3RE"GO(='`4?@_"Z\<_>/;# MT9:MZ4\]/B?D%CR/J.IZF&VY;=S*8;;\9VL+@)8==WAC;!= MOE9`4&G"U7:-P`=2X48JGU(QO*F%!8*=7FCG&4`=%G M5HRS]"7+/K7*=G$FW2C$;2)X'NGM(HAQVT:06AB4M^\8H#L]S]5=9K75IFY- MEZGE727B*;GP93W[VG[TUVJI<@W"*DJ/Q+4>?OOB-2$DRL"V#(.SA]TBR2J? M>X4P^LJVNKQ4?9893AHN/GE5("L%;;F"B#'ZX%6=KQ?&Y>H_`8N.-T01%<>9 M,*J%6K]^99^?G=P3?TA$N"O5,_6WU89P<0E+&RLN]S%E+=BFZHU7`>&A5`*> M&ZJ%$?;,VJ&+2"NPIE#N#@S2#414P,:H!TN>GNZ5"/3L!YM3F/\#W?I1\&!: M+81P"O[3HS;5,[4O6,#SBI)KL:S6"M^?`8-+(9K#4? M'H-F-H.UYL-C<)?-8*WYH!@TR%!7&H=O9)LS9X+9F"0H;&@/.83.?_^7!Y6RM-'JG\@TQF9=\&&>B76,56AZ51CI\(U**8D@2W M@OV/EB,]!J28))I]286%GWC:*?/,L`2>2OX=U,ZZ5.I;[*D>'D!/X^] M2X9[(G^/Q7>B3!IVP_`Y,VF7X)MA'V0)Z,17*"W1+WRDEHKR)O"-U$%5;-Q&M&O`5P7R:>C5Z:IXSEP='_"WL! MV95])OBMW0=K,W9*VT%-THGXXEDIB\.JS4%Q&4RH"-?&-0KK30<5^1>B_V<% M>&B%T84G\8=`QZC+])T&]0)H"*>(3J#TADK_MQ4);KN`?^&D&UL550%``.5PQ5/=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`I6XQ0.FGR@T3"@``;7T``!4`&````````0```*2!BG\``&YE M;F4M,C`Q,3$Q,S!?8V%L+GAM;%54!0`#E<,53W5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`*5N,4#9SM+,LA<``+*A`0`5`!@```````$```"D@>R)``!N M96YE+3(P,3$Q,3,P7V1E9BYX;6Q55`4``Y7#%4]U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`"E;C%`Q!5T@^(@``!)K@$`%0`8```````!````I('MH0`` M;F5N92TR,#$Q,3$S,%]L86(N>&UL550%``.5PQ5/=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`I6XQ0&>>>6GM%P``#+0!`!4`&````````0```*2!'L,` M`&YE;F4M,C`Q,3$Q,S!?<')E+GAM;%54!0`#E<,53W5X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`*5N,4!-#CM`WP@``)A#```1`!@```````$```"D@5K; M``!N96YE+3(P,3$Q,3,P+GAS9%54!0`#E<,53W5X"P`!!"4.```$.0$``%!+ 4!08`````!@`&`!H"``"$Y``````` ` end XML 14 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Organization and Summary of Significant Accounting Policies
3 Months Ended
Nov. 30, 2011
Organization and Summary of Significant Accounting Policies
NOTE 1 - Organization and Summary of Significant Accounting Policies

Basis of Presentation

The unaudited financial statements of New Energy Technologies, Inc. as of November 30, 2011, and for the three months ended November 30, 2011 and 2010, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial reporting. Accordingly, they do not include all of the disclosures required by accounting principles generally accepted in the United States for complete financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended August 31, 2011, as filed with the Securities and Exchange Commission as part of the Company's Form 10-K. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the interim financial information have been included. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year.

Organization

New Energy Technologies, Inc. (the “Company”) was incorporated in the State of Nevada on May 5, 1998, under the name “Octillion Corp.” On December 2, 2008, the Company amended its Articles of Incorporation to effect a change of name to New Energy Technologies, Inc. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Sungen Energy, Inc. (“Sungen”), Kinetic Energy Corporation (“KEC”), New Energy Solar Corporation (“New Energy Solar”) and Nakoda Energy, Inc. (“Nakoda”).

Sungen was incorporated on July 11, 2006, in the State of Nevada and is currently inactive.

KEC was incorporated on June 19, 2008, in the State of Nevada and holds the patents related to the Company’s MotionPower™ technology. The Company’s business activities related to the MotionPower™ technology are conducted through KEC.

New Energy Solar was incorporated on February 9, 2009, in the State of Florida and has entered into a License Agreement, an Addendum to the License Agreement, an Option Agreement and a Sponsored Research Agreement with the University of South Florida Research Foundation, Inc.

On March 16, 2011, pursuant to a February 7, 2011, written consent signed by the shareholders owning a majority of the Company’s issued and outstanding shares and a February 24, 2011, unanimous written consent of the Company’s Board of Directors (the “Board”) (collectively the “Consents”), the Company underwent a one-for-three reverse stock split whereby holders of three shares of the Company’s common stock as of March 15, 2011, received one share of its common stock after the reverse stock split, with all fractional shares being rounded up to the nearest whole share.

All share and per share amounts have been retrospectively restated to reflect the one-for-three reverse stock split effected March 16, 2011 and declared effective by the Financial Industry Regulatory Authority (“FINRA”) as of March 21, 2011.

On March 16, 2011, pursuant to the Consents, the Company filed a Certificate of Amendment to its Certificate of Incorporation increasing its authorized shares of common stock, $0.001 par value, from 100,000,000 to 300,000,000.

On August 19, 2011, the Company established Nakoda, a California corporation and wholly-owned subsidiary of the Company, which began operations in September 2011. Nakoda is an energy savings and management corporation that provides a broad range of energy solutions and savings projects with the goal of implementing energy conservation, load management, and reducing building energy consumption in target markets. During December 2011, management initiated a review of the costs associated with start-up operations, financing, and allocation of resources, and suspended all operations associated with Nakoda pending further review.

The Company is a renewable and alternative energy company, actively developing two novel technologies for generating sustainable electricity, one of which harvests solar energy of the sun and artificial light, and the other harvests the available kinetic energy present in moving vehicles. The Company’s proprietary, patent-pending technologies and products, which are the subjects of 43 patent-filings, have been invented, designed, engineered, and prototyped in preparation for further field testing, product development, and commercial deployment.


The Company’s SolarWindow™ technology generates electricity when glass surfaces are sprayed with electricity-generating coatings, creating, semi-transparent, see-through solar cells. If successfully developed, SolarWindow™ could potentially be used on any of the more than 85 million commercial and residential buildings in the United States alone (U.S. Census Bureau, 2007 American Housing Survey & U.S. Energy Information Administration, 2003 Commercial Buildings Energy Consumption Survey).

The Company’s MotionPower™ technology harvests the available kinetic or motion energy of cars, trucks, buses, and heavy commercial vehicles when they slow down before coming to a stop. MotionPower™ converts this captured energy into electricity. If successfully developed, MotionPower™ could potentially be used to harvest kinetic energy generated by any of the estimated 250 million vehicles registered in America (U.S. Department of Transportation Federal Highway Administration, 2008 Highway Statistics), which drive approximately six billion miles on our nation’s roadways every day (U.S. Environmental Protection Agency).

The Company’s product development programs involve ongoing research and development efforts, and the commitment of significant resources to support the extensive invention, design, engineering, testing, prototyping, and intellectual property initiatives carried-out by its contract engineers, scientists, and consultants.

Going Concern

The Company is a development stage company, does not have any commercialized products and has not generated any revenue since inception. The Company has an accumulated deficit of $10,972,777 as of November 30, 2011, and does not have positive cash flows from operating activities. The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates continuation of the Company as a going concern, which is dependent upon the Company’s ability to establish itself as a profitable business.

In its report with respect to the Company’s financial statements for the year ended August 31, 2011, the Company’s independent auditors expressed substantial doubt about the Company’s ability to continue as a going concern. Because the Company has not yet generated revenues from its operations and does not expect to do so in the near future, its ability to continue as a going concern is wholly dependent upon its ability to obtain additional financing. Currently, the Company is seeking additional financing but has no commitments to obtain any such financing, and there can be no assurance that financing will be available in amounts or on terms acceptable to the Company, if at all.

As of November 30, 2011, the Company had cash and cash equivalents of $1,700,110. The Company will remain engaged in research and product development activities at least through November 30, 2012. Based upon its current and near term anticipated level of operations and expenditures, the Company believes that, absent any modification or expansion of its existing research, development and testing activities, cash on hand should be sufficient to enable it to continue operations through August 31, 2012. However, any significant expansion in scope or acceleration in timing of the Company’s current research and development activities, or commencement of any marketing and sales activities, will require additional funds.

If adequate funds are not available on reasonable terms or at all, it would result in a material adverse effect on the Company’s business, operating results, financial condition and prospects. In particular, the Company may be required to delay, reduce the scope of or terminate one or more of its research programs, sell rights to its SolarWindow™ technology and/or MotionPowerTM technology or other technologies or products based upon such technologies, or license the rights to such technologies or products on terms that are less favorable to the Company than might otherwise be available.

In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon achieving a profitable level of operations and on the ability of the Company to obtain necessary financing to fund ongoing operations. These consolidated financial statements do not give effect to any adjustments which will be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying consolidated financial statements.


Summary of Significant Accounting Policies

Principles of Consolidation
 
These consolidated financial statements presented are those of the Company and its wholly-owned subsidiaries, Sungen, KEC, New Energy Solar and Nakoda. All significant intercompany balances and transactions have been eliminated.

Estimates
 
The preparation of the Company’s consolidated financial statements requires management to make estimates and use assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. On an on-going basis, the Company evaluates its estimates. Actual results and outcomes may differ materially from these estimates and assumptions.

Cash and Cash Equivalents
 
Cash and cash equivalents includes highly liquid investments with original maturities of three months or less. On occasion, the Company has amounts deposited with financial institutions in excess of federally insured limits.

Reclassifications
 
Certain reclassifications have been made to prior fiscal year amounts or balances to conform to the presentation adopted in the current fiscal year.

Fair Value Measurement
 
The Company measures fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The Company utilizes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

Level 1. Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. The Company has no assets or liabilities valued with Level 1 inputs.

Level 2. Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. The Company has no assets or liabilities valued with Level 2 inputs.

Level 3. Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company has no assets or liabilities valued with Level 3 inputs.

Fair Value of Financial Instruments
 
The carrying value of cash and cash equivalents, accounts payable, and accrued liabilities approximate their fair value because of the short-term nature of these instruments and their liquidity. Management is of the opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments.

Research and Development
 
Research and development costs represent costs incurred to develop the Company’s technology, including salaries and benefits for research and development personnel, allocated overhead and facility occupancy costs, supplies, equipment purchase and repair and other costs. Research and development costs are expensed when incurred, except for nonrefundable advance payments for future research and development activities which are capitalized and recognized as expense as the related services are performed.

During the three months ended November 30, 2011 and 2010, the Company incurred $130,192 and $57,122 on research and development activities. From inception (May 5, 1998) to November 30, 2011, the Company incurred $2,047,888 on research and development activities.


Stock-Based Compensation
 
The Company measures all employee stock-based compensation awards using a fair value method on the date of grant and recognizes such expense in its consolidated financial statements over the requisite service period. The Company uses the Black-Scholes pricing model to determine the fair value of stock-based compensation awards on the date of grant. The Black-Scholes pricing model requires management to make assumptions regarding the warrant and option lives, expected volatility, and risk free interest rates. See “Note 5 - Capital Stock” and “Note 6 - Stock Options” for additional information on the Company’s stock-based compensation plans.

Income Taxes
 
The Company accounts for income taxes using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credits and loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carry-forwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized. The Company reports a liability for unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return. Estimated interest and penalties are recorded as a component of interest expense or other expense, respectively.

Segment Reporting
 
The Company’s business is considered as operating in one segment based upon the Company’s organizational structure, the way in which the operations are managed and evaluated, the availability of separate financial results and materiality considerations.

Net Income (Loss) Per Share
 
Pursuant to ASC 260-10-45-10, the computation of basic earnings per share (“EPS”) is based on the weighted average number of shares that were outstanding during the period, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted EPS is based on the number of basic weighted-average shares outstanding plus the number of common shares that would be issued assuming the exercise of all potentially dilutive common shares outstanding using the treasury stock method. However, pursuant to ASC 260-10-45-17, the computation of diluted net income per share shall not assume conversion, exercise or contingent issuance of securities that would have an antidilutive effect on earnings per share. Therefore, when calculating EPS if the Company experienced a loss, there is no inclusion of dilutive securities as their inclusion in the EPS calculation is antidilutive. Furthermore, pursuant to ASC 260-10-45-25, options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants (they are in the money). See “Note 2 - Net Loss Per Share” for further discussion.

All share and per share amounts reflect the 1-for-3 reverse stock split declared effective on March 21, 2011 by FINRA.

Recently Adopted Accounting Pronouncements

The Company reviews new accounting standards as issued. Although some of these accounting standards issued or effective after the end of the Company’s previous fiscal year may be applicable to the Company, it has not identified any standards that it believes merit further discussion. The Company believes that none of the new standards will have a significant impact on its consolidated financial statements.

XML 15 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
Nov. 30, 2011
Aug. 31, 2011
Current assets    
Cash and cash equivalents $ 1,700,110 $ 2,320,185
Deferred research and development costs 132,426 156,279
Deferred offering costs 20,000 20,000
Prepaid expenses and other current assets 19,252 49,382
Total current assets 1,871,788 2,545,846
Equipment, net of accumulated depreciation of $1,341 and $463 at November 30, 2011 and August 31, 2011 20,348 927
Total assets 1,892,136 2,546,773
Current liabilities    
Accounts payable 172,290 119,868
Accrued liabilities 4,369 161,009
Total current liabilities 176,659 280,877
Total liabilities 176,659 280,877
Commitments and contingencies      
Stockholders' equity    
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding at November 30, 2011 or August 31, 2011      
Common stock: $0.001 par value; 300,000,000 shares authorized, 20,638,360 shares issued and outstanding at November 30, 2011 and August 31, 2011 20,638 20,638
Additional paid-in capital 12,667,616 12,593,184
Deficit accumulated during the development stage (10,972,777) (10,347,926)
Total stockholders' equity 1,715,477 2,265,896
Total liabilities and stockholders' equity $ 1,892,136 $ 2,546,773
XML 16 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) (USD $)
12 Months Ended 4 Months Ended
Aug. 31, 2008
Aug. 31, 2007
Aug. 31, 2006
Aug. 31, 2007
Class A Warrants
Stock Issued
Aug. 31, 2007
Class B Warrants
Stock Issued
Aug. 31, 2008
Class C Warrants
Stock Issued
Aug. 31, 2007
Class C Warrants
Stock Issued
Aug. 31, 2008
Class D Warrants
Stock Issued
Aug. 31, 2007
Class D Warrants
Stock Issued
Aug. 31, 2009
Class E Warrants
Stock Issued
Aug. 31, 2007
Class E Warrants
Stock Issued
Aug. 31, 2011
Class F Warrants
Stock Issued
Aug. 31, 2009
Class F Warrants
Stock Issued
Aug. 31, 2008
Class F Warrants
Stock Issued
Aug. 31, 2003
Related Party Transactions
Management Services
Stock Issued
Aug. 31, 1998
Related Party Transactions
Management Services
Stock Issued
Aug. 31, 1998
Third Party
Stock Issued
Restricted common stock issued, per share                             $ 0.001 $ 0.001  
Common stock and warrants issued, per share $ 3.00 $ 1.50 $ 0.50                           $ 0.40
Exercise of Warrants, per share       $ 0.50 $ 0.55 $ 1.50 $ 1.50 $ 1.65 $ 1.65 $ 1.80 $ 1.80 $ 3.75 $ 3.75 $ 3.75      
XML 17 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 18 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
3 Months Ended 163 Months Ended
Nov. 30, 2011
Nov. 30, 2010
Nov. 30, 2011
Cash flows from operating activities      
Loss from continuing operations $ (624,851) $ (1,196,956) $ (10,067,909)
Add: loss from discontinued operations     (162,097)
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation 878 116 5,823
Stock based compensation expense 82,675 247,153 7,382,960
Reversal of stock based compensation expense due to forfeiture of stock options (8,243)   (5,382,858)
Change in fair value of warrant liability   689,346 (2,128,331)
Loss on disposal of fixed assets     5,307
Payable written off     (30,000)
Common stock issued for services     3,000
Common stock issued for debt settlement     103,332
Changes in operating assets and liabilities:      
Decrease (increase) in deferred research and development costs 23,853 (42,074) (132,426)
Decrease (increase) in prepaid expenses and other current assets 30,130 1,262 (39,252)
Increase (decrease) in accounts payable 52,422 (27,911) 202,290
Increase (decrease) in accrued liabilities (156,640) 23,201 4,369
Net cash used in operating activities (599,776) (305,863) (10,235,792)
Cash flows from investing activity      
Purchase of fixed assets (20,299) (1,390) (31,478)
Net cash used in investing activity (20,299) (1,390) (31,478)
Cash flows from financing activities      
Proceeds from the issuance of common stock, exercise of warrants and stock options, net   2,474,730 12,367,380
Repayment of promissory note     (155,000)
Proceeds from promissory notes     155,000
Dividend paid     (400,000)
Net cash provided by financing activities   2,474,730 11,967,380
Increase (decrease) in cash and cash equivalents (620,075) 2,167,477 1,700,110
Cash and cash equivalents at beginning of period 2,320,185 502,528  
Cash and cash equivalents at end of period 1,700,110 2,670,005 1,700,110
Supplemental disclosure of cash flow information:      
Interest paid in cash   251 12,393
Income taxes paid in cash         
Supplemental disclosure of non-cash transactions:      
Accrued management fees converted to equity     103,332
Warrants issued for broker commissions     $ 642,980
XML 19 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Nov. 30, 2011
Aug. 31, 2011
Equipment, accumulated depreciation $ 1,341 $ 463
Preferred stock, par value $ 0.10 $ 0.10
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued      
Preferred stock, shares outstanding      
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 20,638,360 20,638,360
Common stock, shares outstanding 20,638,360 20,638,360
XML 20 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
3 Months Ended
Nov. 30, 2011
Jan. 11, 2012
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Nov. 30, 2011  
Document Fiscal Year Focus 2012  
Document Fiscal Period Focus Q1  
Trading Symbol NENE  
Entity Registrant Name NEW ENERGY TECHNOLOGIES, INC.  
Entity Central Index Key 0001071840  
Current Fiscal Year End Date --08-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   20,638,360
XML 21 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 163 Months Ended
Nov. 30, 2011
Nov. 30, 2010
Nov. 30, 2011
Revenue         
Operating expense      
Selling, general and administrative 650,736 449,740 10,388,642
Research and development 130,192 57,122 2,047,888
Total operating expense 780,928 506,862 12,436,530
Loss from operations (780,928) (506,862) (12,436,530)
Other income (expense)      
Interest income     98,582
Interest expense   (251) (12,393)
Loss on disposal of fixed assets     (5,307)
Gain on dissolution of foreign subsidiary     59,704
Foreign exchange loss (32) (497) (86,405)
Change in fair value of warrant liability   (689,346) 2,128,331
Change in contingent liability 156,109   186,109
Total other income (expense) 156,077 (690,094) 2,368,621
Loss from continuing operations (624,851) (1,196,956) (10,067,909)
Loss from discontinued operations     (162,097)
Net loss $ (624,851) $ (1,196,956) $ (10,230,006)
Net loss per common share - basic and diluted $ (0.03) $ (0.06)  
Weighted average number of common shares outstanding - basic and diluted 20,638,360 19,692,018  
XML 22 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Capital Stock
3 Months Ended
Nov. 30, 2011
Capital Stock
NOTE 5 - Capital Stock

Preferred Stock
 
At November 30, 2011, there were 1,000,000 shares of preferred stock (par value $0.10 per share) authorized, of which no shares were issued and outstanding. The Board has the authority to issue such stock in one or more series, to fix the number of shares and to fix and determine the relative rights and preferences of the shares of any such series so established to the full extent permitted by the laws of the State of Nevada and the Articles of Incorporation.

Reverse Stock Split
 
On March 16, 2011, pursuant to a February 7, 2011, written consent signed by the shareholders owning a majority of the Company’s issued and outstanding shares and a February 24, 2011, unanimous written consent of the Company’s Board, the Company underwent a one-for-three reverse stock split whereby holders of three shares of the Company’s common stock as of March 15, 2011, received one share of its common stock after the reverse stock split, with all fractional shares being rounded up to the nearest whole share.

All share and per share amounts have been retrospectively restated to reflect the one-for-three reverse stock split effected March 16, 2011. FINRA declared the reverse stock split effective as of March 21, 2011.

Common Stock
 
On February 12, 2008, the Company consummated the sale of an aggregate of 1,225,000 shares of its common stock and Class F Callable Warrants to purchase up to an additional 1,225,000 shares of the Company’s common stock for aggregate gross proceeds of $3,675,000 pursuant to the terms of a Securities Purchase Agreement dated February 8, 2008 with certain institutional and other accredited investors. The Class F Callable Warrants were exercisable for a period of three years from the date of issuance at an initial exercise price of $3.75 per share.

On September 1, 2009, the Company adopted guidance which is now part of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 815-40, Contracts in Entity’s Own Equity. The Company determined that its Class F Callable Warrants contained a dilutive issuance provision. As a result, the Company reclassified 1,062,833 of its Class F Callable Warrants to long-term warrant liability. The Company’s Class F Callable Warrants were considered derivative financial liabilities and were therefore required to be adjusted to fair value each quarter. During the three months ended November 30, 2010, the warrants were adjusted to their fair value resulting in a $689,346 loss recorded as Other Expense. During the year ended August 31, 2011, investors exercised 1,054,512 Class F Callable Warrants for aggregate gross proceeds of $3,954,375. On February 12, 2011, all unexercised Class F Callable Warrants expired resulting in the adjustment to their fair value to $0.
XML 23 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
MotionPower Technology
3 Months Ended
Nov. 30, 2011
MotionPower Technology
NOTE 4 - MotionPower™ Technology

Veryst Agreement
 
Through KEC the Company is a party to certain agreements with Veryst Engineering LLC, a Boston area engineering and consulting firm with experience in product development and energy harvesting; one dated November 4, 2008, two dated September 9, 2009 and one dated July 6, 2010 (collectively, the “Veryst Agreements”), all relating to the development of the Company’s MotionPowerTM technologies. Pursuant to SEC Rule 24b-2, the Company submitted a request to the SEC for confidential treatment of certain portions of the November 4, 2008 agreement, relating to the payment terms, scope of work and the milestone terms of the agreement, which has been granted. Accordingly, certain terms and provisions of the November 4, 2008, agreement have not been disclosed.

 
During the three months ended November 30, 2011 and 2010, the Company recorded $2,564 and $10,533, respectively, as research and development expense pursuant to these agreements. From inception (May 5, 1998) to November 30, 2011, the Company recorded $560,880 as research and development expense pursuant to these agreements.

Veryst Engineering LLC has successfully completed its contracted services associated with the Veryst Agreements.

Sigma Design Agreement
 
Through KEC the Company continues to be a party to certain consulting agreements with Sigma Design Company, a Middlesex, New Jersey based engineering and design firm, pursuant to which Sigma Design provides ongoing engineering, product development and testing services primarily relating to the development of the Company’s MotionPower™ technology.

During the three months ended November 30, 2011 and 2010, the Company recorded $74,137 and $26,422, respectively, as research and development expense pursuant to these agreements. From inception (May 5, 1998) to November 30, 2011, the Company recorded $487,831, respectively, as research and development expense pursuant to these agreements. The Company continues to utilize Sigma Design Company on a consulting basis to further test, calibrate, and develop the Company’s MotionPower™ technology.
XML 24 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Events
3 Months Ended
Nov. 30, 2011
Subsequent Events
NOTE 8 - Subsequent Events

During December 2011, management initiated a review of the costs associated with start-up operations, financing, and allocation of resources, and suspended all operations associated with Nakoda pending further review.
XML 25 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Options
3 Months Ended
Nov. 30, 2011
Stock Options
NOTE 6 - Stock Options

On October 10, 2006, the Board adopted and approved the 2006 Incentive Stock Option Plan (the “2006 Stock Plan”) that provides for the grant of stock options to employees, directors, officers and consultants. The 2006 Stock Plan provides for the granting of stock options to purchase a maximum of 5,000,000 shares of the Company’s common stock. Stock options granted to employees under the Company’s 2006 Stock Plan generally vest over two to five years or as otherwise determined by the plan administrator. Stock options to purchase shares of the Company’s common stock expire no later than ten years after the date of grant.

The per share exercise price for each stock option is determined by the Board and may not be below the underlying stock price on the date of grant as listed on the OTC Markets Group, Inc. QB tier (the “OTCQB”), or, if the Company’s common stock is not traded on the date of grant, the first day of active trading following the date of grant.

The Company measures all stock-based compensation awards using a fair value method on the date of grant and recognizes such expense in its consolidated financial statements over the requisite service period. The grant date fair value of stock options is calculated using the Black-Scholes option pricing model which requires management to make assumptions regarding option time to expiration, expected volatility, and risk-free interest rates, all of which impact the fair value of the option and, ultimately, the expense that will be recognized over the life of the option.

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for a bond with a similar term. The Company does not anticipate declaring dividends in the foreseeable future. Volatility is calculated based on the historical weekly closing stock prices for the same period as the expected life of the option. The Company uses the “simplified” method for determining the expected term of its “plain vanilla” stock options. The Company recognizes compensation expense for only the portion of stock options that are expected to vest. Therefore, the Company applies an estimated forfeiture rate that is derived from historical employee termination data and adjusted for expected future employee turnover rates. If the actual number of forfeitures differs from those estimated by the Company, additional adjustments to compensation expense may be required in future periods.

A summary of the Company’s stock option activity for the three months ended November 30, 2011 and the year ended August 31, 2011, and related information follows:

   
Number of
Options
   
Weighted
Average
Exercise
Price ($)
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value ($)
 
                     
Outstanding at August 31, 2010
    900,003       1.71          
Grants
    610,002       5.97          
Exercises
    (73,334 )     1.61          
Forfeitures
    (476,666 )     5.59          
Outstanding at August 31, 2011
    960,005       2.49          
Forfeitures
    (10,000 )     3.27          
Outstanding at November 30, 2011
    950,005       2.48  
8.38 years
    7,000  
                           
Exercisable at November 30, 2011
    223,668       4.16  
7.76 years
    4,900  
                           
Available for grant at November 30, 2011
    3,976,661                    

The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of its first quarter of fiscal 2012 and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all option holders exercised their options on November 30, 2011. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock.

 
The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Statements of Operations for the three months ended November 30, 2011 and 2010, and from May 5, 1998 (inception) to November 30, 2011:

               
Cumulative
 
   
Three Months Ended
   
May 5, 1998
 
   
November 30,
   
(Inception) to
 
      2,011       2,010    
November 30, 2011
 
Stock Compensation Expense:
                     
Selling general and administrative expense
  $ 74,432     $ 247,153     $ 2,000,102  

As of November 30, 2011, the Company had $291,188 of total unrecognized compensation cost related to unvested stock options which is expected to be recognized over a period of 3.75 years.

Stock Option Activity During the Three Months Ended November 30, 2011
 
On December 8, 2011, Mr. Pitcher resigned from the Board. Mr. Pitcher had vested 6,667 stock options and forfeited 10,000 unvested stock options. During the year ended August 31, 2011, the Company recorded stock compensation of $27,784 for the amortization of the fair value of his stock option. Since the stock option was forfeited prior to 10,000 options vesting, $8,243 previously recognized for stock compensation was reversed on November 30, 2011, resulting in total stock compensation expense related to Mr. Pitcher’s stock option grant of $19,541. Mr. Pitcher has until December 8, 2013, to exercise his 6,667 vested stock options.

Stock Option Activity During the Year Ended August 31, 2011
 
On April 5, 2011, the Company granted a stock option to purchase up to 10,000 shares of the Company’s common stock at an exercise price of $2.50 per share, the fair market value of the Company’s common stock on the date of grant, to an employee as partial compensation for services. The stock options expire ten years from the date of grant, on April 5, 2021 and vests as follows: (a) 2,000 shares on December 1, 2011, and (b) 2,000 shares on each of April 1 of 2012, 2013, 2014, and 2015. The stock option is further subject to the terms and conditions of a stock option agreement between the Company and the employee. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that employee ceases to be one of the Company’s employee. Upon termination of such service, the employee will have a specified period of time to exercise vested stock options, if any. The grant date fair value of the stock option granted was $23,536, estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 133.0%, risk-free rate of 2.9%, and a term of 7.67 years. During the three months ended November 30, 2011, the Company recognized $4,217 of expense related to this issuance.

On March 21, 2011, the Board appointed Mr. Todd Pitcher and Mr. Peter Fusaro as directors and granted them each a stock option to purchase 16,667 shares of the Company’s common stock at an exercise price of $3.27 per share, the fair market value of the Company’s common stock on the date of grant. The stock options expire ten years from the date of grant, on March 21, 2021 and vests as follows: (a) 6,667 shares on March 21, 2011; (b) 5,000 shares on March 21, 2012; and (c) 5,000 shares on March 21, 2013. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and each of Mr. Pitcher and Mr. Fusaro. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that either Mr. Pitcher or Mr. Fusaro ceases to be one of the Company’s directors. Upon termination of such service, Mr. Pitcher or Mr. Fusaro will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each of the stock options granted to Mr. Pitcher and Mr. Fusaro was $48,850, estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 133.3%, risk-free rate of 2.0%, and a term of 5.75 years. On December 8, 2011, Mr. Pitcher resigned from the Board. Mr. Pitcher had vested 6,667 stock options and forfeited 10,000 unvested stock options. During the year ended August 31, 2011, the Company recorded stock compensation of $27,784 for the amortization of the fair value of his stock option. Since the stock option was forfeited prior to 10,000 options vesting, $8,243 previously recognized for stock compensation was reversed on November 30, 2011 resulting in total stock compensation expense related to Mr. Pitcher’s stock option grant of $19,541. During the three months ended November 30, 2011, the Company recognized $5,496 of expense related to Mr. Fusaro's option grant and $8,243 of other income related to Mr. Pitchers unvested options described above.
 

On January 17, 2011, the Board appointed Mr. Javier Jimenez as a director and granted him a stock option to purchase 16,667 shares of the Company’s common stock at an exercise price of $6.51 per share, the fair market value of the Company’s common stock on the date the stock option agreement was executed by Mr. Jimenez, January 19, 2011. The stock option expires ten years from the date of grant, on January 19, 2021 and vests as follows: (a) 6,667 shares on January 19, 2011; (b) 5,000 shares on January 19, 2012; and (c) 5,000 shares on January 19, 2013. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and Mr. Jimenez. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that Mr. Jimenez ceases to be one of the Company’s directors. Upon termination of such service, Mr. Jimenez will have a specified period of time to exercise vested stock options, if any. The grant date fair value of the stock option granted to Mr. Jimenez was $97,250 estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 133.4%, risk-free rate of 2.0%, and a term of 5.75 years. During the three months ended November 30, 2011, the Company recognized $10,941 of expense related to this issuance.

On December 23, 2010, the Board approved, and the Company granted, a stock option to each of the Company’s three non-employee directors to purchase 16,667 shares of its common stock at an exercise price of $5.94 per share, the fair market value of the Company’s common stock on the date of grant. Each stock option expires ten years from the date the applicable stock option agreement was executed, on January 17, 2021, and vests as follows: (a) 6,667 shares on January 17, 2011; (b) 5,000 shares on January 17, 2012; and (c) 5,000 shares on January 17, 2013. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and each director. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that the director ceases to be one of the Company’s directors. Upon termination of such service, the director will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each of the stock options granted to each of the Company’s three non-employee directors was $89,228 ($267,683 total) estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 134.4%, risk-free rate of 2.8%, and a term of 5.75 years. During the three months ended November 30, 2011, the Company recognized $30,114 of expense related to these issuances.

On December 17, 2010, the Board approved, and the Company granted, Mr. Andrew Farago, the Company's former Chief Operating Officer, a stock option to purchase 500,000 shares of the Company’s common stock at an exercise price of $6.21 per share, the fair market value of the Company’s common stock on the date of grant. The grant date fair value of the stock option granted to Mr. Farago was $2,878,274 estimated using a Black-Scholes model containing the following assumptions: dividend yield of 0%, volatility of 134.4%, risk-free rate of 2.7%, and a term of 6.8 years. The stock option expired ten years from the date of grant and vested in certain blocks based on Mr. Farago achieving certain milestones. Effective as of August 12, 2011, Mr. Andrew Farago resigned as the Chief Operating Officer. On the date of his resignation Mr. Fargo had vested 83,334 as a result of the Company appointing two new directors to its Board, who were recommended by Mr. Farago. During the year ended August 31, 2011, the Company recognized $479,712 as stock based compensation expense related to Mr. Farago’s 83,334 vested options which Mr. Farago has until August 12, 2012, to exercise.

Stock Option Grants During the Year Ended August 31, 2010

On December 15, 2009, the Board approved, and the Company granted, a stock option to each of three of its non-employee directors permitting each to purchase, subject to applicable vesting provisions, 16,667 shares of the Company’s common stock at an exercise price of $1.32 per share, the fair market value of the Company’s common stock on the date of grant. Each stock option expires five years from the date of grant, on December 15, 2014 and vests as follows: (a) as to 6,667 shares on December 16, 2009; (b) as to 5,000 shares on December 16, 2010; and (c) as to 5,000 shares on December 16, 2011. The stock options are further subject to the terms and conditions of a stock option agreement between each director and the Company. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that the director ceases to be a director of the Company. Upon termination of such service, the director will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each 16,667 stock option was estimated at $1.05 each, for a total of $17,500, using the Black-Scholes option pricing model with the following weighted average assumptions: 0% dividend yield, expected volatility of 140.41%, risk-free interest rate of 1.38%, and expected life of 3.25 years. During the three months ended November 30, 2011 and 2010, the Company recorded stock compensation of $1,969 and $5,906, respectively for the amortization of the fair value of these stock options.
 
 
Stock Options Granted to and Forfeited by John A. Conklin
 
On April 1, 2010, the Company entered into a consulting agreement with Mr. John A. Conklin whereby Mr. Conklin provided technical advice, guidance, and management oversight to help advance the commercial development of the Company’s technologies, including but not necessarily limited to its SolarWindow™ and MotionPower™ technologies. In consideration of Mr. Conklin’s services, the Company paid Mr. Conklin $11,000 per calendar month for the first three calendar months of the consulting agreement and $12,444 for each calendar month of service thereafter. In additional consideration of Mr. Conklin’s services, the Company granted Mr. Conklin a stock option to purchase up to 83,334 shares of the Company’s common stock at an exercise price of $1.62 per share, the fair market value of the Company’s common stock on the date of grant. The stock option granted Mr. Conklin vests upon the achievement of specific technical, product development, and/or business milestones. The grant date fair value of the 83,334 stock options was estimated at $1.44 each for a total of $119,975, using the Black-Scholes option pricing model with the following weighted average assumptions: 0% dividend yield, expected volatility of 139.53%, risk-free interest rate of 2.59%, and expected life of five years. Under the terms of the stock option agreement, the stock option agreement terminates and there will be no further vesting of stock options effective as of the date that Mr. Conklin ceases to provide consulting services to the Company. Upon termination of such service, Mr. Conklin will have a specified period of time to exercise vested stock options, if any.

Upon Mr. Patel’s resignation, the Company appointed Mr. Conklin to serve as the Company’s President, CEO, and CFO, effective August 9, 2010. Pursuant to Mr. Conklin’s Employment Agreement dated August 9, 2010, the 83,334 stock options previously granted to him on April 1, 2010, were forfeited. During the year ended August 31, 2010, the Company recorded stock compensation of $13,131 for the amortization of the fair value of the 83,334 stock options. Since the stock option was forfeited prior to any of it vesting, the $13,131 previously recognized for stock compensation was reversed on August 9, 2010, the date of forfeiture, resulting in a net $0 impact to the consolidated financial statements.

Pursuant to Mr. Conklin’s Employment Agreement dated August 9, 2010, the Board granted a stock option to purchase up to 666,666 shares of the Company’s common stock, subject to certain vesting requirements, at an exercise price of $1.65 per share. The stock option expires ten years from the date of grant, on August 9, 2020. Subject to the restrictions and earlier termination provisions set forth in the stock option agreement, the option vests as follows:

1. as to 166,667 shares or such portion thereof as may be determined by the Board at its sole discretion, when one or more of the following items related to the development, production, manufacturing, and sale of any commercially viable product have been successfully executed: (a) completion of final design and/or engineering; (b) the establishment of manufacturing facilities, whether in-house or outsourced; and (c) the initial filing of any product safety approval applications, if required, in order to allow for the commercial sale of products by the Company;

2. as to 166,667 shares upon commencing commercial sales of any of the Company’s products, as reported in the Company's financial statements, whether to retail customers or wholesale customers;

3. 33,333 shares for each calendar year of service in an Executive Position for the next five years (166,667 shares in the aggregate), which shall become exercisable as to 33,333 shares on August 9, 2011 and 33,333 shares on each anniversary thereof through August 9, 2015.

4. as to 166,667 shares when, to the Board’s satisfaction, the Company enters into a favorable business partnership with a third-party commercial organization in the industry segment related to the Company’s product development and sales efforts, under any of the following conditions:

(a) a product development relationship whereby the third-party partner makes a significant financial investment, as determined at the Board’s discretion, directed towards the development of the Company’s products; or
(b) a product development relationship whereby the third-party partner invests significant research and development resources, as determined at the Board’s discretion, directed towards the development of the Company’s products; or
(c) a strategic partnership with the third-party partner where, as determined at the Board’s discretion, such a partnership provides significant business advantages to the Company which it would otherwise not have, whether related to product development, commercial sales, industry position, or business reputation.
 
 
The fair market value of the Company’s common stock on the date of grant was $1.62 per share. The grant date fair value of the 666,666 stock options was estimated at $1.50 each, for a total of $1,008,814, using the Black-Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, expected volatility of 134.81%, risk-free interest rate of 2.21%, and expected life of 7.2 years. During the three months ended November 30, 2011 and 2010, the Company recorded stock compensation of $26,823 and $235,822, respectively for the amortization of the fair value of this stock option.

The following table summarizes information about stock options outstanding and exercisable at November 30, 2011:
 
     
Stock Options Outstanding
   
Stock Options Exercisable
 
           
Weighted
   
Weighted
         
Weighted Average
   
Weighted
 
Range of
   
Number of
   
Average
   
Average
   
Number
   
Remaining
   
Average
 
Exercise
   
Options
   
Contractural
   
Exercise
   
of Options
   
Contractual
   
Exercise
 
Prices
   
Outstanding
   
Life (years)
   
Price
   
Exercisable
   
Live (Years)
   
Price
 
                                       
$ 1.32       50,001       3.04     $ 1.32       35,001       3.04     $ 1.32  
$ 1.65       666,667       8.70     $ 1.65       33,334       8.70     $ 1.65  
$ 2.50       10,000       9.35     $ 2.50       2,000       9.35     $ 2.50  
$ 2.55       33,334       6.78     $ 2.55       19,998       6.78     $ 2.55  
$ 3.27       23,334       9.31     $ 3.27       13,334       9.31     $ 3.27  
$ 4.98       16,667       6.28     $ 4.98       9,999       6.28     $ 4.98  
$ 5.94       50,001       9.14     $ 5.94       20,001       9.14     $ 5.94  
$ 6.21       83,334       9.05     $ 6.21       83,334       9.05     $ 6.21  
$ 6.51       16,667       9.15     $ 6.51       6,667       9.15     $ 6.51  
                                                     
Total
      950,005       8.38     $ 2.48       223,668       7.76     $ 4.16  

In addition to stock compensation recorded for the stock option grants and forfeitures discussed above, the Company recorded stock compensation of $3,115 and $5,425 during the three months ended November 30, 2011 and 2010, respectively for stock options previously granted and vesting over time.

The Company does not repurchase shares to fulfill the requirements of options that are exercised. Further, the Company issues new shares when options are exercised.
XML 26 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Related Party Transactions
3 Months Ended
Nov. 30, 2011
Related Party Transactions
NOTE 7 - Related Party Transactions

A related party is generally defined as (i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

For services rendered in the capacity of a Board member, non-employee Board members received $2,500 during our quarter ended November 30, 2010, and $3,750 per quarter starting in our second quarter ending February 28, 2011. New Board member compensation is pro rated in their first quarter. During the three months ended November 30, 2011 and 2010, the Company incurred $29,100 and $7,500, respectively in cash based Board compensation. Additionally, during the three months ended November 30, 2011 and 2010, the Company incurred $43,392 and $11,331, respectively in stock based compensation related to stock options granted (See “Note 6 - Stock Options” above) for services rendered by non-employee directors of the Company, which is included in professional fees.

March 21, 2011, Todd Pitcher was elected to the Board and received $3,750 per quarter for his Board related services. On May 19, 2011, the Company entered into an Advisory Engagement Agreement (the “Agreement”) with Aspire Clean Tech Communications, Inc., a private corporation wholly owned by Todd Pitcher, Director. Pursuant to the Agreement Mr. Pitcher will provide ongoing corporate advisory and support services - until the parties agree otherwise in writing - in exchange for compensation of $3,500 per month plus reimbursement of business related, out-of-pocket expenses. On July 1, 2011, the Agreement was amended to increase the monthly compensation from $3,500 to $10,000 due to the increased level of time required for Mr. Pitcher to execute his duties. On September 30, 2011 the Agreement was further amended to include the addition of a $1,000 per month health insurance reimbursement retroactively applied to include the month of July 2011.


On December 8, 2011, Mr. Pitcher resigned from the Board and ceased performing services for the Company. The Company paid Mr. Pitcher $30,000 upon receipt of an executed Mutual Termination and Release.

On February 2, 2011, the Company entered into an employment agreement with Mr. Scott Taper pursuant to which Mr. Taper was appointed the Company’s Vice President of Business Development. Pursuant to the terms of the employment agreement, Mr. Taper was entitled to an annual salary of $90,000, which would increase to $100,800 if certain milestone were met, and a stipend of $1,000 per month to cover medical insurance premiums until such time as the Company could provide an alternative medical insurance plan. The employment agreement provides that Mr. Taper’s employment by the Company was “at-will employment” and may be terminated by Mr. Taper or the Company at any time, with or without cause, and for any reason whatsoever, upon written notice to the other. On February 28, 2011, Mr. Taper, resigned as the Company’s Vice President of Business Development.

On February 1, 2011, the Company entered into a consultancy agreement with Mr. Elliot Maza pursuant to which Mr. Maza was appointed the Company’s Chief Financial Officer. Pursuant to the terms of the consultancy agreement, Mr. Maza is entitled to a monthly fee of $7,500. The consultancy agreement provides that Mr. Maza’s engagement is on a part-time basis and is “at-will” and may be terminated by Mr. Maza or the Company at any time, with or without cause, and for any reason whatsoever, upon written notice to the other. On August 31, 2011, Mr. Maza, resigned as the Company’s CFO.

On December 17, 2010, the Company entered into an employment agreement with Mr. Farago pursuant to which Mr. Farago was appointed the Company’s Chief Operating Officer. Pursuant to the employment agreement, Mr. Farago was entitled to an annual salary of $150,000, to increase to $250,000 if the Company consummates either an equity or debt financing or series of financings with net proceeds of at least $7,000,000 and a stipend of $1,000 per month to cover medical insurance premiums until such time as the Company could provide an alternative medical insurance plan. The employment agreement provides that Mr. Farago’s employment by the Company was “at-will employment” and may be terminated by Mr. Farago or the Company at any time, with or without cause, and for any reason whatsoever, upon written notice to the other. Also on December 17, 2010, the Board approved, and the Company granted, Mr. Farago a stock option to purchase 500,000 shares of the Company’s common stock at an exercise price of $6.21 per share, the fair market value of the Company’s common stock on the date of grant. The stock option expires ten years from the date of grant and is subject to various vesting terms. Effective as of August 12, 2011, Mr. Andrew Farago resigned as the Chief Operating Officer. On the date of his resignation Mr. Fargo had vested 83,334 options which Mr. Farago has until August 12, 2012 to exercise.

The law firm of Sierchio & Company, LLP, of which Joseph Sierchio, one of our directors, is a principal, has provided counsel to us since the Company's inception. In July 2008, the Company asked Mr. Sierchio to join the Company's Board. During the three months ended November 30, 2011 and 2010, the law firm of Sierchio & Company, LLP provided $62,175 and $21,638, respectively, of legal services. At November 30, 2011, the Company owed S&C LLP $40,800 which is included in accounts payable.

The Company’s corporate office is located at 9192 Red Branch Road, Suite 110, Columbia, Maryland 21045. On December 1, 2009, the Company entered into a one year sublease agreement with MVP Law Group, P.A., of which the Company's former Chief Executive Officer and President is a founder. Mr. Patel sold this practice and has an “Of Counsel” relationship with MVP Law Group. Rent for this office space is $1,100 per month through November 30, 2011. The Company’s sublease with MVP Law Group, P.A., renewed effective December 1, 2011, for an additional twelve months at $1,100 per month.

All related party transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.
XML 27 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
3 Months Ended 4 Months Ended 12 Months Ended 163 Months Ended
Nov. 30, 2011
Aug. 31, 1998
Aug. 31, 2011
Aug. 31, 2010
Aug. 31, 2009
Aug. 31, 2008
Aug. 31, 2007
Aug. 31, 2006
Aug. 31, 2005
Aug. 31, 2004
Aug. 31, 2003
Aug. 31, 2002
Aug. 31, 2001
Aug. 31, 2000
Aug. 31, 1999
Nov. 30, 2011
Common stock and warrants issued           $ 3,395,955 $ 500,000 $ 500,000                
Dividend paid - spin off of MircoChannel Technologies Corporation             (400,000)                  
Net loss (624,851) (12,326) (3,619,750) (233,136) 1,961,175 (5,721,545) (1,442,769) (157,982) (103,142) (19,787) (97,662) (54,935) (12,904) (12,446) (77,946) (10,230,006)
Comprehensive income                                
Foreign currency translation adjustments         (10,693) 12,504 (1,811)                  
Net loss (624,851) (12,326) (3,619,750) (233,136) 1,961,175 (5,721,545) (1,442,769) (157,982) (103,142) (19,787) (97,662) (54,935) (12,904) (12,446) (77,946) (10,230,006)
Ending Balance 1,715,477 140,674 2,265,896 349,392 2,528,790 2,941,589 1,414,622 207,202 (134,816) (31,674) (11,887) (17,557) 37,378 50,282 62,728 1,715,477
Exercise of stock options     30,800                          
Stock Issued
                               
Comprehensive income                                
Stock based compensation 82,675   2,855,630 661,040 183,312 3,600,303                    
Stock Issued | Third Party
                               
Common stock and warrants issued   150,000                            
Stock Issued | Management Services | Related Party Transactions
                               
Comprehensive income                                
Restricted common stock issued   3,000                 103,332          
Stock Issued | Class A Warrants
                               
Comprehensive income                                
Exercise of Warrants             500,000                  
Stock Issued | Class B Warrants
                               
Comprehensive income                                
Exercise of Warrants             550,000                  
Stock Issued | Class C Warrants
                               
Comprehensive income                                
Exercise of Warrants           10,000 490,000                  
Stock Issued | Class D Warrants
                               
Comprehensive income                                
Exercise of Warrants           11,000 484,000                  
Stock Issued | Class E Warrants
                               
Comprehensive income                                
Exercise of Warrants         12,000   528,000                  
Stock Issued | Class F Warrants
                               
Comprehensive income                                
Exercise of Warrants     3,954,375   1,032,500 218,750                    
Stock Issued Reversal
                               
Comprehensive income                                
Stock based compensation (8,243)   (1,304,551) (478,971) (3,591,093)                      
ASC 815-40
                               
Comprehensive income                                
Cumulative adjustment upon adoption of ASC 815-40       (2,128,331)                        
Comprehensive Income (Loss)
                               
Net loss (624,851) (12,326) (3,619,750) (233,136) 1,961,175 (5,721,545) (1,442,769) (157,982) (103,142) (19,787) (97,662) (54,935) (12,904) (12,446) (77,946)  
Comprehensive income                                
Foreign currency translation adjustments         (10,693) 12,504 (1,811)                  
Net loss (624,851) (12,326) (3,619,750) (233,136) 1,961,175 (5,721,545) (1,442,769) (157,982) (103,142) (19,787) (97,662) (54,935) (12,904) (12,446) (77,946)  
Ending Balance (624,851) (12,326) (3,619,750) (233,136) 1,950,482 (5,709,041) (1,444,580) (157,982) (103,142) (19,787) (97,662) (54,935) (12,904) (12,446) (77,946) (624,851)
Common Stock
                               
Common stock and warrants issued (in shares)           1,225,000 333,333 1,000,000                
Common stock and warrants issued           1,225 333 1,000                
Comprehensive income                                
Ending Balance (in shares) 20,638,360 3,375,000 20,638,360 19,533,533 19,533,533 19,251,533 17,954,866 14,708,200 13,708,200 13,708,200 13,708,200 3,375,000 3,375,000 3,375,000 3,375,000 20,638,360
Ending Balance 20,638 3,375 20,638 19,533 19,533 19,251 17,955 14,708 13,708 13,708 13,708 3,375 3,375 3,375 3,375 20,638
Rounding due to reverse one for three stock split effective March 16, 2011     (3)                          
Exercise of stock options (in shares)     50,318                          
Exercise of stock options     50                          
Common Stock | Stock Issued | Third Party
                               
Common stock and warrants issued (in shares)   375,000                            
Common stock and warrants issued   375                            
Common Stock | Stock Issued | Management Services | Related Party Transactions
                               
Comprehensive income                                
Restricted common stock issued (in shares)   3,000,000                 10,333,200          
Restricted common stock issued   3,000                 10,333          
Common Stock | Stock Issued | Class A Warrants
                               
Comprehensive income                                
Exercise of Warrants (in shares)             1,000,000                  
Exercise of Warrants             1,000                  
Common Stock | Stock Issued | Class B Warrants
                               
Comprehensive income                                
Exercise of Warrants (in shares)             1,000,000                  
Exercise of Warrants             1,000                  
Common Stock | Stock Issued | Class C Warrants
                               
Comprehensive income                                
Exercise of Warrants (in shares)           6,667 326,667                  
Exercise of Warrants           7 327                  
Common Stock | Stock Issued | Class D Warrants
                               
Comprehensive income                                
Exercise of Warrants (in shares)           6,667 293,333                  
Exercise of Warrants           7 293                  
Common Stock | Stock Issued | Class E Warrants
                               
Comprehensive income                                
Exercise of Warrants (in shares)         6,667   293,333                  
Exercise of Warrants         7   293                  
Common Stock | Stock Issued | Class F Warrants
                               
Comprehensive income                                
Exercise of Warrants (in shares)     1,054,512   275,333 58,333                    
Exercise of Warrants     1,055   275 58                    
Additional Paid-in Capital
                               
Common stock and warrants issued           3,394,730 499,667 499,000                
Comprehensive income                                
Ending Balance 12,667,616 149,625 12,593,184 7,058,035 8,661,526 11,025,089 3,790,377 741,624 242,624 242,624 242,624 149,625 149,625 149,625 149,625 12,667,616
Exercise of stock options     30,750                          
Additional Paid-in Capital | Stock Issued
                               
Comprehensive income                                
Stock based compensation 82,675   2,855,630 661,040 183,312 3,600,303                    
Additional Paid-in Capital | Stock Issued | Third Party
                               
Common stock and warrants issued   149,625                            
Additional Paid-in Capital | Stock Issued | Management Services | Related Party Transactions
                               
Comprehensive income                                
Restricted common stock issued                     92,999          
Additional Paid-in Capital | Stock Issued | Class A Warrants
                               
Comprehensive income                                
Exercise of Warrants             499,000                  
Additional Paid-in Capital | Stock Issued | Class B Warrants
                               
Comprehensive income                                
Exercise of Warrants             549,000                  
Additional Paid-in Capital | Stock Issued | Class C Warrants
                               
Comprehensive income                                
Exercise of Warrants           9,993 489,673                  
Additional Paid-in Capital | Stock Issued | Class D Warrants
                               
Comprehensive income                                
Exercise of Warrants           10,993 483,707                  
Additional Paid-in Capital | Stock Issued | Class E Warrants
                               
Comprehensive income                                
Exercise of Warrants         11,993   527,707                  
Additional Paid-in Capital | Stock Issued | Class F Warrants
                               
Comprehensive income                                
Exercise of Warrants     3,953,320   1,032,225 218,692                    
Additional Paid-in Capital | Stock Issued Reversal
                               
Comprehensive income                                
Stock based compensation (8,243)   (1,304,551) (478,971) (3,591,093)                      
Additional Paid-in Capital | ASC 815-40
                               
Comprehensive income                                
Cumulative adjustment upon adoption of ASC 815-40       (1,785,560)                        
Accumulated Other Comprehensive Income (Loss)
                               
Comprehensive income                                
Foreign currency translation adjustments         (10,693) 12,504 (1,811)                  
Ending Balance           10,693 (1,811)                  
Deficit Accumulated During the Development Stage
                               
Dividend paid - spin off of MircoChannel Technologies Corporation             (400,000)                  
Net loss (624,851) (12,326) (3,619,750) (233,136) 1,961,175 (5,721,545) (1,442,769) (157,982) (103,142) (19,787) (97,662) (54,935) (12,904) (12,446) (77,946)  
Comprehensive income                                
Net loss (624,851) (12,326) (3,619,750) (233,136) 1,961,175 (5,721,545) (1,442,769) (157,982) (103,142) (19,787) (97,662) (54,935) (12,904) (12,446) (77,946)  
Ending Balance (10,972,777) (12,326) (10,347,926) (6,728,176) (6,152,269) (8,113,444) (2,391,899) (549,130) (391,148) (288,006) (268,219) (170,557) (115,622) (102,718) (90,272) (10,972,777)
Deficit Accumulated During the Development Stage | ASC 815-40
                               
Comprehensive income                                
Cumulative adjustment upon adoption of ASC 815-40       $ (342,771)                        
XML 28 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
SolarWindow Technology
3 Months Ended
Nov. 30, 2011
SolarWindow Technology
NOTE 3 - SolarWindow™ Technology

Stevenson-Wydler Cooperative Research and Development Agreement with the Alliance for Sustainable Energy

On March 18, 2011, in the Company’s efforts to advance the commercial development of its SolarWindow™ technology, it entered into a Stevenson-Wydler Cooperative Research and Development Agreement (the “CRADA”) with the Alliance for Sustainable Energy, LLC, which is the operator of The National Renewable Energy Laboratory (“NREL”) under its U.S. Department of Energy contract. Under terms of the CRADA, NREL researchers will make use of the Company’s exclusive intellectual property and NREL’s background intellectual property in order to work towards specific product development goals.

Pursuant to SEC Rule 24b-2, the Company submitted a request to the SEC for confidential treatment of certain portions of the CRADA, which has been granted. Accordingly, certain terms of the CRADA have not been disclosed. The disclosure of such confidential information may potentially harm the Company’s competitive position and jeopardize its ability to effectively negotiate future development and sublicensing agreements on preferential terms; and, ongoing relationship with NREL and its ability to negotiate favorable terms with NREL in regards to the ongoing development of the Company’s technologies.

Pursuant to the CRADA, during the three months ended November 30, 2011 and 2010, the Company recorded $33,668 and $0, respectively, as research and development expense. From inception (May 5, 1998) to November 30, 2011, the Company recorded $159,576 as research and development expense.


University of South Florida Research Foundation, Inc. License Agreement, Option Agreement and Sponsored Research Agreement

Through New Energy Solar the Company is a party to a License Agreement, an Addendum to the License Agreement, an Option Agreement and a Sponsored Research Agreement with the University of South Florida Research Foundation, Inc. These agreements provide for the Company’s support of a project relating to the development of the SolarWindow™ technology and grant it an exclusive worldwide commercial license under certain patents relating to the SolarWindow™ technology. Pursuant to SEC Rule 24b-2, the Company has submitted requests to the SEC for confidential treatment of certain portions of these agreements, which have been granted. Accordingly, certain terms of these agreements have not been disclosed.

On July 5, 2011, the Company entered into a letter agreement pursuant to which the Company agreed to reimburse the University of South Florida (“USF”) for filing fees associated with USF’s Provisional Patent and future PCT Applications (the “Applications”) for certain identified technologies (the “Letter Agreement”). Pursuant to the terms of the Letter Agreement, the Company committed to reimburse USF for all documented, out-of-pocket costs directly related to the filing and maintenance of the Applications. In return, USF granted the Company the exclusive right to negotiate a definitive option or license agreement with USF for the technologies underlying the Applications for a period of time after USF files a Provisional Patent for an identified technology (the “Negotiation Period”). Should the Negotiation Period expire without the Company and USF entering into an agreement, the Company could extend the Negotiation Period for an additional period of time by paying USF a one-time payment of a specified sum. If after this additional time the Company and USF fail to enter into an agreement, USF is free to enter into negotiations and license the underlying technologies to a third-party.

During the three months ended November 30, 2011 and 2010, the Company recorded $17,853 and $20,167, respectively, as research and development expense pursuant to these agreements. From inception (May 5, 1998) to November 30, 2011, the Company recorded $308,723 as research and development expense pursuant to these agreements.

University of Illinois at Urbana-Champaign Sponsored Research Agreement

Through Sungen the Company was a party to a Sponsored Research Agreement with the University of Illinois at Urbana-Champaign (“UIUC”) that provided for the Company’s support of the development of a new technology to integrate films of silicon nanoparticle material on glass substrates. This agreement expired on August 22, 2008. As of such date, the Company had advanced a total of $266,709 to UIUC pursuant to the terms of the agreement. Pursuant to the terms of the agreement, the Company was to advance an additional $156,109 to UIUC, which is included in other accrued liabilities at August 31, 2011. The Company had not made the advance as the advance was contingent on the determination as to whether funds previously paid to UIUC under the terms of the agreement had been fully expended. The Company was of the opinion that to the extent these funds were not expended, they are refundable to the Company.

During the three months ended November 30, 2011, The Company evaluated the status of the aforementioned agreement and related contingent liability to UIUC. The Company determined that the $156,109 liability is no longer valid and has been eliminated to other income.

The Company has not recorded any research and development expense pursuant to this agreement since its fiscal year ending August 31, 2008. During the period from inception (May 5, 1998) to August 31, 2011, the Company recorded $422,818 as research and development expense pursuant to this agreement and a $156,109 credit to other income during the three months ended November 30, 2011.
XML 29 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 212 104 1 false 17 0 false 3 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/DocumentDocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/StatementOfFinancialPositionClassified CONSOLIDATED BALANCE SHEETS false false R3.htm 104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 105 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/StatementOfIncomeAlternative CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 106 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) false false R6.htm 107 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) false false R7.htm 108 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/StatementOfCashFlowsIndirect CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 109 - Disclosure - Organization and Summary of Significant Accounting Policies Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock Organization and Summary of Significant Accounting Policies false false R9.htm 110 - Disclosure - Net Loss Per Share Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Net Loss Per Share false false R10.htm 111 - Disclosure - SolarWindow Technology Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/NotesToFinancialStatementsResearchAndDevelopmentDisclosureTextBlock SolarWindow Technology false false R11.htm 112 - Disclosure - MotionPower Technology Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/NotesToFinancialStatementsDevelopmentAndServicesAgreementTextBlock MotionPower Technology false false R12.htm 113 - Disclosure - Capital Stock Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Capital Stock false false R13.htm 114 - Disclosure - Stock Options Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/NotesToFinancialStatementsCompensationAndEmployeeBenefitPlansTextBlock Stock Options false false R14.htm 115 - Disclosure - Related Party Transactions Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock Related Party Transactions false false R15.htm 116 - Disclosure - Subsequent Events Sheet http://www.newenergytechnologiesinc.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock Subsequent Events false false All Reports Book All Reports Warning: The equity rendering routine was not applied to 106 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT). None of the elements feature the 'periodStartLabel' preferred label role. Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Nov. 30, 2010' Process Flow-Through: Removing column 'Aug. 31, 2010' Process Flow-Through: Removing column 'Aug. 31, 2009' Process Flow-Through: Removing column 'Aug. 31, 2008' Process Flow-Through: Removing column 'Aug. 31, 2007' Process Flow-Through: Removing column 'Aug. 31, 2006' Process Flow-Through: Removing column 'Aug. 31, 2005' Process Flow-Through: Removing column 'Aug. 31, 2004' Process Flow-Through: Removing column 'Aug. 31, 2003' Process Flow-Through: Removing column 'Aug. 31, 2002' Process Flow-Through: Removing column 'Aug. 31, 2001' Process Flow-Through: Removing column 'Aug. 31, 2000' Process Flow-Through: Removing column 'Aug. 31, 1999' Process Flow-Through: Removing column 'Aug. 31, 1998' Process Flow-Through: 104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 105 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '4 Months Ended Aug. 31, 1998' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2011' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2010' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2009' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2007' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2006' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2005' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2004' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2003' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2002' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2001' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2000' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 1999' Process Flow-Through: 106 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Process Flow-Through: Removing column '3 Months Ended Nov. 30, 2010' Process Flow-Through: 107 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Process Flow-Through: 108 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS nene-20111130.xml nene-20111130.xsd nene-20111130_cal.xml nene-20111130_def.xml nene-20111130_lab.xml nene-20111130_pre.xml true true